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Abstract 
The canonical Wnt signaling pathway is important during early embryogenesis and has been 
implicated in stem cell self-renewal. The essential intracellular mediator of this pathway is β-
catenin, which is stabilized in the presence of a Wnt ligand and thus becoming translocated into 
the nucleus, where it interacts with TCF/LEF transcription factors to activate target gene 
expression. In addition, β-catenin, as a component of adherens junctions, is involved in 
calcium-dependent cell-cell adhesion. This role of β-catenin during development has not been 
well studied. 
Ablation of β-catenin in mouse leads to developmental arrest at the primitive streak stage of 
embryogenesis. Conversely, stabilization of β-catenin in the mouse zygote results in premature 
epithelial-mesenchymal transition in the epiblast of post-implantation embryo. However, these 
experiments did not address to what extent the phenotypic changes can be attributed to the 
signaling or cell-adhesion function of β-catenin. In order to gain insight into this problem, I 
established a mouse embryonic stem (mES) cell based system. This involved the derivation of 
ES cells deficient for β-catenin (β-catΔ/Δ). These cells showed no defects in self-renewal, but 
during embryoid body differentiation I noticed cell-adhesion defects and increased apoptosis 
around day 5. These differences occur because of alterations in plakoglobin levels, a molecule 
highly related to β-catenin. Moreover, plakoglobin knock-down experiments in β-catΔ/Δ ES cells 
suggest that cell-cell adhesion is most likely essential for proper maintenance of ES cell 
pluripotency. Secondly, in order to distinguish between adhesive and transcriptional functions 
of β-catenin, I re-expressed signaling-defective isoforms of β-catenin in β-catΔ/Δ ES cells. When 
these ES cell lines are differentiated in vitro, the adhesion defect and increased apoptosis 
observed during β-catΔ/Δ ES cell differentiation are rescued. Futhermore, marker analysis of 
differentiated EBs revealed that β-catenin cell-adhesion function is required for endoderm 
lineage formation. In addition, I found that β-catenin cell-adhesion function is essential for 
cellular survival, but not for formation and terminal differentiation of the neuroectoderm 
lineage.  
My studies also revealed that the canonical Wnt pathway is not active in self-renewing mES 
cells in the presence of leukemia inhibitory factor (LIF), but can sustain to some extent 
pluripotency in a LIF-independent manner when activated extrinsically.  
In conclusion, my findings show for the first time the importance of β-catenin cell-adhesion 
function in endoderm and ectoderm formation and suggest that cell-cell adhesion is essential for 
self-renewal of mES cells. 
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Zusammenfassung 
Der kanonische Wnt-Signalübertragungsweg ist wichtig für die frühe embryonale Entwicklung 
und es gibt Hinweise, dass er auch für die Selbsterneuerungskapazität von Stammzellen benötig 
wird. Das essentielle intrazelluläre Molekül dieses Signalweges ist β-catenin, welches in 
Anwesenheit eines Wnt-Liganden stabilisiert und in den Kern transportiert wird, wo es dann 
mit TCF/LEF Tanskriptionsfaktoren interagiert und Zielgene anschaltet. Zusätzlich spielt β-
catenin als Komponente der Adhäsionsverbindungen, in der Kalzium-abhängigen Zell-Zell 
Adhäsion eine Rolle. Diese Funktion von β-catenin während der Entwicklung ist bisher nicht 
gut charakterisiert. 
Mäuse in denen β-catenin deletiert wurde zeigen einen Entwicklungsarrest im Stadium der 
Bildung der Primitivrinne. Im umgekehrten Fall kommt es durch die Stabilisierung des β-
catenin Proteins, d.h. Aktivierung des Signalweges, in der Mauszygote zu einem vorzeitigen 
Übergang vom epithelialen in den mesenchymalen Zustand im Epiblasten des eingenisteten 
Embryos. Diese Experimente geben jedoch keinen Aufschluss darüber, ob die phänotypischen 
Veränderungen durch die Funktion von β-catenin im Wnt-Signalweg oder in der Zelladhäsion 
bedingt sind. Um Einblick in dieses Problem zu gewinnen, habe ich ein zelluläres System 
basierend auf der embryonalen Mausstammzelle (mES) entwickelt. Dafür war es notwendig 
mES Zellen zu generieren, die kein funktionales β-catenin haben (β-catΔ/Δ). Diese Zellen wiesen 
keine Defekte in ihrer Selbsterneuer-ungskapazität auf, aber während der Differenzierung in 
sogenannte emryonen-ähnliche Strukturen zeigten sie einen Zelladhäsionsdefekt und 
gesteigerten Zelltod am Tag 5. Diese Unterschiede sind durch veränderte 
Proteinkonzentrationen von Plakoglobin bedingt, einem Molekül das dem β-catenin Protein 
sehr ähnlich ist. Zusätzlich zeigten Plakoglobin knock-down Experimente in β-catΔ/Δ ES Zellen 
dass die Zelladhäsion wahrscheinlich für die Erhaltung der Pluripotenz der ES Zellen wichtig 
ist. Um zwischen der Funktion von β-catenin im Wnt-Signalweg und der Zelladhäsion zu 
unterscheiden habe ich im zweiten Schritt β-catΔ/Δ ES Zellen generiert in denen β-catenin 
Isoformen exprimiert werden die für die Signal- nicht aber für die Zelladhäsionsfunktion defekt 
sind. Diese Zellen zeigen keinen Zelladhäsiondefekt oder Zelltod während der Differenzierung. 
Außerdem ergab eine Markeranalyse dieser differenzierten Zellen, dass die 
Zelladhäsionsfunktion von β-catenin für die Bildung der endodermalen Keimblattlinie benötigt 
wird. Zudem weisen diese Experimente darauf hin, dass diese Funktion von β-catenin für das 
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Überleben der Zellen benötigt wird, dass sie aber nicht absolut essentiell für die terminale 
Differenzierung der neuroektodermalen Linie ist.  
Meine Studien haben außerdem gezeigt, dass der kanonische Wnt-Signalübertragungs-weg in 
ES Zellen unter Selbsterneuerungsbedingungen in Anwesenheit des Leukemia Inhibitorischen 
Faktors (LIF) nicht active ist, allerdings kann der aktivierte Wnt/β-catenin-Signalweg LIF-
unabhängig die Pluripotenz der ES Zellen in einem gewissen Ausmaß aufrechterhalten.  
Zusammenfassend möchte ich festhalten, dass meine Arbeit zum ersten Mal die Notwendigkeit 
der β-catenin Zelladhäsionsfunktion für die Bildung der endodermalen und z.T der 
ektodermalen Keimblätter zeigt und zudem darauf hinweist, dass Zell-Zell 
Adhäsionsverbindungen für die Selbsterneuerungskapazität der Maus ES Zellen essentiell sind.  
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Abbreviations 
AC Adenylyl cyclase 
AKT1 Protein Kinase B 
APC Adenomatous Polyposis Coli  
aPKC Atypical protein kinase C 
Axin Axis Inhibition protein 
BCL9-2 B-cell lymphoma 9-2 
BIO              GSK3 inhibitor IX 
BMP Bone Morphogenic Protein 
bp base pairs 
BSA Bovine Serum Albumin 
CaCl2 Calcium Chloride 
CAM Cell Adhesion Molecule  
CamKII Ca2+/calmodulin-dependent protein kinase 2 
cAMP Cyclic Adenosine Monophosphate 
CBP Creb-binding protein 
CHIR           CHIR99021  
CKIε Casein Kinase 1 
c-Myc Myc proto-oncogene protein  
CREB cAMP response element-binding factor 
DEPC Diethylpyrocarbonat 
dH2O Deionized water 
Dkk Dickkopf 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO Dimethylsulfoxid 
DTA Diphtheria toxin A 
DTT Dithiothreitol 
Dvl Dishevelled 
EB Embryoid body 
EDTA Ethylenediaminetetraacetic acid 
EMT Epithelial-Mesenchymal Transition  
EpCAM Epithelial Cell Adhesion Molecule 
ERK Extracellular Signal-Regulated Kinase 1 
ES Embryonic Stem (cells) 
EtOH Ethanol 
FCS Fetal Calf Serum 
fl floxed 
Fz Frizzled 
GSK3 Glycogen Synthase Kinase 3 
GTPase Guanosine Triphosphate enzyme  
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HCl Hydrochloric acid 
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
ICAM-1  Inter-Cellular Adhesion Molecule 1 
ICM Inner Cell Mass 
IF Immunofluorescence 
IHC Immunohistochemistry 
iPS induced Pluripotent Stem (cells) 
Jak Janus kinase signal transducer and activator of transcription 
JNK C-Jun N-terminal kinase 
KCL Potassium chloride 
KOH Potassium hydroxide 
LEF lymphoid enhancer binding factor-1 
Lgs Legless 
LiCl Lithium chloride 
LIF Leukemia Inhibitory Factor 
Lrp 5/6 Low-density lipoprotein receptor-related protein 5/6 
M Molar 
MAP1B Microtubule-associated protein 1B 
MAPK Mitogen-Activated Protein Kinase  
MED Mediatior for transcriptional initiation  
MEF Mouse Embryonic Fibroblast 
MEK Mitogen-activated protein kinase kinase 1 
MgCl2 Magnesium chloride 
ml milliliter 
mM millimolar 
mTOR Mammalian Target of Rapamycin 
NaCl Sodium chloride 
NaOH Sodium hydroxide 
NaPi Sodium phosphate 
NFAT Nuclear Factor of Activated T-cells 
ng nanogram 
ON Over Night 
Par Partitioning-defective  
pBARLS      Beta-catenin Activated Reporter, L-Firefly luciferase, S-puromycin selectable 
PBS Phosphate-buffered saline 
PCP Planar cell polarity 
PD03            PD0325901 
PECAM-1 Platelet Endothelial Cell Adhesion Molecule 1  
PFA Paraformaldehyde 
pfuBARLS fuBAR - found unresponsive Beta-catenin Activated Reporter 
PGK Phosphoglycerate kinase 
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PI3K Phosphoinositide 3 kinase 
PKA Protein kinase A 
PKC Protein kinase C 
Pygo Pygopus 
Rac1 Ras-related C3 botulinum toxin substrate 1 
RAP1 small GTPase 
Ror2 Receptor tyrosine kinase-like orphan receptor 2 
rpm revolutions per minute 
RT Room Temperature 
RT-PCR Reverse Transcriptase Polymerase Chain Reaction 
RYK Receptor related to tyrosine kinase 
SDS Sodium Dodecyl Sulfate 
SIPA1L1 Signal-induced proliferation-associated 1 like 1 
Src Avian sarcoma virus transforming gene 
SSC Sodium Chloride-Sodium Citrate buffer 
SSEA-1  Stage-Specific Embryonic Antigen 1 
TAE Tris-Acetate-EDTA buffer 
TBE Tris-Borate-EDTA buffer 
TCF T-cell factor 
TE Tris-EDTA buffer 
Tris Tris(hydroxymethyl)aminomethane 
TSC2 Tuberous Sclerosis Complex 2 
U Units 
UV Ultraviolet 
WB Western Blot 
Wg Wingless (Drosophila) 
WRE Wnt Responsive Element 
WT Wild-type 
β-TrCP  β-Transducin repeat-Containing Protein 
µg microgram 
µl microliter 
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Introduction 
One of the most complex processes in biology is the embryonic development of multicellular 
organisms. It is based on the cross-talk between evolutionary conserved signaling pathways that 
provide necessary cell-cell communication signals. Secreted molecules, such as Wnts, BMPs 
and Hedgehogs, released by one cell population can cause responses in neighboring or distantly 
located cells. The activation of downstream signaling cascades determines the cell fate or other 
differentiation parameters. Strict control of the extracellular ligand release is a very crucial 
cellular process. Insufficient or excess activity can have fatal consequences including severe 
developmental abnormalities or, later, cancer.  
1. Wnt signaling pathway 
The Wnt signaling pathway is a molecular mechanism that evolutionary conserved from worms 
to man (Wodarz and Nusse, 1998). The activation of Wnt signaling is achieved by the 
extracellular Wnt signals that stimulate numerous intracellular transduction cascades including 
canonical (also known as Wnt/β-catenin) and non-canonical signaling pathways. Activation of 
these pathways coordinates wide variety of cellular processes including cell fate decision, 
proliferation, differentiation, apoptosis and migration (Logan and Nusse, 2004). 
1.1. Wnt ligands 
The term Wnt is a combination out of the names of the Drosophila melanogaster segment 
polarity gene Wingless (Wg) and the mouse protooncogene Int-1, which was originally 
discovered as an integration site for mouse mammary tumor virus (Nusse and Varmus, 1982). 
The vertebrate Int-1 was found to be a homolog of the Drosophila Wg and renamed to Wnt-1, 
connecting development to cancer (Rijsewijk et al., 1987). Since the discovery of Wnt-1 in 
early 1980s, 19 Wnt genes in mammals were identified and divided into 12 subfamilies 
according to sequence similarity (Coudreuse and Korswagen, 2007). Additionally, Wnts were 
classified into the “canonical” (including Wnt1, Wnt3a and Wnt8) and “non-canonical” 
(including Wnt5a and Wnt11) classes, depending on the activation of β-catenin-dependent and 
β-catenin-independent signaling cascades respectively. However, recent discoveries 
demonstrated that this classification is not absolutely correct (van Amerongen et al., 2008). Wnt 
activities are likely to depend on receptor complexes on the membrane, presence of specific 
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signaling molecules and cofactors in the cell. As such the “non-canonical”, Wnt5a is shown to 
activate or inhibit β-catenin in different studies (He et al., 1997; Mikels and Nusse, 2006; Yang 
et al., 2009). Another example is Wnt11, which originally has been shown to regulate cell 
movements in Xenopus and Zebrafish gastrulation, and neural tube formation via non-canonical 
Wnt signaling pathway (De Calisto et al., 2005; Tada et al., 2002). However, recent studies 
demonstrated that Wnt11 activates the Wnt/β-catenin pathway in dorsal/ventral axis formation 
(Tao et al., 2005). Moreover, Wnt11 can form a complex with Wnt5a to activate canonical and 
non-canonical Wnt signaling via a tyrosine sulfation mechanism in Xenopus axis formation 
(Cha et al., 2008; Cha et al., 2009). Taken together, certain Wnts (if not all) can activate 
multiple mechanisms, most likely by activating different receptor complexes on the membrane. 
1.2. Non-canonical Wnt signaling pathways 
In contrast to the canonical Wnt pathway, which signals through β-catenin, the so-called “non-
canonical” Wnt pathways do not involve β-catenin transcriptional function (Semenov et al., 
2007). Non-canonical pathways are very diverse and in most cases are not well characterized. 
They are classified, as listed in the following, into several groups according to receptor complex 
on the membrane: 
A) In the Wnt/PCP pathway, binding of Wnt5a or Wnt11 to Fz receptor leads to activation 
of Dvl and small GTPases (Klein and Mlodzik, 2005; Wang and Nathans, 2007). However, 
there can be some exceptions in PCP signaling in different organs: this pathway can be 
activated in a ligand-independent way in the Drosophila wing and eye imaginal disc 
epithelia, via graded activity of the Fz receptor, which determines proximo-distal 
orientation of the wing hairs and mirror-imaged patterning of ommatidia, respectively 
(Chen et al., 2008a); (Seifert and Mlodzik, 2007). 
B) In the Wnt/Ca2+ pathway, binding of Wnt ligands (e.g. Wnt5a) to Fz leads to activation 
of heterotrimeric G-proteins and PLC resulting in an increased Ca2+ concentration and 
activation of downstream effectors, such as PKC, NFAT or CaMKII (Kohn and Moon, 
2005). 
C) In the Wnt/Ror2 signaling pathway, Wnt5a interaction with the Ror2 receptor leads to 
activation of PI3K-JNK pathway (Schambony and Wedlich, 2007). 
D) Wnt/RAP1 signaling is activated by Wnt8 binding to Fz, which triggers activation of 
CKIε, which can phosphorylate SIPA1L1 and enhance Rap1 activation. This pathway 
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regulates actin cytoskeleton organization and cell-cell adhesion during vertebrate 
gastrulation (Tsai et al., 2007). 
E) In Wnt/GSK3 signaling, Dvl inhibits and activates GSK3 and JNK phosphorylation of 
MAP1B, respectively, resulting in increased microtubule stability during axonal 
remodeling (Salinas, 2007). 
F) In Wnt/PKA signaling, a Wnt1/Wnt7a complex binds to Fz and activates G protein and 
AC resulting in increased cAMP levels, which leads to activation of PKA and CREB for 
instance in tumorigenesis of endocrine tissues (Rosenberg et al., 2002). 
G) In Wnt/aPKC signaling, Wnt/Fz interaction via Dvl induces aPKC activation and leads 
to inhibition of the Par1/MARK2 kinase by phosphorylation, regulating axon formation via 
microtubules assembly (Zhang et al., 2007). 
H) In the Wnt/RYK signaling, membranous RYK binds to Wnt and regulates axons or cell 
migration in Drosophila and mice, involving probably Src kinase as a downstream factor. 
This pathway does not involve any Wnt/β-catenin signaling components apart of Wnts 
(Bovolenta et al., 2006). 
I) In Wnt/mTOR signaling, Wnt/Fz/Lrp5/6 interaction results in inhibition of GSK3 
phosphorylation of TSC2, thereby activating mTOR-mediated translational regulation in 
tumorigenesis. (Inoki et al., 2006). 
Taken together, the presence of specific receptor-ligand pairs at the cell membrane directs 
signaling outcome. Moreover, such classification is not absolutely strict, as these pathways can 
overlap or intersect with one another.   
1.3. The canonical Wnt pathway 
Since the first discovery of Wnt proteins 27 years ago the canonical Wnt (also known as Wnt/β-
catenin) pathway has been extensively studied and is so far the best understood Wnt pathway. 
The existing structural and molecular data has provided detailed information about the 
sequential steps in the pathway. However, some of the data are controversial and there are still 
many unanswered questions. In the following I will introduce key components and summarize 
the up-to-date features of the canonical Wnt signaling cascade.   
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1.3.1. β-catenin and plakoglobin 
The canonical Wnt pathway involves a key mediator – β-catenin (or Armadillo (arm) in 
Drosophila), which as a component of adherens junctions also plays a role in calcium-
dependent intercellular adhesion (Gavert and Ben-Ze'ev, 2007). β-catenin or Arm protein was 
first discovered in Drosophila as a product of segment polarity gene armadillo (Nusslein-
Volhard and Wieschaus, 1980). Later it was shown to play a role in the cell-cell adhesion 
(Kemler, 1993; Ozawa et al., 1989). The core region of β-catenin contains 12 arm repeats (Fig. 
1), which bind to Wnt pathway components (APC and TCF/LEF) and components of adherens 
junctions (E-cadherin and α-catenin). The phosphorylation sites for the serine/threonine kinases 
GSK and CKI are located in the amino-terminal domain (NTD) of β-catenin, while the 
transactivator domain is located in the carboxyl terminal domain (CTD). Crystal structure of β-
catenin full-length protein has been resolved recently and a new element has been found 
following 12 arm repeats, a C-helix, being involved in transcriptional activity, but not in cell-
cell adhesion (Xing et al, 2008). The function of β-catenin protein in cell-cell adhesion and Wnt 
signaling will be discussed later. 
                    
Figure 1 – Structure and interactions of β-catenin protein 
 
Plakoglobin (or γ-catenin) is a close homologue of β-catenin and also contains 12 arm repeats 
flanked by N-terminal and C-terminal domains. Similar to β-catenin it can be found in  
adherens junctions and participates in intercellular adhesion (Sacco et al., 1995). Unlike β-
catenin, plakoglobin is also a component of another type of intercellular junctions, known as 
desmosomes, where it interacts with desmoglein and desmocollin (Cowin et al., 1986). Several 
studies suggest that plakoglobin is capable to participate in the Wnt pathway. However, so far 
the mechanism by which plakoglobin becomes transcriptionally active is unknown. A signaling 
role for plakoglobin was first described in Xenopus overexpression experiments, where, similar 
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to Wnt/β-catenin pathway activation, it caused axis duplication (Karnovsky and Klymkowsky, 
1995). Furthermore, plakoglobin transcriptional activity was demonstrated in mammalian F9 
cells that lack β-catenin (Maeda et al., 2004). However, deletion studies of plakoglobin in 
mammalian cells revealed that β-catenin and plakoglobin have differential nuclear translocation 
and transactivation potentials (Simcha et al., 1998; Zhurinsky et al., 2000b). While plakoglobin 
has been shown to compete with β-catenin for binding to TCF-4 or LEF-1 in different 
mammalian cell lines (Miravet et al., 2002; Zhurinsky et al., 2000a), the work in F9 cells 
deficient for β-catenin implies that plakoglobin is insufficient for LEF/TCF-dependent 
transcriptional activation by Wnt3a stimulation (Shimizu et al., 2008). It has to be noted that 
involvement of plakoglobin in the Wnt signaling machinery was demonstrated only upon 
plakoglobin overexpression and is not based on in vivo data. Thus, up to now it is controversial 
whether endogenous plakoglobin participates in the canonical Wnt pathway.  
1.3.2. The canonical Wnt pathway step by step 
The crucial events of the canonical Wnt signaling are: 1) activation by Wnt ligands at the cell 
surface; 2) tight control of cytosolic β-catenin levels, which is achieved by 
activation/inactivation of Axin, a component of the destruction complex in the cytoplasm and 3) 
regulation of β-catenin nuclear function (Fig. 2B). 
In the absence of a Wnt ligand (Fig. 2A) β-catenin participates in adherens junctions, while 
cytosolic β-catenin is targeted for degradation by the 26S proteasome via the Axin complex 
(Kimelman and Xu, 2006). How β-catenin being recruited to and leaves the Axin complex is 
currently not well understood. The Axin complex is composed of the two scaffolding proteins 
AXIN1 and APC, and two kinases CK1 and GSK3 (Fig. 2A). The active Axin complex enables 
N-terminal phosphorylation of β-catenin first at serine 45 by CKI, followed by threonine 41, 
serine 37, and serine 33 phosphorylation by GSK3. Probably, concomitantly APC becomes 
phosphorylated on its 20 aa repeats by CK1 and GSK3 (Liu et al., 2006; Xing et al., 2003). This 
causes displacement of β-catenin from the Axin complex. Indeed, the phosphorylation of β-
catenin at serine 37 and 33 exposes β-catenin protein for ubiquitination by the E3 ubiquitin 
ligase β-TrCP and 26S proteasome mediated degradation.   
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Figure 2 - The “off” and “on” states of the canonical Wnt signaling pathway 
(A) In the absence of WNT signaling, (B) Activation of Wnt signaling cascade by Wnt ligand binding to Fz/Lrp5/6 
receptors on the membrane (from (Staal et al., 2008)). Explanations can be found in the text. 
It is still not entirely clear how Wnt ligands induce the inhibition of the Axin complex. In the 
current model (Fig. 2B) binding of Wnt proteins to Fz receptor and co-receptors LDL-receptor 
protein 5 and 6 (LRP5/6) leads to the formation of a Fz/LRP5/6 complex and phosphorylation 
of LRP5/6 (Tamai et al., 2004). The phosphorylation of LRP5/6 is a key event of Wnt 
activation and it is carried out by GSK3 and CK1 (Zeng et al., 2005). Subsequently, Dvl is 
recruited to the C-terminus of Fz and facilitates together with phosphorylated LRP5/6 the 
translocation of Axin to the cell membrane (Cliffe et al., 2003; Wallingford and Habas, 2005; 
Wong et al., 2003). However, another model proposes that Fz-Dvl recruitment of the Axin-
GSK3 complex initiates LRP6 phosphorylation by GSK3 (Zeng et al., 2008). As a consequence 
of the Axin complex localization to the cell membrane, Axin cannot be phosphorylated, thus 
preventing β-catenin phosphorylation leading to its accumulation in the cytoplasm. 
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The next step in the canonical Wnt signaling cascade is the translocation of stabilized β-catenin 
from the cytoplasm to the nucleus. The exact mechanism of β-catenin shuffling to the nucleus is 
still not well understood. An earlier study suggested that β-catenin can enter the nucleus 
interacting directly with nuclear pore complex (Henderson and Fagotto, 2002). A recent very 
elegant study, however, demonstrated that β-catenin stabilization induced by Wnt is not 
sufficient for its nuclear localization (Wu et al., 2008). Here, a new mechanism was proposed 
involving Rac1-mediated JNK2 activation by Wnt3a triggering β-catenin phosphorylation at 
serine residues 191 and 605 leading to nuclear translocation (Wu et al., 2008).  
When stabilized β-catenin enters the nucleus and interacts with TCF/LEF transcription factors 
to activate target gene expression. While in Drosophila and C. elegans, this is mediated by a 
single TCF gene, four TCF/LEF transcription factors exist in the mammalian genome: TCF1, 
LEF1, TCF3 and TCF4 (http://www.stanford.edu/~rnusse/axindshtcf/tcf2.html). They bind to a 
specific Wnt responsive element (WRE) on the DNA (Fig. 3). Nevertheless, TCF/LEF 
molecules can exert different responses on target gene expression: TCF1 and TCF4 can act as 
repressors or activators; LEF1 is primarily acting as an activator, whereas TCF3 is mostly 
acting as a repressor, but sometimes also as an activator (Arce et al., 2006; Hoppler and 
Kavanagh, 2007)  
Binding of β-catenin to TCF/LEF transcription factors is accompanied by the interaction of 
different co-activators with C-terminus domain of β-catenin (Fig. 3). Many co-activators were 
recently identified including Lgs/BCL9-2 and Pygo (Kramps et al., 2002), MED, p300/CBP, 
the TIP60 histone acetyltransferases adaptor molecule TRRAP (Takemaru and Moon, 2000), 
MLL1/2 histone methyltransferases (HMTs), the SWI/SNF family member of ATPases BRG1,  
involved in chromatin remodeling, and the PAF1 complex, involved in transcription elongation 
and histone modifications (Mosimann et al., 2009). The interaction with numerous histone 
modifying enzymes suggests that TCF/β-catenin binding to WRE results in widespread 
chromatin remodeling of the target loci (Parker et al., 2008). 
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Figure 3 - Nuclear TCF/β-Catenin co-activator complexes 
Interestingly, it has recently been shown that the interaction of β-catenin and co-activators with 
the WRE of the c-Myc gene is dynamic allowing replacement with the transcriptional 
repressors complex Groucho/TLE1 (Sierra et al., 2006); (Wang and Jones, 2006). Thus, these 
new data provide an intriguing mechanism of dynamic Wnt-responsive gene activation.  
Unlike general co-activators of transcription, the co-factors Lgs and Pygo have been described 
to have a specific β-catenin-dependent activity in Drosophila (Mosimann et al., 2009). Upon 
Wg stimulation β-catenin binds to Lgs and recruits Pygo, while in the absence of a Wg signal 
Pygo co-occupies chromatin loci with TCF. In contrast, the mammalian Lgs homologue, BCL9-
2 functions as a cell-type specific and Pygo-independent co-activator of Wnt signaling 
(Sustmann et al., 2008). 
Activation of the canonical Wnt pathway coordinates a wide variety of cellular processes 
including cell fate decision, proliferation, differentiation, apoptosis and migration (Logan and 
Nusse, 2004). This requires activation of canonical Wnt signaling target genes in a cell-type- 
and organism-specific manner. So far only Axin2 was described to be a “universal” target gene 
of the Wnt pathway. As a fine-tuning mechanism Wnt signaling components such as Fz, LRPs, 
Dkk1, Axin2, TCF/LEF, Naked (a Dvl antagonist) and β-Tcrp are regulated either positively or 
negatively by the TCF/β-catenin complex (Logan and Nusse, 2004). This kind of regulation 
creates the feed-back loop mechanisms controlling cell-autonomous coordination of the 
canonical Wnt pathway. 
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2. Cell-cell adhesion  
Cell-cell adhesion has been extensively implicated in morphogenesis that includes such 
fundamental biological processes as the regulation of cell shape, cell movement and sorting into 
complex organization in tissues and organs (Gumbiner, 2005). When cell-cell adhesion is 
deregulated it modulates tumorigenesis (Logan and Nusse, 2004).  
The first cell-cell adhesion components, called CAMs, were discovered almost 30 years ago 
(Brackenbury et al., 1977; Takeichi, 1977; Thiery et al., 1977). Several types of adhesion 
molecules can be distinguished including members of the integrin, cadherin, immunoglobulin 
and proteoglycan families. Integrins and proteoglycans are part of the cell-matrix as well as 
cell-cell dependent adhesion. In contrast, cadherins specifically control intercellular adhesion. 
The cadherins are a family of calcium-dependent CAMs. Each member of the cadherin family 
was found to regulate cell-cell adhesion of particular cell types, thus coordinating the 
organization of the multicellular organism. This family encompasses more than 30 members, all 
with a similar molecular weight and common basic structure (Gumbiner, 1996) and includes 
classical cadherins of type I, closely related cadherins of type II, desmosomal cadherins 
(desmocollins and desmogleins), protocadherins and a variety of cadherin-related molecules. 
Several types of cell-cell adhesion complexes can be recognized including adherens junctions, 
desmosomes, gap junctions and tight junctions (Giepmans and van Ijzendoorn, 2009). In the 
following I will focus on the calcium-dependent cell-cell adhesion complexes: adherens 
junctions and desmosomes.  
2.1. Adherens junctions 
E-cadherin is a member of the type I cadherin family (van Roy and Berx, 2008). It was found to 
be expressed already in the two-cell stage of embryogenesis and later on its expression 
increases gradually together with cellular compaction (Shirayoshi et al., 1983). Notably, E-
cadherin-/- embryos can undergo compaction, because of the presence of maternal E-cadherin. 
Only later in development, after the blastocyst stage, they exhibit a defect in trophectoderm 
formation and fail to develop further (Larue et al., 1994). 
E-cadherin is part of the adherens junctions (Fig. 4A), where it interacts via its cytoplasmic 
domain with the central arm domains of β-catenin or plakoglobin, while binding between β-
catenin (or plakoglobin) and α-catenin achieved by their N-terminal domains interaction. α-
catenin serves as the bridging molecule connecting E-cadherin to the actin cytoskeleton 
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(Hartsock and Nelson, 2008). Recent data suggest that α-catenin exists in monomeric and 
dimeric form and it is not continuously bound to β-catenin and actin cytoskeleton (Drees et al., 
2005; Yamada et al., 2005). This led to the proposal of a dynamic crosstalk between the α-
catenin plasma membrane pool (monomeric, β-catenin bound), the cytoplasmic pool 
(monomeric) and the cytoskeletal pool (dimeric, actin-bound), where α-catenin switches 
between the adherens complex and binding to the actin cytoskeleton. 
 
Figure 4 – Adherens junctions and desmosomes 
(A) Structure of adherens junctions (Modified from (van Roy and Berx, 2008) (B) Structure of desmosomes 
(Modified from Schmidt and Koch, 2007). Explanations can be found in the text. 
2.2. Desmosomes 
Interestingly, unlike β-catenin, plakoglobin can bind to both classical (E-cadherin) and 
desmosomal cadherins. Moreover, plakoglobin initially was identified as a cytoplasmic 
component of desmosomes (Franke et al., 1987). Desmosomes are adhesion complexes specific 
for cells derived from the ectodermal lineages (Schmidt and Koch, 2007). Based on knock-
down experiments of different desmosomal components, desmosomes maintain integrity and 
stability of the skin and the heart (Bierkamp et al., 1996; Chidgey et al., 2001; Grossmann et al., 
2004; Koch et al., 1997; Ruiz et al., 1996). They first appear in the trophectodermal layer of 32-
cell-stage embryo during early preimplantation development (Fleming et al., 1991) and are 
found later also in epithelial layer derivatives.  
Structurally, desmosomes comprise of cadherins and cytoplasmic plaque (Fig. 4B). 
Desmosomal cadherins, desmocollin and desmoplakin are transmembrane proteins connecting 
two adjacent cells. Their C-terminus end facing the cytoplasmic compartment that connected to 
intermediate filaments through a cytoplasmic plaque comprised of desmoplakin, plakoglobin 
and plakophilin proteins (Holthofer et al., 2007). 
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Interestingly, the analysis of plakoglobin-/- mice revealed that β-catenin can partially substitute 
for plakoglobin in desmosomes of the skin (Bierkamp et al., 1999). Similarly, plakoglobin can 
substitute for β-catenin in adherens junctions in β-catenin-/- mice (Huelsken et al., 2000). These 
results suggest that β-catenin and plakoglobin can substitute each other in adhesion complexes 
to support tissue integrity and stability.  
3. Balance between cell-cell adhesion and Wnt signaling 
As described above, β-catenin and plakoglobin can function in the cell-cell adhesion as well as 
Wnt signaling. Therefore, nature requires a mechanism to control the balance between the 
nuclear, cytoplasmic and adhesion pool of β-catenin.  
How exactly β-catenin is being released from cell junctions to participate in Wnt signaling?  
For instance, in C. elegans this problem was solved through the existence of multiple β-catenin 
forms that participate separately in adhesion and transcription (Schneider et al., 2003). 
However, in other organisms only one form of β-catenin exists. Findings by Piedra et al. shed 
some light on the mechanism that regulates disassembly of β-catenin from the adhesion 
complex (Piedra et al., 2001). This involves phosphorylation of β-catenin at tyrosine 654, which 
prevents E-cadherin/β-catenin interaction. Three years later Brembeck et al. presented a 
detailed mechanism explaining how β-catenin switches from adhesive to transcriptional 
function (Brembeck et al., 2004). Here it was proposed that the co-factor BCL9-2 binds to and 
phosphorylates β-catenin at tyrosine 142. It results in a dissociation of β-catenin from α-catenin 
causing epithelial-mesenchymal transition (EMT), nuclear translocation of the BCL9-2/β-
catenin complex and activation Wnt/β-catenin target genes. Using zebrafish as a model 
organism the authors showed that BCL9-2 acts downstream of Wnt8/β-catenin regulating 
mesoderm formation (Brembeck et al., 2004). However, in this study the role of BCL9-2-
induced switch of β-catenin from adhesion to transcription function in earlier developmental 
events, such as dorsal organization and posteriorization of anterior neuroectoderm, was not 
demonstrated.   
Interestingly, in vitro studies using BCL9, the human homolog of mouse BCL9-2, showed cell-
type specific β-catenin activation (Sustmann et al., 2008). Moreover, BCL9/β-catenin 
interaction does not involve Pygo like in Drosophila. Authors also found that C-terminus of β-
catenin is required for this interaction. 
In another study, using lysophosphatidic acid to dissociate E-cadherin/β-catenin complex from 
the membrane, it was shown that the E-cadherin/β-catenin complex accumulates in the 
Natalia Lyashenko Introduction 
[26] 
 
perinuclear endocytic recycling compartment and can enter the nucleus upon Wnt stimulation 
(Kam and Quaranta, 2009). However, in this study the authors did not provide any significant 
physiological proof for such a mechanism.   
4. Self-renewal of mouse ES cells 
4.1. Origin of ES cells 
During early pre-implantation development after fertilization of the mouse oocyte, the zygote 
undergoes first three mitotic divisions to form the 8-cell stage embryo (Fig. 5A-C). After the 
next two rounds of cell division at the developmental stage referred to as morulae (Fig. 5D,E), 
blastomeres segregates into the smaller inner cells and the larger outer cells (Fleming, 1987). 
The first segregation of cell, specialized in the development of extraembryonic (derived from 
the large outer cells of the morulae) versus embryonic tissues, occurs at the blastocyst stage 
(Fig. 5F) (Gardner, 1983). The population of cells in the blastocyst that gives rise to the whole 
embryo proper and extraembryonic endoderm is called ICM (Fig. 5F,G). The blastocyst is a 
spherical structure with polarized ICM and a fluid-filled cavity (blastocoele), surrounded by a 
cell layer – the trophectoderm. The trophectoderm gives rise to the embryonic part of the 
placenta, a structure unique to all mammalian species (Niwa et al., 2005). 
Remarkably, in 1981 two independent groups of researches isolated and in vitro cultured for the 
first time “pluripotential” cells, later called ES cells, from the ICM of the mouse blastocyst 
(Evans and Kaufman, 1981; Martin, 1981). After this breakthrough ES cells were isolated from 
different mammalian species including human (Thomson et al., 1998). One of the defining 
features of ES cells is pluripotency, an ability to contribute to all three germ layers: 
endoderm, mesoderm and ectoderm. Pluripotency of murine ES cells was demonstrated by 
injecting them into a host blastocyst, where they can contribute ideally to the whole organism 
including germ cells (Beddington and Robertson, 1989). 
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Figure 5 - Cell lineage formation from zygote to egg cylinder stage 
(A-G) Schematics of the morphological changes and cell lineage specification that occur in a mouse embryo, from 
its fertilization at embryonic day 0.5 (E0.5) to the late blastocyst stage (E4.5). The colored bars show the 
progressive allocation of totipotent blastomeres to outer and inner cells and to the trophectoderm and inner cell 
mass lineages. The cell types in the embryos are color coded. (H) Egg cylinder stage. DVE, distal visceral 
endoderm; Abemb (abembryonic) - Emb (embryonic) axis of the blastocyst. (modified from (Rossant and Tam, 
2009) 
 
The fact that ES cells are derived from the blastocyst does not mean that they are identical to 
ICM cells. ES cells do not exist in vivo. It is a cell type that is captured at the stage of blastocyst 
development and can divide in vitro under proper culture conditions for indefinite time and 
produce identical pluripotent progeny. This feature of ES cells was called self-renewal 
(Chambers and Smith, 2004).   
 
blastocoele 
ICM 
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4.2. Molecular basis for mouse ES cell self-renewal 
4.2.1. Transcription factors preventing differentiation 
Recent extensive studies revealed that maintenance of the pluripotent state of ES cells is 
controlled by transcriptional factor network, including three major regulators: Oct3/4 (POU5FI 
or Oct4), Nanog and Sox2 (Boheler, 2009; Yamanaka et al., 2008). The POU family 
transcription factor Oct3/4 is expressed in blastomeres and later its expression restricted to the 
ICM. Ablation of Oct3/4 in mice leads to failure in ICM formation (Nichols et al., 1998). 
Notably, deletion of Oct3/4 in ES cells promotes differentiation towards the trophoblast lineage 
and overexpression primarily promotes endoderm-like cell differentiation (Niwa et al., 2000). 
The homeodomain protein Nanog is expressed exclusively in the ICM (Chambers et al., 2003; 
Mitsui et al., 2003). Overexpression of Nanog in ES cells results in LIF-independent 
maintenance of pluripotency in serum-containing and serum-free media (Ying et al., 2003). 
Moreover, Nanog not only supports pluripotency, but also serves as an inhibitor of ES cell 
commitment towards neuroectoderm (Ying et al., 2003), primitive endoderm (Mitsui et al., 
2003) and mesoderm (Suzuki et al., 2006). The HMG domain-containing factor Sox2 is 
expressed in the ICM and also in the extraembryonic ectoderm lineage (Avilion et al., 2003). 
Functional studies revealed that Sox2 cooperates with Oct3/4 to maintain pluripotency and to 
prevent differentiation into trophectoderm (Li et al., 2007).  
Recent groundbreaking work identified that Oct3/4 and Sox2, together with Klf4 and c-Myc 
(so-called Yamanaka’s factors) are essential factors to convert mouse somatic cells to the 
induced pluripotent stem cells (iPS cells), that have ES cell-like characteristics (Takahashi and 
Yamanaka, 2006). Only one year later the groups of Yamanaka and Tompson simultaneously 
succeeded in the establishment of human iPS cells (Takahashi et al., 2007; Yu et al., 2007). 
Numerous research groups started to work on iPS cell technology since then and most of the 
efforts are now put to decipher the underlying mechanisms of such reprogramming and to 
explore the usage of iPS cells in medicine and drug therapy.  
Oct3/4, Sox2 and Nanog are probably the most crucial transcription factors governing self-
renewal of ES cells (Orkin, 2005). Thus, a lot of effort went into the identification of their 
downstream targets and self-regulatory mechanisms of this circuit. To gain more inside into the 
transcriptional regulatory network that maintains the ES cell pluripotent state, several groups 
combined genomic and proteomic approaches resulting in an expanded circuit of transcriptional 
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factors and their interactions (Chen et al., 2008b; Kim et al., 2008). Genome-wide mapping data 
of transcription factor targets by ChIP-Chip and ChIP-sequencing and proteomics data allowed 
the creation of a complex interaction map (Fig. 6) (Kim et al., 2008; Wang et al., 2006). This 
map shows the core regulatory circuit of the nine proteins examined in the study by Kim and 
colleagues: Oct4, Sox2, Nanog, Rex1, Dax1, Zfp281, Myc and Klf4 surrounded by newly 
identified transcription factors including Sall4 (Zhang et al., 2006), REST (Singh et al., 2008) 
and Rif1 (Loh et al., 2006).   
 
 
Figure 6 - Expanded regulatory network of transcription factors involved in ES cell pluripotency 
This diagram is based on target data and protein-protein interaction data. Yellow circles represent the nine factors 
examined in the study by Kim et al. The size of each circle reflects the degree of factor co-occupancy of the 
promoter of the gene encoding each factor. Arrowheads indicate the direction of transcriptional regulation. (From 
Kim, Chu et al., 2008) 
4.2.2. Signaling molecules 
Together with transcription factors many intracellular signaling pathways have been implicated 
to act in the maintenance of ES cell pluripotency.  
Originally, ES cells were derived and propagated on a layer of mitotically-inactivated MEFs in 
the presence of FCS, with the MEFs producing soluble factors that inhibit differentiation of ES 
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cells (Smith and Hooper, 1983). Later it was possible to substitute the MEF layer through the 
addition of conditioned media from a Buffalo rat liver cell line (Smith and Hooper, 1987). 
Fractionation of this conditioned media revealed a presence of secreted protein LIF acting as 
the main component sustaining mouse ES cells pluripotency (Smith et al., 1988; Williams et al., 
1988). In contrast to mouse, LIF is dispensable for the maintenance of human ES cells self-
renewal (Humphrey et al., 2004). LIF binds to the LIFR/gp130 receptor complex on the cell 
membrane and activates the JAK/STAT3 signaling cascade (Niwa et al., 1998). One of the 
target genes of STAT3 is c-Myc that controls ES cell proliferation (Cartwright et al., 2005). 
However, culturing of ES cells only in the presence of LIF without FSC in not sufficient to 
maintain their pluripotency, but the need for FCS can be replaced by BMP4 in combination 
with LIF (Ying et al., 2003). BMP4 signaling through Smad phosphorylation activates 
expression of Id proteins, which are negative transcriptional modulators in various cell types 
(Ruzinova and Benezra, 2003). Additionally, it has also been reported that BMP4-dependent 
inhibition of the p38 MAPK may also contribute to the maintenance of pluripotency (Qi et al., 
2004). Taken together, BMP and LIF are the two cytokines that are sufficient to sustain self-
renewal of mouse ES cells.   
Recently, LIF-dependent activation of PI3K/AKT signaling pathway was implicated in self-
renewal of mouse as well as human ES cells (Kim et al., 2005; Paling et al., 2004). Treatment 
of mouse ES cells with the PI3K inhibitor LY294002 in the presence of LIF dramatically 
decreases the proportion of undifferentiated colonies (Paling et al., 2004; Storm et al., 2007). 
The underlying mechanism was recently uncovered by several independent research groups, 
which showed that the expression of Nanog and c-Myc is directly regulated by PI3K through 
GSK3β inactivation (Bechard and Dalton, 2009; Storm et al., 2007; Storm et al., 2009). 
Withdrawal of either LIF or treatment with LY294002 in the presence of LIF, results in the 
translocation of GSK3β from the cytoplasm to the nucleus where it phosphorylates c-Myc, 
targeting it for degradation (Bechard and Dalton, 2009).   
Interestingly, the activation of the RAS/RAF/MEK/ERK pathway has been shown to negatively 
regulate self-renewal of mouse ES cells. Upon withdrawal of LIF, ERK activity increases, but 
this effect can be suppresses by the addition of inhibitor PD98059 of MEK, a key component of 
RAS/RAF/MEK/ERK signaling pathway (Burdon et al., 1999). On the basis of these results 
Ying and colleagues developed defined ES cell culture conditions in serum-free medium 
making use of the intrinsic mechanisms of ES cells to maintain the pluripotent state (Ying et al., 
2008). This does not involve LIF/STAT3 signaling, but propagation of ES cells in serum-free 
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medium supplemented with MEK inhibitor PD0325901 and very specific GSK3 inhibitor 
CHIR99021. Under these conditions the inhibition of GSK3 and MEK is sufficient to maintain 
cellular growth and viability by preventing the intrinsic ES cell differentiation commitment. 
4.3. Wnt signaling and self-renewal 
Recently, activation of the canonical Wnt signaling pathway has been shown to maintain self-
renewal of mouse and human ES cells. Sato and colleagues demonstrated that activation of the 
canonical Wnt pathway through inhibition of GSK3, using the GSK3 inhibitor BIO, was 
sufficient to maintain self-renewal of both mouse and human ES cells (Sato et al., 2004). 
Moreover, addition of BIO during early steps of mouse ES cells derivation increased the 
efficiency to establish ES cell lines (Umehara et al., 2007). Other studies suggest that BIO 
might have some additional effects in mouse ES cells, that it might not only act through 
activation of the Wnt/β-catenin pathway, but also influence the LIF/STAT3 signaling pathway 
through an unknown mechanism (Ogawa et al., 2006), which as newer studies suggest might be 
the activation of cMyc (Bechard and Dalton, 2009). However, BIO was not sufficient to 
maintain self-renewal of human ES cells longer than two passages (Dravid et al., 2005), 
suggesting that active Wnt signaling is dispensable for self-renewal maintenance in human ES 
cells.  
Another way to stimulate canonical Wnt signaling in ES cells is the addition of Wnt proteins. 
Wnt3a conditioned medium can support the self-renewal state of mouse ES cells, but only in 
the presence of low concentrations of LIF (Ogawa et al., 2006). On the other hand, the same 
study showed that activation of the canonical Wnt pathway by recombinant Wnt3a alone only 
promotes proliferation and leads to differentiation of mouse and human ES cells (Dravid et al., 
2005; Ogawa et al., 2006). Thus, these studies together with other studies suggest that β-catenin 
might act synergistically with LIF maintaining mouse ES cell self-renewal (Hao et al., 2006; 
Takao et al., 2007). Takao and colleagues had shown that nuclear β-catenin levels decrease 
upon LIF withdrawal from ES cell culture. However, in contrast to the study by Ogawa and 
colleagues, it was shown here that ES cells expressing an activated mutant form of β-catenin 
can be cultured in the absence of LIF for at least one month. The proposed mechanism was that 
β-catenin interacts with Oct3/4 to activate Nanog promoter (Takao et al., 2007). Hao and 
colleagues had shown that the canonical Wnt signaling up-regulates Stat3 gene expression (Hao 
et al., 2006). In a recent study it was shown that ES cells lacking β-catenin have decreased 
levels of the stem cell markers Rex-1 and Nanog (Anton et al., 2007). In contrast to this analysis 
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in a very recent study by another group it was shown that β-catenin-/- ES cells can be 
propagated without LIF in the presence of FCS for 12 days and maintain expression of Oct3/4 
(Soncin et al., 2009). However, the source of the β-catenin-/- ES cells in the study by Soncin and 
colleagues is unclear. Thus it is possible that the ES cells used in the two different studies might 
vary in their genetic background or behave differently depending on the culture conditions. 
Altogether, the published data on the role of the Wnt/β-catenin signaling in ES cell self-renewal 
are slightly controversial and require further investigations. 
4.4.  Cell-cell adhesion and self-renewal 
Mouse ES cells have specific morphological characteristics that distinguish them 
phenotypically from differentiated cells. They grow in compact multilayered colonies, 
consisting of cells with discernible borders and low cytoplasm to nucleus ratio (Evans and 
Kaufman, 1981). One of the defined features of the ES cell colony morphology undergoing 
differentiation is a change from dome-shaped multilayered to spread monolayered appearance. 
Thus ES cell differentiation and the associated changes of the compact colony architecture are 
probably accompanied by alterations in the expression of cell-cell and cell-matrix adhesion 
molecules.  
Many adhesion-related molecules have been found to be expressed in the ICM of the blastocyst 
and in mouse ES cells, these include SSEA-1 (Kojima et al., 1994), CD9 (Oka et al., 2002), 
ICAM-1 (Tian et al., 1997), PECAM-1 (CD31) (Redick and Bautch, 1999), EpCAM, E-
cadherin (Larue et al., 1994; Tian et al., 1997), β-catenin and plakoglobin (Ohsugi et al., 1997). 
Interestingly, the SSEA-1, CD9, PECAM-1, EpCAM and ICAM-1 are also considered ES cell 
characteristic markers, as their expression is lost upon differentiation (Cui et al., 2004; 
Furusawa et al., 2004). Only recently the involvement of adhesion-related molecules in ES cell 
self-renewal was studied and EpCAM (Gonzalez et al., 2009) and PECAM-1 (Furusawa et al., 
2004) were implicated in being important for mouse ES cell self-renewal. 
The adhesion molecule EpCAM is a transmembrane glycoprotein expressed in normal 
epithelial and cancer cells (Trzpis et al., 2007). Beside its adhesion function, EpCAM was 
recently implicated as a target gene of Wnt/β-catenin signaling and as a signal transducer of the 
pathway (Maetzel et al., 2009). The EpCAM intracellular domain is being released from the 
membrane and binds to the LEF/β-catenin complex in the nucleus to activate target genes 
transcription. Moreover, EpCAM expression is necessary, but not sufficient for ES cell 
maintenance (Gonzalez et al., 2009).          
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PECAM-1 (or CD31) is a glycoprotein that belongs to the immunoglobulin superfamily (Ilan et 
al., 2000). Originally characterized as an endothelial marker, PECAM-1 isoforms are expressed 
in ES cells and have been implicated in the activation of STAT3 and as such it may play a role 
in LIF-mediated maintenance of undifferentiated ES cells (Ilan et al., 2001). Moreover, 
PECAM-1-/- ES cells are unable to contribute to the epiblast and have only low levels of 
Oct3/4 expression (Furusawa et al., 2004). Interestingly, PECAM-1 can also associate with 
thyrosine-phosphorylated β-catenin or plakoglobin and modulate adherens junction assembly 
(Biswas et al., 2006; Biswas et al., 2005). This interactions link PECAM-1 to cell adhesion and 
maintenance of self-renewal in mouse ES cells.   
5. Early mouse development versus in vitro differentiation 
5.1. ES cells as a model for developmental studies 
A recent potentially therapeutic avenue of ES and, more recently iPS cell research focuses on 
their directed differentiation into the specialized cells. The generation of pure populations of 
committed cell types would be beneficial in many ways, to recapitulate development, to model 
human disease-related issues in culture and might allow eventually replacement cell therapy for 
treatment of certain degenerative human diseases (Irion et al., 2008). 
As described earlier mouse ES cells are derived from the ICM of the blastocyst (see chapter 
4.1.). At implantation, the ICM segregates into unpolarized embryonic ectoderm (epiblast) and 
primitive endoderm (Fig. 5G). Later in development an egg cylinder forms (Fig. 5H), 
characterized by proximal-distal and anterior-posterior patterning of the embryo and cavitation 
of epiblast. At this stage the epiblast is polarized in a process referred to as gastrulation, 
characterized by extensive cell migration and formation of the three primary germ layers. 
Gastrulation is associated with primitive streak formation, which elongates from the posterior 
part of the embryo due to organized epiblast cell movements and EMT, giving rise to mesoderm 
and definitive endoderm. Cells in the anterior part of the epiblast do not migrate and give rise to 
ectoderm (Tam and Loebel, 2007).   
Although the normal process of gastrulation cannot be fully recapitulated during in vitro ES cell 
differentiation, cell types, specific for the different germ layers can form. Hence, in vitro ES 
cell differentiation studies can be used to study early developmental events in more detail and 
in a quantitative manner, using for instance germ layer-specific reporter ES cell lines. Here in 
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principle a reporter gene, for example eGFP or LacZ, is inserted into the genomic locus of a 
germ layer specific marker gene. This enables to monitor the appearance of certain germ layer 
in culture during differentiation. Germ layer specific loci have been used extensively in 
developmental studies including Mixl1 (Davis et al., 2008; Ng et al., 2005), Brachyury (Lacaud 
et al., 2004) and Axin2 (ten Berge et al., 2008) for primitive streak, Foxa2 (Gadue et al., 2005) 
for endoderm and Flk1 (Fehling et al., 2003) for mesoderm formation. 
The culture conditions are very important when studying ES cells differentiation. Upon 
withdrawal of LIF ES cells start to differentiate. The presence or absence of FCS, growth 
factors, antagonists of certain signaling pathways and the microenvironment can influence the 
differentiation of ES cells into specific somatic lineages (Gadue et al., 2005) or even into germ 
cells (Geijsen and Daley, 2006; Geijsen et al., 2004). One of the commonly used methods to 
differentiate ES cells into lineage specific derivatives is the embryoid body (EB) aggregates 
formation (Burkert et al., 1991; Ling and Neben, 1997). The time points of the appearance of 
specific marker genes during EB differentiation correlate pretty well with those of their 
endogenous appearance during early developmental stages including gastrulation, cavitation 
and early organogenesis (Desbaillets et al., 2000; Leahy et al., 1999). Moreover, as shown 
recently EBs exhibit a high degree of self-organization and axis formation capacity upon Wnt 
signaling stimuli (ten Berge et al., 2008).  However, not only the culture time also the size of 
EBs is a crucial factor for the induction of the expression of different lineage markers (Karp et 
al., 2007). Thus, small EBs preferentially differentiate towards endoderm, while big EBs 
differentiate primarily into mesoderm derivatives due to the differential expression of Wnt5a 
and Wnt11 (Hwang et al., 2009). 
5.2. Wnt signaling in early mouse development 
Wnt signaling comprises many different components and a variety of intracellular pathways. 
However, loss-of-function and gain-of-function phenotypes of different components of the Wnt 
signaling pathways are quite divergent in terms of their stage of developmental arrest (Tam and 
Loebel, 2007). Moreover, some of the loss-of-function mutants have very mild phenotypes or 
no phenotypes at all in embryonic development. For example, Wnt5a is co-expressed with 
Wnt3a in primitive streak embryos, but Wnt5a mutants do not have an early developmental 
phenotype with regard to the primitive streak (Cha et al., 2004; Yang et al., 2009). Deletion of 
β-catenin in mice leads to an early developmental arrest around E6,5 associated with defects in 
primitive streak formation, lack of mesoderm formation and increased apoptosis in the 
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ectoderm (Haegel et al., 1995; Huelsken et al., 2000). Similarly, mice carrying mutations of 
both Lrp5 and Lrp6 fail to establish a primitive streak, but the establishment of anterior visceral 
endoderm and anterior epiblast occurs normally (Kelly et al., 2004). Similar defects are found 
in Wnt3 knock-out mice (Liu et al., 1999). In contrast, Wnt3a knockout mice develop through 
gastrulation stage, but display posterior axis defects and no mesoderm formation (Takada et al., 
1994).  
On the other hand, constitutive activation of β-catenin in the mouse zygote results in normal 
blastocyst development, but premature EMT in the epiblast of the post-implantation embryo 
(Kemler et al., 2004). 
Recently an interesting model about the role of Wnt-signaling in development was proposed. 
This model postulates that Wnt signaling coordinates the transcriptional noise, which defines 
cell fate decisions rather than influences cell fates directly (Arias and Hayward, 2006). One of 
the examples supporting this idea is that the expression of the mesodermal gene Brachyury, a 
Wnt/β-catenin target, still occurs in Wnt3a mutant mice, but does not peak at its normal time of 
development (Galceran et al., 2001).     
Overall, the published data would suggest that the canonical Wnt pathway is primarily required 
for the early post-implantation mouse development, while there is little knowledge about the 
roles of the non-canonical pathways based on mouse knock-out phenotypes.  
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Goal of the thesis 
The specific aim my thesis was to establish β-catenin-deficient mouse ES cells and β-catenin 
signaling-defective mouse ES cells in order to distinguish between the adhesion and 
transcriptional functions of β-catenin in mouse ES cell self-renewal and differentiation. 
 
In my project I have addressed and accomplished the following points: 
1) Establishment of β-cateninfl/fl and β-catenin-deficient (β-cat∆/∆) mouse ES cells 
2) Characterization of self-renewal potentials of β-cat∆/∆ ES cells 
3) Utilization of β-cat∆/∆ ES cells to examine the activity of different canonical Wnt pathway 
activators with regard to self-renewal 
4) Elucidate intercellular junction complexes of ES cells and their influence on self-renewal 
mechanisms 
5) Characterization of the differentiation potentials of β-cat∆/∆  ES cells 
6) Rescue experiments by introducing WT and putative signaling-defective forms of β-
catenin into β-cat∆/∆ ES cells  
7) Analysis of the differentiation potentials of the signaling-defective ES cell lines 
8) Generation and preliminary characterization of tamoxifen-inducible β-cateninex3fl/ex3fl ES 
cells to study the effects of a gain in Wnt-signaling in ES cell self-renewal and 
differentiation.  
 
In addition, I was involved in another project that was not included in my dissertation, but of 
which the manuscript entitled “Mice lacking the orphan receptor Ror1 have distinct skeletal 
abnormalities and are growth retarded” is included.  
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Materials and Methods 
1. Establishment of ES cells 
1.1. In the presence of LIF and serum 
1.1.1. MEF isolation  
The MEF cells were prepared from MF1 fetuses at 13,5 days post-coitum. Embryos were 
isolated and cleaned from embryonic membranes and placenta in 37 °C pre-warmed sterile 
PBS. Using fine sterilized scissors, after removal of liver, embryos were cut into little pieces 
and incubated in 0,5% Trypsin-EDTA (Gibco) at 37 °C in CO2 incubator for 15 minutes. 
Trypsin was inactivated by addition of pre-warmed MEF medium (high glucose DMEM 
containing 10% FCS, 2mM L-glutamine, 2mM penicillin/streptomycin, all Sigma-Aldrich). 
Subsequently suspension of cells was seeded onto T75 tissue-culture flasks (1 embryo per 
flask). After several passages cells were frozen in small aliquots or irradiated using γ-
irradiation.   
1.1.2. Isolation of β-cateninfl/fl ES cells 
Irradiated MEFs were seeded onto 4-well tissue culture plates one day before blastocyst 
isolation. 3,5 days post-coitum blastocysts were flushed from β-cateninfl/fl females mated 
naturally with β-cateninfl/fl males (Huelsken et al., 2001) with a syringe in 37 °C pre-warmed 
sterile PBS and transferred to M2 medium (Sigma-Aldrich) using a sterile glass capillary. 
Subsequently blastocysts were individually seeded onto prepared 4-well plates in ES cells 
medium (high glucose DMEM containing 15% FCS, 2mM L-glutamine, 2mM 
penicillin/streptomycin, 1mM sodium pyruvate, 1x MEM non-essential amino acids, 0,1 mM 
β-mercaptoethanol, all Sigma-Aldrich; and 1:250 dilution LIF-conditioned medium produced 
using LIFα-5COS cells, a kind gift of Uta Möle-Steinlein) and incubated at 37 °C, 5% CO2. 
After 3-4 days blastocysts hatched naturally from zona pellucida and attached to the MEF 
layer. After 5-7 days, depending on the growth speed and morphology, a clump of cells (inner 
cell mass) was transferred to a drop of pre-warmed PBS using a sterile glass capillary and then 
to a drop of 0,05% trypsin-EDTA (Gibco), incubated for 3 minutes at 37 °C and plated to the 
fresh well containing MEFs (this step was defined as passage 1). After the first passage, 
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colonies with ES-like morphology were selected for propagation, storage and further 
experiments. Two independent ES cell lines were isolated with this method and one (NLβ-12) 
was used for further experiments.  Later on this ES cell line was propagated without feeder 
layer.  
1.1.3. Generation of β-cateninΔ/Δ ES cell clones 
To delete exon2 to exon6 of β-catenin in ES cells, 0.5x10E5 β-cateninfl/fl ES cells were infected 
with Adeno-Cre virus (University of Iowa) at MOI ~ 150. Next day cells were seeded 
individually on 96-well plate. Then they were passaged with multichannel pipette (Eppendorf) 
and one plate was used for genomic DNA isolation (see section “Mini-Southern blot”) and 
subsequent PCR to screen for deletion. Out of 96 clones 50% were β-cateninΔ/Δ, 25% β-
cateninfl/Δ and 25% β-cateninfl/fl. 
1.2. In serum-free LIF-free conditions  
1.2.1. Isolation of tamoxifen-inducible β-cateninex3fl/ex3fl ES cells  
4-well plates were covered with 0,1% gelatin for 30 minutes. 3,5 days post-coitum blastocysts 
were flushed from β-cateninex3fl/ex3fl ;Rosa26CreERT2/CreERT2  females with a syringe in 37 °C pre-
warmed sterile PBS and transferred to M2 medium (Sigma-Aldrich) using a sterile glass 
capillary. After removal of the zona pellucida by treatment with Tyrode’s solution (T1788, 
Sigma-Aldrich) for 30 seconds, embryos were individually seeded onto gelatinized 4-well 
plates in serum-free 2i ES cells medium (N2B27 medium (StemCellSciences) supplemented 
with 1000 U/ml EsgroLIF (Chemicon), Gsk3-inhibitor 3 µM CHIR and MEK-inhibitor 1 µM 
PD03 (both from StemGent)) and placed into a 37 °C CO2 incubator. After 10 days inner cell 
mass outgrowths were individually trypsinized and seeded onto fresh gelatinized plates (this 
step is defined as passage 1). After 5 days ES-like colonies were selected for propagation, 
storage and further experiments. Six ES cell lines were isolated with this method (E3BR1, 2, 4, 
3, 3-2, 5) and two (E3BR3-2 and E3BR5) were used for chimaera generation and further 
experiments. To induce Cre expression, 1µM of Tamoxifen (Sigma) was used. 
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1.3. Blastocyst injections 
Blastocyst injections were performed by IMP/IMBA mouse service facility (Hans-Christian 
Theussl and Jacek Wojciechowski) using standard techniques. NLβ-12 (on feeder, passage 18), 
E3BR3-2 and E3BR5 (feeder-free, passage 8) ES cell lines were used for injection. Male and 
female chimeras were crossed to C57Bl/6 mice and their offspring were genotyped for the 
presence of original mutant alleles.  
2. Genotyping of mice and ES cells 
2.1. Genomic DNA isolation 
Mouse ear or tail samples were digested in 250µl lysis buffer (50 mM KCl, 1.5 mM MgCl2, 10 
mM Tris pH8.5, 0.01% gelatin, 0.45% NP40, 0.45% Tween20, 100 µg/ml proteinase K) at 55 
ºC ON. Next day samples were heat inactivated at 95 ºC for 15 minutes and stored at 4 ºC.   ES 
cells pellets were digested in 100 µl ES lysis buffer (10mM Tris-HCl, pH 7.5; 10mM EDTA; 
10mM NaCl; 0,5% sarcosyl; 1mg/ml proteinase K added directly before use) at 55 ºC ON. 
Next day samples were heat inactivated and 95 ºC for 15 minutes and stored at +4 ºC. 
2.2. PCR genotyping 
For β-catenin fl/del genotyping a three primer PCR strategy was used. Primers were as follows: 
forward primer HAR057 AGAATCACGGTGACCTGGGTTAAA, reverse primer HAR058 
CAGACAGACAGCACCTTCAGCACTC, reverse primer HAR047 CAGCCAAGGAGAGCA 
GGTGAGG. PCR was performed using 1-3µl of genomic DNA and the TAKARA Taq PCR 
system (Roche) (2.5 µl 10x MgCl2-containing PCR buffer, 2 µl 2.5 mM each dNTPs, 0.5µl 
10mM primer mix (forward and reverse), 0.2 µl TAKARA Taq polymerase (5U/µl) and 
dH2O). Reaction conditions were: 95ºC 5’, 34x (95ºC 10’’, 65ºC 20’’, 72ºC 3’), 72ºC 5’, 4 º 
forever. Product sizes were: WT = 310 bp; fl = 350 bp; del = 650 bp. 
For β-catenin ex3floxed genotyping a two primer PCR strategy was used. Primers were as 
follows: forward primer HAR1518 AGAATCACGGTGACCTGGGTTAAA, reverse primer 
HAR1519 CATTCATAAAGGACTTGGGAGGTGT. PCR was performed using 1-3µl of 
genomic DNA and the TAKARA Taq PCR system (see above). Reaction conditions were: 
94ºC 5’, 34x (95ºC 30’’, 60ºC 30’’, 72ºC 2’), 72ºC C5’, 4 º forever. Product sizes were: wt = 
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350 bp; ex3fl = 650 bp. PCR products were analyzed on 0.8 -1.2% (depending on the product 
size) agarose gel. 
3. Analysis of self-renewal and differentiation of ES cells 
3.1. Alkaline phosphatase (AP) staining 
For AP staining the alkaline phosphatase kit (Sigma-Aldrich) was used according to 
manufacturer’s instructions. Briefly, TRIS tablet was resuspended in 10 ml H2O, and then 
Naphtol tablet was added and mixed thoroughly. Solution was filtered though a paper filter and 
added to PBS-washed ES cells for 3 hours at 37 ºC till WT ES cell colonies appeared intensive 
red in a control plate. Later staining was stopped by washing with PBS 3 times and plates were 
stored at 4 ºC. 
3.2. Immunocytochemistry on round coverslips 
ES cells or EBs were seeded onto gelatin-covered 12 mm glass coverslips (Novodirect), fixed 
in 4% PFA in PBS for 20 minutes. For immunofluorescence fixed ES cells or EBs were 
permeabilized in 0,5% Triton-X diluted in PBS for 10 minutes, blocked by incubation in 2% 
BSA in PBS for 1 hour RT and then incubated with primary antibodies for 1 hour RT or 
overnight at 4°C. The antibodies were diluted in 2% BSA/PBS. Dilutions are listed in Table 1.   
Samples were then incubated for 1 hour at RT in the dark with goat Alexa 488 anti-mouse or 
rabbit IgG antibody, donkey Alexa 488 anti-goat IgG antibody or goat Alexa 674 anti-mouse 
or rabbit IgG antibody (all from Molecular Probes) diluted 1:1000 in 2% BSA in PBS. 
Afterwards samples were incubated with 10µg/ml DAPI (Sigma) for 5 minutes to stain the 
nuclei and mounted with ProLong® Gold antifade reagent (Invitrogen/Molecular Probes). 
Pictures were taken using the LSM 510 Meta/Axiovert200M confocal microscope.  
 
Table 1 - Antibodies used in this study 
ANTIBODY HOST SUPPLIER DILUTION APPLICATION 
α-nanog rabbit Abcam 1:100 IF 
α-nanog rabbit Abcam 1:1000 WB 
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α-Oct3/4 mouse Santa Cruz 1:100 IF 
α-β-catenin C-term mouse BD Transductions 1:250 IF 
α-β-catenin C-term mouse BD Transductions 1:2000 WB 
α- β-catenin N-term mouse Alexis 
Biochemicals 
1:200 IF 
α- β-catenin N-term mouse Alexis 
Biochemicals 
1:2000 WB 
α- β-catenin N-term mouse Alexis 
Biochemicals 
1:200 IHC 
α-E-cadherin mouse BD Transductions 1:200 IF 
α-E-cadherin mouse BD Transductions 1:1000 WB 
α-plakoglobin mouse BD Transductions 1:200 IF 
α-plakoglobin mouse BD Transductions 1:6000 WB 
α-cTnT mouse Abcam 1:100 IF 
α- α-catenin mouse Chemicon 1:100 IF 
α-GFAP rabbit Dako 1:400 IF 
α-GFAP rabbit Dako 1:1000 IHC 
α-β3-tubulin mouse Santa Cruz 1:200 IF 
α-β3-tubulin mouse Santa Cruz 1:100 IHC 
α- α-fetoprotein (AFP) rabbit Dako 1:200 IF 
α- α-fetoprotein (AFP) rabbit Dako 1:1000 IHC 
α-nestin mouse Millipore 1:100 IF 
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α-myc tag mouse Cell signalling 1:200 IF 
α-myc tag mouse Cell Signalling 1:1000 WB 
α-HNF-3β goat Santa Cruz 1:100 IF 
α-PECAM-1 rat BD Biosciences 1:200 IF 
α-tubulin mouse Sigma 1:6000 WB 
α-Stat3 mouse Cell Signaling 1:1000 WB 
α-p-Stat3(705Tyr) mouse Cell Signaling 1:1000 WB 
α-SMA rabbit Thermo Fisher 
Scientific 
1:100 IHC 
 
3.3. Induction of EB formation in vitro 
ES cells were dispersed by addition of 0,05% trypsin-EDTA for 5 minutes and counted. 
1,0x10E6 cells per 20 ml of EB medium (ES cell medium without LIF) were plated onto 15 cm2 
bacterial petri dish. This step is defined as day 0 of differentiation. Medium was changed every 
second day and EB’s were harvested at different time points, fixed for immunofluorescence or 
pelleted for protein or RNA isolation. 
3.4. Teratoma formation in vivo 
3.4.1. Injection of ES cells into nude mice 
ES cells were dispersed by addition of 0,05% trypsin-EDTA for 5 minutes, washed with PBS 
and counted. 0,5x10E6 cells were resuspended in PBS and mixed 1:1 with Matrigel (BD 
biosciences) on ice. 200 µl of total suspension were injected subcutaneously in the trunk of 
MF1 nude mice, control ES cells on the left side and mutant ES cells on the right side of a 
single mouse. Two weeks after injection, teratomas were recovered and fixed with 4% PFA in 
PBS ON, dehydrated to 75% EtOH and processed in Tissue-TeK VIP Tissue Processor and 
embedded in paraffin. Serial sections of teratomas were made at 5 µm, collected on 
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SuperFrostPlus slides (Microm), stained with hematoxylin and eosin (both from Sigma-
Aldrich) or subjected for immunohistochemistry. 
3.4.2. Immunohistochemistry on paraffin sections 
Paraffin sections of teratomas were processed using the VENTANA machine (by Vukoslav 
Komnenovic, Histo lab). Briefly, sections were dewaxed and rehydrated, antigen-retrieval was 
done using citrate buffer pH6,0. For dilutions of antibodies see Table 1. Slides were 
counterstained with hematoxylin. Pictures were taken using the Axioplan2/LeicaDFC320 
microscope. 
3.5. Induction of neural differentiation in monolayer cultures 
For low and high density monolayer differentiation 0,9x10E4 cells/cm2 and 4,0x10E4 cells/cm2 
respectively of ES cells were plated on laminin-covered coverslips in N2B27 medium 
(StemCellSciences). Medium was changed every second day. For nestin staining cells were 
fixed with 4% PFA in PBS at day 4 and for β3-tubulin staining at day 14 of differentiation. 
Nestin-positive and β3-tubulin-positive cells were counted in random fields and standard 
deviation was calculated in Microsoft Excel program. 
3.6. Fluorescence activated cell sorting (FACS) 
3.6.1. Detection of apoptotic cells 
ES cells and day 5 EBs were dispersed using 0,05 % trypsin-EDTA (GIBCO) for 5 minutes 
and washed several times with PBS. For apoptosed cell detection cells were stained using 
Vybrant ® Apoptosis Assay Kit #2 (Invitrogen/Molecular Probes) according to manufacturer’s 
instructions. Briefly, PBS-washed cells were stained with 5 µl of Alexa Fluor® 488 anti-
annexinV (AnV) antibodies and 1 µl of 100µg/ml propidium iodide (PI) for 15 min and 
acquired on FACS Calibur (Becton Dickinson). Analysis of results was done with FlowJo 
software (Tree Star). The populations of interest were gated as following: live cells - AnV- PI- ; 
apoptotic cells - AnV+ PI- ; dead cells - AnV- PI+; necrotic cells - AnV+ PI+ 
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3.6.2. SSEA-1 FACS sorting 
ES cells were dispersed using 0,05% trypsin-EDTA (GIBCO) for 5 minutes and washed several 
times with PBS. After fixation with 4% PFA for 20 minutes cells were permaebilized with 
0,5% Triton-X diluted in PBS for 10 minutes, blocked by incubation in 2% BSA in PBS for 1 
hour RT and then incubated with mouse anti-SSEA-1 antibodies (Chemicon) (1:500) for 1 hour 
RT. The antibodies were diluted in 2% BSA/PBS. Cells were then incubated for 1 hour at RT in 
the dark with goat Alexa 488 anti-mouse IgG antibody (Molecular Probes) diluted 1:1000 in 
2% BSA in PBS. Afterwards cells were put on ice and sorted with CellQuest software (BD 
Biosciences) on CALIBUR machine. Data were analyzed with FlowJo software. 
4. RT-PCR and microarray 
4.1. RNA isolation 
ES cells or EBs were dispersed with 0,05% trypsin-EDTA (GIBCO), washed with PBS several 
times and pelleted by centrifugation. Cell pellets were lysed in 1 ml TRI Reagent (Sigma) and 
incubated at RT for 5 min. 300µl of chloroform was added, shook by flicking for 15 seconds, 
incubated for 5 minutes at RT and centrifuged at 13000 rpm for 15 minutes. The aqueous upper 
phase was transferred into the fresh tube. The RNA was precipitated by addition of 0.5 ml 
isopropanol and centrifuged at 13000 rpm for 10 minutes at 4°C. The RNA was subsequently 
washed in 70% EtOH/H2O-DEPC, air dried and resuspended in H2O-DEPC. DNAse treatment 
was performed with DNAse A (Roche) according to manufacturer’s instruction. RNA 
concentration was determined by OD measurement using Nanodrop 1000 spectrometer 
(ThermoScientific). Resuspended RNA was stored at - 80°C. 
For the microarray analysis RNA was isolated from ES cells using QIAGEN-mini-RNA kit 
according to manufacturer’s instructions and concentration was measured using the 
AgilentBioanalyzer. 
4.2. 1st strand cDNA synthesis 
1-2 µg RNA was mixed with 1µl polydT (500µg/ml, HAR089), 1µg dNTPs (10mM each, 
Eppendorf) and H2O at a final volume of 10µl).  Then the mix was incubated at 65°C for 5 
minutes and cooled on ice for 5 minutes. Afterwards 4µl 5x first strand buffer, 2µl 0.1M DTT 
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(both Invitrogen), and 1µl RNase Inhibitor (Roche) were added. The mixture was incubated for 
2 minutes at 42°C, before 1µl of Superscript II Reverse Transcriptase (Invitrogen) was added, 
and then incubated for 50 minutes at 42°C. The reverse transcriptase was inactivated at 70°C 
for 15 minutes, and the RNA of RNA:DNA duplexes was digested by incubation for 20 
minutes at 37°C with RNaseH (Invitrogen). The cDNA was subsequently diluted 1 in 10 with 
dH2O.  
4.3. Semiquantitative RT-PCR 
RT-PCR was performed using 2-3µl of the 1 in 10 dilution of 1st strand cDNA and the 
TAKARA Taq PCR system (see 2.2). Primers were designed to amplify cDNA across exon-
intron junctions and are listed in the Table 2. 
 
Table 2 – List of primers used in semi-quantitative RT-PCR 
Gene 
name 
# stock Sequence Annealing 
T, ˚C 
Product 
size, bp 
Nanog 
HAR1194 CCTCAGCCTCCAGCAGATGC 58 100 
HAR1195 CCGCTTGCACTTCACCCTTTG 
Oct3/4 
HAR2113 CACGAGTGGAAAGCAACTCA 
60 612 
HAR2114 CTGGGAAAGGTGTCCCTGTA 
Fgf5 
HAR2107 GCGACGTTTTCTTCGTCTTC 
60 492 
HAR2108 GAAGTGGGTGGAGACGTGTT 
Nestin 
HAR2101 GATCGCTCAGATCCTGGAAG 
60 491 
HAR2102 GCTCTGGGAGGACACCAGTA 
T 
HAR2095 CCGGTGCTGAAGGTAAATGT 
60 702 
HAR2096 ATTGTCCGCATAGGTTGGAG 
Mixl1 
HAR2188 AGTTGCTGGAGCTCGTCTTC 
60 444 
HAR2189 CTCCCAGATCTCCCTGAGTG 
Cer1 
HAR2085 GCTTGTTCTCTTGCCTCTGG 
60 502 
HAR2086 GTCTTCATGGGCAATGGTCT 
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Foxa2 
HAR2258double GTTAAAGTATGCTGGGAGCCG  
61 219 
HAR2259double CGCCCACATAGGATGACATG 
Hand1 
HAR2089 CGCCTGGCTACCAGTTACAT 
60 533 
HAR2090 TGGTCTTCTCCAGTCCCATC 
Eomes 
HAR2262double GGCAAAGCGGACAATAACAT 
60 300 
HAR2263double GTTTTGGTAGGCCGTCACAG 
 
Gata6 
HAR2079 GCCAACTGTCACACCACAAC 60 474 
HAR2080 CCTCTTGGTAGCACCAGCTC 
4.4. Real-time PCR 
Real-time PCR was performed using 3µl of 1 in 10 diluted 1st strand cDNA in a total reaction 
volume of 25µl. The reaction was performed using the TAKARA PCR system (see 1.4.2.) with 
the addition of 0.2µl SybrGreen (Roche, 1:100 dilution in TAKARA PCR 10x Buffer) and 
dH2O. Reaction conditions were  94°C 3’, 40x (94°C 5’’, 60°C 10’’, 72°C 15’’), plate read at 
72°C, 80°C, and 85°C, melting curve: from 60°C-99°C, read every 0.4°C 5’’.  Products were 
analyzed by agarose gel electrophoresis and melting curves. Values were calculated using the 
comparative ∆C(t) method and normalized to HPRT values. Primers were designed to amplify 
cDNA across exon-intron junctions and are listed in Table 3. 
 
Table 3 – List of primers used in real-time PCR 
Gene 
name 
# stock Sequence Annealing 
T, ˚C 
Product 
size, bp 
Axin2 
  
HAR1430 AAGCCTGGCTCCAGAAGATCACAA 
60 134 
HAR1431 TTTGAGCCTTCAGCATCCTCCTGT 
Sox2 
  
HAR1206 GGCAGCTACAGCATGATGCAGGAGC 60 
  
  
  
HAR1207 CTGGTCATGGAGTTGTACTGC 
Rex1 
  
HAR1196 GGACTAAGAGCTGGGACACG 60 
  
161 
  
HAR1197 CCTGCTTTTTGGTCAGTGGT 
Oct3/4 HAR1192 GAAGCAGAAGAGGATCACCTTG 58 129 
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  HAR1193 TTCTTAAGGCTGAGCTGCAAG   
Nanog 
  
HAR1194 CCTCAGCCTCCAGCAGATGC 58 
  
100 
  
HAR1195 CCGCTTGCACTTCACCCTTTG 
HPRT 
  
HAR1167 AGCTACTGTAATGATCAGTCAACG 60 
  
198 
  HAR1168 AGAGGTCCTTTTCACCAGCA 
 
4.5. Microarray analysis 
The in-house 47MM, 51MM and 52MM microarray platforms manufactured by Martin Radolf 
and Harald Scheuch (Biooptics department, IMP) were used to compare β-cateninfl/fl ES cells 
versus β- cateninΔ/Δ ES cells and upon stimulation with recombinant Wnt3a (R&D 
Biosystems). Microarrays were screened by hybridization with Cy3- and Cy5-labeled probes 
that were prepared by oligo-dT-primed reverse transcription of 3-5ug of total RNA in the 
presence of Cy3-dUTP or Cy5-dUTP. RNA was isolated from 2 clones of β-cateninfl/fl ES 
cells, 2 clones of β-cateninΔ/Δ ES cells and rWnt3a (R&D Biosystems)-treated ES cells clones. 
The activation and repression ratios of individual spots were calculated using GenePixPro5 
chip software. 
5. Luciferase assay 
5.1. Generation of stable TOPFLASH and FOPFLASH ES cell lines 
One day before infection with virus, ES cells were seeded onto 6-well plates at a concentration 
of 0,1X10E5 cells/well. The day of infection pBARLS and pfuBARLS lentiviruses (kindly 
provided by Randall Moon) were thawed on ice, mixed with ES cell medium at a 1:50 ratio and 
added to the cells. The next day, the medium was replaced with fresh medium containing 2 
µg/ml puromycin (Sigma). After 7 days of selection cells were pooled together, passaged 
several times, tested for responsiveness to Wnt-signaling activation using BIO and frozen in 
aliquots. These cells are in the following referred to as TOPFLASH and FOPFLASH reporter 
ES cell lines. 
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5.2. Luciferase activity measurement 
TOPFLASH and FOPFLASH reporter ES cell lines were seeded onto 12-well plates in 
concentration 0,5X10E5 cells/well in triplicates. On the next day the cells were treated with 
200ng/ml rWNT3a (R&D Systems), 50% Wnt3a condition medium (CM, kindly provided by 
R. Latham), 3 µM CHIR (Stemgent) or 2 µM BIO (Calbiochem). Cells treated with PBS served 
as a control. Luciferase assay was performed 24 hours later using Dual-Glo luciferase assay kit 
(Promega). All subsequent steps were performed in the dark. High glucose DMEM 
supplemented with 1% FCS (Sigma-Aldrich) was mixed 1:1 with lysis buffer (Dual-Glo 
luciferase substrate and buffer mix), 100 µl/well of this suspension was added. The plate was 
incubated on a shaker for 10 minutes at RT. Cells were resuspended by pipetting several times 
and 50 µl of the cell suspension were transferred into the white 96-well reader plate. Lysis 
buffer without cells was measured as blank control. Luciferase activity was measured in 
Synergy Fluorescence Plate Reader. For calculations the blank values were subtracted from 
experimental values and the activity of reporter was normalized to the activity of untreated 
cells.      
6. Western blot analysis 
6.1. Protein extraction from ES cells and EBs 
Frozen cell pellets were resuspended in appropriate amount of protein extraction buffer (a mix 
1:1 Tween20 buffer and NP40 buffer. Tween20-buffer: 50mM HEPES pH7.5, 150mM  NaCl, 
10mM EDTA, 0,2% Tween20; NP40-buffer: 1% NP40, 50mM TrispH7.5, 150mM   NaCl, 
10mM EDTA. Protease/Phosphatase inhibitors (Roche) added immediately before use). The 
obtained suspension was then incubated on ice for 5 minutes and centrifuged for 10 minutes at 
13000 rpm at 4 °C. The supernatant was transferred into a new tube, and protein concentration 
was measured using following method: 1µl supernatant diluted in 1ml 1:5 BIORAD Protein 
Assay: H2O incubated for 10 minutes at RT and ODλ595 was measured. Protein concentration 
was determined using following formula: 23,256 x OD595+0,109 =μg/μl. 
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6.2. Western Blot  
10µg of protein extract was mixed with 2x protein loading buffer (125mM Tris-HCl pH6.8, 4% 
SDS, 20% Glycerol, ß-Mercaptoethanol 1:20, 0.02% Bromophenol blue) and boiled at 95 °C 
for 5 minutes before it was chilled on ice and loaded onto the polyacrylamid gel. 8-10 % 
resolving gel and 4 % stacking gel were poured between two glass plates fixed in the plastic 
holder.  The gel was run at 40mA until the dye reached the resolving gel, then at 90mA. After 
separation the gel was equilibrated in transfer buffer for at least 10 minutes. PVDF membrane 
was briefly washed in 100% methanol, washed with H2O and then equilibrated in transfer 
buffer for 10 minutes. Wet blotting was performed at 400mA for 1 hour. Membrane was 
washed in TBST and then blocked with 4% non-fat milk in TBST for 1 hour at RT on a shaker 
before it was incubated with primary antibodies diluted in TBST for 1 hour at RT. Antibodies 
with dilutions used are listed in the Table 1. After washing 3 times in TBST for 5 minutes each 
membrane was incubated for 1 hour at RT with secondary antibodies diluted in TBST. After 
washing 3 times in TBST for 5 minutes, signals were detected with ECL Western Blot detection 
reagent (Amersham Biosciences) and the membranes were exposed to Hyperfilm ECL.  
7. Transmission electron microscopy 
Cells were grown for 2 days on gelatinized 12 mm UV-sterilized Aclar coverslips (kindly 
provided by Marlene Brandstaeter, EM facility). After rinsing in pre-warmed PBS cells were 
fixed in 2% glutaraldehyde for 1 hour RT, rinsed 3 times with PBS, osmicated with 2% OsO4 
and rinsed again 3x with PBS. Then the coverslips were dehydrated in a graded series of EtOH 
(40%, 60%, 80%, 95% and 100%) 10 minutes in each step. 
For embedding coverslips were incubated in a 1:1 100% EtOH/epoxy resin mixture for 30 
minutes at RT. Then they were transferred upside down onto drops of 100% resin in a plastic 
Petri dish and incubated for 30 minutes. This step was repeated one additional time. After 
preincubation coverslips were placed onto resin filled lids of Beem capsules and polymerized 
48 hours at 60°C. After polymerization Aclar coverslips were pilled off and resin blocks 
containing the cells were processed for sectioning on Leica Ultracut UCT microtome. Sections 
were collected on the metal grids, post-stained with Reynolds lead citrate (PbNO3)2 and uranyl 
acetate and images were taken using FEI Morgagni 268 electron microscope.           
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8. RNAi experiments 
8.1. Transient transfection of plakoglobin siRNA 
One day before transfection ES cells were seeded onto 6-well plates in concentration 2,5X10E4 
cells/well. The next day 7,5 µl Lipofectamine2000 (Invitrogen) were mixed with 250 µl of 
OptiMEM I (Gibco) and incubated for 5 minutes at RT. Meanwhile, 75µl (5µM stock) of anti-
plakoglobin OnTarget siRNA mix (Dharmacon) were mixed with 250 µl of OptiMEM I 
(Gibco), at the same time 75µl control anti-LaminA/C siRNA (Dharmacon) were mixed with 
250µl of OptiMEM I. Then, diluted Lipofectamine2000 was mixed with diluted siRNA and 
incubated for 20 minutes at RT. Finally, this mix was added to the cells with 2ml of ES cells 
medium in each well. After 24 hours ES cell medium was replaced.  
8.2. Generation of inducible plakoglobin RNAi β-catΔ/Δ ES cell line 
8.2.1. Generation of β-catΔ/Δ R26rtTA ES cell lines 
Targeting vector pR26/N-SA-rtTAsM2-pA was kindly provided by Martin Leeb (Anton Wutz 
lab, IMP). Schematic map of this vector is shown on the Fig. 7. This targeting vector contains 
as a backbone pBluescript and is a modified version of the pRosa26-1 vector from P.Soriano 
lab (Fig. 8), which contains 5’ and 3’ homology arms of Rosa26 gene and a negative-selection 
diphtheria toxin (DTA) cassette under control of phosphoglycerate kinase (PGK) promoter 
downstream of 3’ homology arm. rtTA cassette was inserted between the splice acceptor (SA) 
and polyadenylation (polyA) site. For positive selection a neomycin (Neo) resistance cassette 
under control of PGK promoter was inserted downstream of polyA site. 
8.2.2. Linearization of targeting vector and DNA purification 
50µg of pR26/N-SA-rtTAsM2-pA targeting construct were digested in a total volume of 300µl 
5x with 5µl of ClaI restriction enzyme (20 U/µl, New England Biolabs) according to the 
manufacturer’s instructions. The digest was performed for 4 h at 37°C. The DNA was purified 
by the addition of 30µl 3M sodium acetate (pH 7,5) and 300 µl 
phenol/chloroform/isoamylalcohol (25:24:1). The three reactions (300 µl each) were merged in 
15ml Falcon tube and centrifuged 30 minutes at 13200 rpm at RT. Supernatant was transferred 
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to a new tube and DNA was precipitated by addition of 1:10 100 % cold ethanol. Precipitated 
DNA in ethanol was chilled ON at -20°C. After centrifugation at 13200 rpm for 15 minutes at 
4°C the supernatant was discarded. DNA pellet was washed with 70% cold ethanol (-20°C) 2 
times and air dried for 1 hour. DNA was resuspended in 150 µl TE. 
 
 
Figure 7 - Generation of inducible RNAi β-catΔ/Δ ES cell line 
(A) pR26-SA-rtTA-pA-Neo targeting construct was linearized with ClaI restriction enzyme and electroporated into 
β-catΔ/Δ ES cells. After homologous recombination in Rosa26 locus correctly targeted clones were screened by 
Southern blot and several β-catΔ/Δ R26rtTA ES cell lines were expanded (B) pSiren-RetroQ-Tet plasmid was 
transfected into β-catΔ/Δ R26rtTA ES cell line. Puromycin-resistant colonies were expanded and final lines were 
named inducible plakoglobin RNAi β-catΔ/Δ ES cells.   
8.2.1. Electroporation of β-catΔ/Δ ES cells with targeting constructs 
ES cells were expanded in T25 flask until nearly confluent. Cells were trypsinized, spun down 
at 1000 rpm and resuspended in 10ml of prewarmed 1xPBS. After washing the cells were 
resuspended in 800µl 1xPBS and transferred into the 0,4mm electroporation cuvette (Biorad). 
50 µg of linearized targeting construct were added into the same cuvette. After careful mixing 
A B 
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to avoid bubbles, electroporation was performed at 25 and 400V in two pulses with 
GenePulserII (Biorad). Afterwards the cells were resuspended in prewarmed ES cell medium 
and plated on five 15 cm cell culture dishes. 
 
8.2.2. Selection for neomycin-resistant ES cell clones 
Electroporated ES cells were cultured ON in ES cell medium.  After 24 hours medium was 
replaced by ES cell medium containing G418 (Gibco) at concentration 750µg/µl. Cells were 
kept under these selection condition for about 7 days, then single resistant ES cell colonies were 
picked, trypsinized and plated individually into 96-well plates followed by further expansion, 
freezing and Southern blot analysis. 
 
 
Figure 8 - Map of pRosa26-1 vector (from P. Soriano) 
Plasmid contains Rosa26 5’ fragment, XbaI – cloning site, Rosa26 3’ fragment and PGK-DTA bpA cassette. PGK 
- phosphoglycerate kinase, DTA - diphtheria toxin A, bpA - polyA sequence  
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8.2.3. Hairpin design 
Design of plakoglobin specific small hairpin RNAs (shRNAs) and further generation of 
inducible plakoglobin RNAi β-catΔ/Δ ES cell line was done using the Knockout Tet RNAi 
System P (Clontech).  
The four hairpins (see below) were designed according to the manufacturer’s instructions and 
contained a sense (green) and antisense (red) sequences for the plakoglobin mRNA, a hairpin 
loop sequence in the middle, a termination sequence poly(T) and 5’ BamHI and 3’ EcoRI 
overhangs (indicated in yellow) for directional cloning into pSiren-RetroQ-Tet vector. ClaI 
restriction enzyme (grey) was included after poly(T) for the confirmation of cloned insert after 
ligation and transformation reactions.   
 
Hairpin 1 HAR2055 (Top strand) 
5’GATCCGACACCTACGACTCGGGCATTTCAAGAGAATGCCCGAGTCGTAGGTGTTTTTTTATCGATG3’ 
Hairpin 1 HAR2056 (Bottom strand) 
3’GCTGTGGATGCTGAGCCCGTAAAGTTCTCTTACGGGCTCAGCATCCACAAAAAAATAGCTACTTAA5’ 
Hairpin 2 HAR2057 (Top strand) 
5’GATCCGCCAAGCTGCTCAACGATGATTCAAGAGATCATCGTTGAGCAGCTTGGTTTTTTATCGATG3’ 
Hairpin 2 HAR2058 (Bottom strand) 
3’GCGGTTCGACGAGTTGCTACTAAGTTCTCTAGTAGCAACTCGTCGAACCAAAAAATAGCTACTTAA5’ 
Hairpin 3 HAR2059 (Top strand) 
5’GATCCGGGAACTACAGCTACGAGAATTCAAGAGATTCTCGTCGCTGTCGTTCCTTTTTTATCGATG3’ 
Hairpin 3 HAR2060 (Bottom strand) 
3’GCCCTTGATGTCGATGCTCTTAAGTTCTCTAAGAGCAGCGACAGCAAGGAAAAAATAGCTACTTAA-5’ 
Hairpin 4 HAR2061 (Top strand) 
5’GATCCGTGAGTGTAGATGACGTCAATTCAAGAGATTGACGTCATCTACACTCATTTTTTATCGATG3’ 
Hairpin 4 HAR2062 (Bottom strand) 
3’GCACTCACATCTACTGCAGTTAAGTTCTCTAACTGCAGTAGATGTGAGTAAAAAATAGCTACTTAA5’ 
 
 
Annealing of oligonucleotides and ligation the double-stranded oligonucleotides into pSiren-
RetroQ-Tet was done according to the manufacturer’s instructions. After ligation and 
purification, pSiren-RetroQ-Tet plasmids (several clones for each hairpin) were sequenced 
using HAR2187 primer 5’-CTTGAACCTCCTCGTTCGACCCCGCCTC-3’ to find the correct 
insertion of the hairpins. 
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8.2.4. Transfection of pSiren-RetroQ-Tet-plako-shRNA vector 
One day before transfection β-catΔ/Δ ES cell were seeded onto 6-well plates in concentration 
2,5X10E4 cells/well. The next day 9µl Lipofectamine2000 (Invitrogen) were mixed with 250 µl 
of OptiMEM I (Gibco) and incubated for 5 minutes at RT. Meanwhile, 3µg of DNA were 
mixed with 250µl of OptiMEM I (Gibco). Then, diluted Lipofectamine2000 was mixed with 
diluted DNA and incubated for 20 minutes at RT. Finally, the mix was added to the cells with 
2ml of ES cells medium in each well. After 24 hours the medium was replaced with fresh one 
supplemented with 2µg/ml Puromycin (Gibco). After 6 days under puromycin selection 
resistant colonies were picked and amplified.  
9. Generation and analysis of rescued ES cells 
9.1. Cloning and transfection of pCAGGS constructs 
9.1.1. Linearization of pCaggs-PGKneo and inserts 
The WT β-catenin open reading frame (ORF) was excised from HAR755 plasmid by double 
digestion with Asp718 and XhoI restriction enzymes in buffer B (Roche) for 2 hours at 37°C. 
The ORFs of myc-tagged ΔC and M6 human β-catenin were excised from HAR991 and 
HAR992 plasmids respectively by double digestion with Asp718 and XbaI restriction enzymes 
in buffer B (Roche) for 2 hours at 37°C. The pCAGGS-PGKneo plasmid (HAR423) was 
linearized by digestion with XhoI restriction enzyme in buffer H (Roche) for 2 hours at 37°C.  
To fill the 5’ overhanging ends generated by the restriction enzymes 1µl of 10mM each dNTPs 
(Takara) and 1 µl Klenow enzyme (1 U/µl, Roche) were added to 50µl of digested DNA and 
incubated at 37°C for 15 minutes. Enzyme was inactivated by incubation at 75°C for 10 
minutes. 
To dephosphorylate the 5’ ends after linearization and 5’ repair 5µl of 10x Antarctic 
phosphatase buffer and 1µl Antarctic phosphatase (both Roche) were added to 50µl of 
linearized vector DNA and incubated for 15 minutes at 37°C.   
After blunting and dephosphorylation products were loaded on the 0,8% TAE gel and run at 
120V until bands were separated. Correct sized bands were cut out and DNA was extracted 
with QIAGEN gel purification kit according to manufacturer’s instructions.  
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9.1.2. DNA ligation and transformation of competent E.coli cells 
For ligation 9,5µl fragment DNA and 0,5µl vector were mixed with 10µl Takara ligation 
solution I (Takara Inc.) and incubated in a 16 °C water bath ON.  
The next day DH5α competent frozen E.coli cells (-80°C) were incubated on ice for 20 minutes. 
200µl of DH5α cells were then mixed with the ligation reaction and incubated on ice for 30 
minutes. The DNA was transformed into DH5α cells by heat-shock for 1 minute 30 seconds at 
42°C. After transformation the mixture was left on ice for 5 minutes. Then 700µl LB without 
antibiotics was added and E. colis were incubated for 30 minutes at 37°C and centrifuged for 1 
minute at 13500 rpm. The cell pellet was resuspended in 100µl of LB with 50µg/ml ampicillin, 
plated on LB+Amp plates using glass beads and incubated ON in 37°C incubator. 
Single colonies were picked and grown in LB+Amp for subsequently mini-prep analysis 
(Qiagen mini prep kit). After restriction analysis, positive correctly orientated clones were 
verified by sequencing and subsequently maxi-preped (Promega Maxi prep kit). 
9.1.3. Transfection of β-cateninΔ/Δ ES cells with unlinerized plasmid 
DNA 
One day before transfection ES cells were seeded onto 6-well plates in concentration 2,5X10E4 
cells/well. The next day 9µl Lipofectamine2000 (Invitrogen) were mixed with 250 µl of 
OptiMEM I (Gibco) and incubated for 5 minutes at RT. Meanwhile, 3µg of DNA were mixed 
with 250µl of OptiMEM I (Gibco). Then, diluted Lipofectamine2000 was mixed with diluted 
DNA and incubated for 20 minutes at RT. Finally, the mix was added to the cells with 2ml of 
ES cells medium in each well. After 24 hours the medium was replaced with fresh one 
supplemented with 600µg/ml G418 (Gibco). After 6 days under G418 selection resistant 
colonies were picked and amplified. 
9.2. Generation of WT, ΔC and M6 targeting vectors 
9.2.1. Targeting vector description 
Targeting vector pR26-SA-XbaI-pA-loxP-hygro-loxP was kindly provided by Karen Ng (Anton 
Wutz lab, IMP). This targeting vector contains as a backbone pBluescript and is a modified 
version of the pRosa26-1 vector from P.Soriano lab (Fig. 8), which contains 5’ and 3’ 
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homology arms of Rosa26 gene and the DTA cassette downstream of 3’ homology arm. An 
XbaI cloning site was inserted between the SA and the polyA sites. pRosa26-1 vector was 
modified by inserting the SA and polyA sites fused to the XbaI site in between  the 5’ and 3’ 
homology arms. In addition, a hygromycin resistance (HygroR) cassette surrounded by loxP 
sites was inserted downstream of polyA site. 
9.2.2. Linearization of targeting vector and inserts 
The WT β-catenin ORF was excised from HAR755 plasmid by double digestion with Asp718 
and XhoI restriction enzymes in buffer B (Roche) for 2 hours at 37°C. The ORFs of myc-
tagged ΔC and M6 human β-catenin were excised from HAR991 and HAR992 plasmids 
respectively by double digestion with Asp718 and XbaI restriction enzymes in buffer B (Roche) 
for 2 hours at 37°C. The pR26-SA-XbaI-pA-loxP-hygro-loxP vector was linearized by 
digestion with XbaI restriction enzyme in buffer H (Roche) for 2 hours at 37°C. Blunting of the 
insert ends, dephosphorylation of the vector and ligation were performed as described in section 
9.1.1. 
9.2.3. Linearization of the targeting constructs 
50µg of WT and ΔC β-catenin targeting constructs were digested in a total volume of 300µl 
with 5µl of ClaI restriction enzyme (20 U/µl, New England Biolabs) and the M6 targeting 
construct was digested with AclI restriction enzyme (New England Biolabs) according to the 
manufacturer’s instructions. The rest was done as in the chapter 8.2.2 
9.2.4. Electroporation of β-cateninΔ/Δ ES cells with targeting 
constructs 
The same procedure as in the chapter 8.2.3 
9.2.5. Selection for neomycin-resistant ES cell clones 
Electroporated ES cells were cultured ON in ES cell medium.  After 24 hours medium was 
replaced by ES cell medium containing G418 (Gibco) at concentration 750µg/µl. Cells were 
kept under these selection condition for about 7 days, then single resistant ES cell colonies were 
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picked, trypsinized and plated individually into 96-well plates followed by further expansion, 
freezing and Southern blot analysis. 
10. Mini-Southern and Southern blot 
10.1. Mini-Southern blot 
Day1: Cell lysis in 96-well plate 
ES cells clones resistant to hygromycin were cultured in a 96-well plate until they were 
confluent and medium turned yellow twice a day. Before lysis cells were washed 2 times with 
PBS, 50 µl of ES-cell lysis buffer (Chapter 2.1) were added per well and incubated ON at 60°C 
in a moist chamber.  
Day 2: Isolation of genomic DNA and restriction digest in 96-well plate 
150 µl/well of salt/ethanol solution (150 µM NaCl per 10ml 100%EtOH) were added carefully 
to precipitate DNA, plates were left undisturbed for 2 hours. The solution was removed by 
flipping the plate upside down and blotting it on paper towels. The precipitated DNA was 
washed 3 times with 70% EtOH and airdried for 1 hour at RT. 
For the DNA restriction digest 30 µl/well of the restriction mix (3 µl of 10 x restriction buffer, 
0,3 µl spermidine (100 mM), 0,3 µl RNase A (10 mg/ml), 20 U of BamHI enzyme, H2O to a 
total volume of 30 µl) was added. Plates were incubated for 30 minutes at 37°C on a shaker; 
the digestion was performed ON at 37°C in the incubator. 
 
Day 3: Southern blotting  
1 µl/well of 6 x loading buffer were added to the 30 µl of digested genomic DNA and the 
samples were loaded on 0,8 % agarose gel containing TBE as a buffer. Electrophoresis was 
performed at 55 V for at least 5 hours. A picture was taken against fluorescent ruler and the 
DNA was nicked under UV light for 5 minutes. For depurination the gel was incubated for 15 
minutes in 0,125M HCl. Then the gel was rinsed with deionized H2O and incubation for 30 
minutes in 0.4 M NaOH to denature the douplestranded DNA. Southern blotting by capillary 
transfer was set up using a Hybond N+ nitrocellulose membrane (GE Healthcare) for at least 
24 hours in 0.4 M NaOH as transfer buffer. 
Day 4: Hybridization and exposure 
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Blot was disassembled and DNA was crosslinked to the membrane using a Stratagene UV 
Crosslinker. 
The 5’ external probe was excised from a plasmid HAR730 with EcoRI restriction enzyme 
(New England Biolabs), separated from the vector by electrophoresis and purified from the gel 
with Gel purification kit (Qiagen). 25 ng of the probe were labelled with 32P dCTPs using the 
RediPrime II Random Labelling Kit (GE Healthcare) according to the manufacturer’s 
instructions. The labelled probe was separated from unincorporated radioactive nucleotides 
with a G-50 ProbeQuant microcolumn (GE Healthcare). The membrane was pre-hybridized in 
25 ml Church’s buffer (1% BSA, 1mM EDTA, 0.5M NaPi, 7% SDS) for 1 hour at 65°C. The 
labelled probe was heated to 95°C for 5 minutes, chilled on ice and spun down and then added 
to the 25 ml Church’s in the hybridization tube. The hybridization was carried out at 65°C ON. 
After discarding the hybridization solution, the membrane was washed three times for 30 
minutes each in Southern-Washing buffer (40ml 1M NaPi (pH7.2), 100ml 20% SDS, up to 2L 
with H20) 
The membrane was sealed with Saran wrap and exposed in exposure cassette with X-Omat 
Blue film (Kodak) at -80°C for 4-5 days. 
10.2. Southern blot 
For Southern Blot analysis 15 µg of genomic DNA were digested with BamHI enzyme. The 
reactions contained the following components: 15 µg of genomic DNA, 3 µl of 10 x restriction 
buffer, 2 µl of restriction enzyme (10 U/µl), 0.3 µl of RNase A (10 mg/ml) and H2O was added 
to a total volume of 30 µl. 
The reaction was incubated at 37°C ON. The next day additional 10U of enzyme were added. 
After an additional incubation at 37°C for 2 hours, loading buffer was added to the samples and 
they were loaded on a 0.8% agarose gel containing TBE as buffer. The digested DNA was 
separated on the gel for at least 5 hours at 55 V. The blot was set up and hybridized as 
described in the section “Mini-Southern Blot”.  
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Results 
1. β-catenin and self-renewal of mouse ES cells 
1.1. Generation of new β-catenin-deficient ES cell lines   
ES cells were derived from 3.5 dpc old blastocysts of β-catenin fl/fl intercrossed females 
(Huelsken et al., 2001) and isolated on a feeder layer in the presence of LIF. Initially, two 
individual β-catenin fl/fl (β-catfl/fl) ES cell lines were established and tested, but only (NLβ-12) 
was chosen for further experiments described later. The expanded ES cell line, which was 
injected into blastocysts gave chimaeras and transmitted through the germline (Fig. 9A, B). 
This experiment confirmed that the chosen ES cell line was fully pluripotent. After the initial 
establishment of β-catfl/fl ES cell lines, the lines were propagated without feeder layer in the 
presence of LIF and serum.  
 
 
Figure 9- The β-catfl/fl ES cell line (NLβ-12) contributes to chimaeras and is transmitted through the 
germline 
(A) Chimaeric pups showing varying contribution of β-catfl/fl ES cells. Genotyping of these pups (1, 3, 10, 4, 30, 
40) correlates with their coat color, with 1 being highly chimaeric and 4 having low chimaerism. (B) The high 
(80%) chimaeric female was mated to C57BL/6 (black) male and produced one agouti pup, indicating the 
transmission of the β-catfl/fl derived genome. Genotyping of these pups confirmed that the agouti pup (1) is 
heterozygous for the β-catenin floxed allele. 
 
B A 
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From the β-catfl/fl ES-cells several β-catenin-deficient ES (β-cat∆/∆) cell lines were established 
through infection with an Adeno-Cre virus. Individual subclones were generated by dilution 
cloning and genotyped by PCR in order to identify β-cat∆/∆ ES cell clones (Fig. 10A).  Two 
independent β-cat∆/∆ ES subclones (3B and 1B) were used for further characterization (Fig. 
10A). The β-cat∆/∆ ES cells showed a similar proliferation behavior as control β-catfl/fl ES cells 
(Fig. 10B). β-cat∆/∆ ES cell colonies resembled those of β-catfl/fl ES cells in their appearance, 
with the exception that an increased number of single cells were noted in the cultures (Fig. 
10C).  
 
Figure 10 – Genotyping and 
growth of β-catfl/fl and β-
catΔ/Δ ES cells lines 
 
(A) PCR genotyping of DNA 
isolated from subclones after 
infection with AdenoCre virus 
and subcloning. (B) Population 
doublings of cultures of 
indicated β-catfl/fl and β-catΔ/Δ 
ES cells lines grown for 5 days 
on gelatinized plates in ES cell 
media containing LIF without 
feeder layer. Every day cells 
were collected and counted. 
Error bar=SEM  
(C) Morphological appearance 
of β-catl/fl and β-catΔ/Δ ES cells 
lines.  Arrows indicate single 
cells. 
 
 
 
 
 
 
 
 
To address whether it is possible to culture β-cat∆/∆ ES cells without serum, I employed the 
serum-free cell culture system called 2i (Ying et al., 2008). This media consists of N2 and B27 
supplements plus 1µM mitogen-activated protein kinase kinase (MEK) inhibitor PD0325901 
and 3µM Gsk3 inhibitor CHIR99021. Addition of 1000U/ml LIF to this culture media promotes 
the propagation of WT ES cells (Dr. A. Smith, personal communications). Interestingly, the 
A 
B 
C 
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morphology of β-catfl/fl and β-cat∆/∆ ES cells changed already one day after replacing the 
normal ES cell medium-containing serum and LIF with the 2i + LIF medium (Fig. 11): for both 
genotypes the ES cell colonies became more compact. However, after several passages in 
serum-free medium β-cat∆/∆ ES cells started to detach from the gelatin-coated tissue culture 
dishes, while control β-catfl/fl ES cells were growing normally. This defect could not be rescued 
by culturing the cells on a more adhesive surface, such as a laminin-coated surface. Thus, this 
result suggests that β-cat∆/∆ ES cells have a defect in cell-to-surface adhesion in a serum-free 
cell culture system.   
To explain why the slight morphological defect was observed in serum-containing and serum-
free cultures, I decided to check the localization of adhesion-related molecules in β-cat∆/∆ ES 
cells. Colonies of β-cat∆/∆ ES cells stained negative for β-catenin by immunofluorescence (IF) 
in contrast to control colonies, where β-catenin was expressed in the cell membranes (Fig. 
12A). However, the staining for plakoglobin was increased in β-cat∆/∆ ES cells (Fig. 12B), 
while the E-cadherin staining was unchanged (Fig. 12C). These data were confirmed by 
Western Blot analysis, which revealed a 2-3 fold increase in plakoglobin levels in β-cat∆/∆ ES 
cells, while E-cadherin levels were not altered (Fig. 12D). However, no significant change was 
observed in plakoglobin transcript levels by real-time PCR analysis (data not shown).  Thus, 
similar to what has been observed in F9 teratocarcinoma stem cells, plakoglobin probably 
substitutes for β-catenin in cell-cell adhesion in ES cells (Fukunaga et al., 2005).  
 
Figure 11 – Culturing β-catfl/fl and β-cat∆/∆ ES cells in serum-free medium  
Phase-contrast images showing morphology of β-catfl/fl and β-cat∆/∆ ES cells in LIF+serum medium or in serum-free 
2i +LIF medium after 1 passage. Images were taken with 10x objective. 
Natalia Lyashenko Results 
[62] 
 
 
Figure 12 – Adhesion-specific molecules in β-catfl/fl and β-catΔ/Δ ES cells 
(A) β-catenin localizes to the membrane in β-catΔ/Δ ES cells, but is absent in β-catfl/fl. (B) E-cadherin is localized to 
the membrane in both β-catΔ/Δ and β-catfl/fl ES cells. (C) Plakoglobin localizes to the membrane and its levels are 
much higher in β-catΔ/Δ ES cells. (D) Western blot analysis showing that β-catenin protein is absent in β-catΔ/Δ ES 
cells, E-cadherin levels are not changed and plakoglobin levels are increased in β-catΔ/Δ ES cells. Scale bars = 
10µm. 
In the literature it has been reported that plakoglobin has a weak signaling activity in vitro and 
that overexpression of plakoglobin in a β-catenin deficient (β-catlacZ/lacZ) ES cell clone can 
activate a TOPFLASH reporter, suggesting that plakoglobin might also be able to substitute in 
part for the β-catenin signaling activity (Conacci-Sorrell et al., 2002; Williams et al., 2000). 
Thus, I analyzed next whether there was a detectable endogenous TCF-mediated gene 
expression using a new, highly sensitive lentiviral luciferase reporter called BAR (Beta-catenin 
Activated Reporter), which contains 12 multimerized TCF binding sites and a control reporter 
fuBAR (found-unresponsive Beta-catenin Activated Reporter), containing mutagenized TCF 
binding sites (Biechele and Moon, 2008).  β-catfl/fl control and β-cat∆/∆ ES cells were infected 
with the BAR (TOPFLASH) or the fuBAR (FOPFLASH) lentiviruses, and selected for 
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puromycin-resistant ES cell clones. After one week of puromycin selection resistant clones of 
infected β-catfl/fl or β-cat∆/∆ ES cells were pooled together, respectively, and used for luciferase 
assay measurements.   Only minor reporter activity could be detected in control β-catfl/fl ES 
cells as well as in β-cat∆/∆ ES cells without external stimulation (Fig. 13B).    
 
 
 
Figure 13 - Activation of Wnt signaling in β-catfl/fl but not in β-catΔ/Δ ES cells 
(A) Luciferase assay in puro-resistant, stable β-catfl/fl and β-cat∆/∆ ES cells infected with the lentiviral β-catenin 
TOPFLASH (BAR) or FOPFLASH (fuBAR) reporter. Results from triplicates after 24h treatment without 
stimulation (-) or after stimulation with rWnt3a, Wnt3aCM or BIO. At least three independent measurements per 
sample were performed. Data were normalized to TOPFLASH values of either untreated β-catfl/fl or β-cat∆/∆ ES 
cells. Control FOPFLASH (fuBAR) luciferase measurements shown on the left. (B) Basic TOPFLASH activity of 
untreated β-catfl/fl or β-cat∆/∆ ES cells. Data were normalized to FOPFLASH reporter (C) Real-time PCR analysis 
of Axin2 transcript levels in β-catfl/fl and β-cat∆/∆ ES cells. Error bars=SEM *p<0.05; **p<0.01 (Anova with Tukey 
HSD test).  
 
 
This result is consistent with previously published observations (Anton et al., 2007), where only 
low or no detectable TOPFLASH activation was detected in unstimulated WT ES cells. 
However, upon stimulation with either Gsk3 inhibitor BIO (Sato et al., 2004), recombinant  
To determine the functional consequence of canonical Wnt signaling activation by external 
stimulation on endogenous target genes, I extended my analysis to a known TCF target gene, 
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Axin2 (Jho et al., 2002). I measured Axin2 gene expression levels 24 hours after stimulation 
with Wnt3aCM and BIO by real-time PCR (Fig. 13B). Control and β-cat∆/∆ ES cells had similar 
low levels of Axin2 without stimulation. However, upon stimulation with Wnt3aCM or BIO 
Axin2 was two and three-fold increased respectively in control, but not in β-cat∆/∆ ES cells.      
Thus, my data suggest that β-cat∆/∆ ES cells are not responsive to Wnt stimulation and that the 
2-3 fold increase in total plakoglobin levels cannot substitute for β-catenin/TCF-mediated 
signaling activity.  
1.2. Generation of CAG WT, ΔC and M6 ES cells  
In order to address whether reintroduced wild-type (WT) mouse β-catenin would be functional 
in transcription I stably expressed it in β-cat∆/∆ ES cells. In parallel I established β-cat∆/∆ ES 
cells expressing two putative signaling-defective versions of human β-catenin, C-terminus 
deleted (ΔC) Δ696-781 aa and L774A/W776A (M6), which were myc-tagged at their N-termini 
(Fig. 14A, both gifts from Dr. R. Grosschedl). The C-terminus of β-catenin contains the 
transactivation domain, which has been reported to interact with multiple transcriptional co-
activators. The two point mutations (L774A/W776A) in C-terminus of β-catenin have been 
shown to impair, in part, the transactivation potential of full-length β-catenin (Sustmann et al., 
2008). 
For long-term stable expression, I used a neomycin-selectable vector in which the transgene 
expression is under control of a CMV early enhancer/chicken β actin (CAG) promoter, because 
in initial experiments driving β-catenin expression by a CMV promoter β-catenin was hardly 
detectable by western blot (data not shown). The CAG promoter has been reported to result in 
higher levels of transgene expression in mouse ES cells in comparison to the CMV promoter 
(Alexopoulou et al., 2008). Thus, I cloned WT, ΔC or M6 β-catenin ORFs into pCAGGS-
PGKneo plasmid and established several stable ES cells lines for each β-catenin variant. 
Western blot analysis confirmed that WT, myc-tagged ΔC or M6 β-catenin were expressed at 
significant levels in the clones that I chose for further experiments (Fig. 14C). 
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Figure 14 – Generation of pCAGGS WT, ΔC and M6 rescued β-catΔ/Δ ES cells 
(A) Schematic representation of the rescue β-catenin constructs. NTD, N-terminal domain (blue); CTD, C-terminal 
domain (red); Arm repeats are in yellow. Nubmers indicate amino acids. (B) IF images of β-catfl/fl and β-cat∆/∆ ES 
cells as well as β-cat∆/∆ ES cells rescued with WT, ΔC or M6 β-catenin variants. β-catenin is stained in green, an 
anti-C-terminal β-catenin antibody was used with the exception of ΔC rescued cells, which were stained with an 
anti-myc antibody, DAPI nuclear staining is blue. Scale bar = 10µm. (C) Western blot analysis of β-cat∆/∆ ES cells 
rescued with WT, ΔC or M6 β-catenin variants. Membranes were blotted with anti-N-terminal β-catenin antibodies 
and anti-myc antibodies. Anti-tubulin staining was used as a loading control. (C) TOPFLASH reporter assay in ES 
cell lines stably expressing TOFLASH (BAR) reporter. Luciferase activity was measured 24 hours after treatment 
with CHIR99021 in triplicates. Experiment was repeated at least 3 times. Data were normalized to TOPFLASH 
values of β-catfl/fl untreated cells. Error bar=SEM. 
 
 
 
A B 
C 
D 
Natalia Lyashenko Results 
[66] 
 
Immunocytochemical stainings revealed that WT, ΔC or M6 β-catenin proteins all localized to 
the cell membrane in β-cat∆/∆ ES cells (Fig. 14B), similar to the β-catenin localization in control 
β-catfl/fl ES cells.  
In order to assess responsiveness to activation of Wnt signaling in the rescued β-cat∆/∆ ES cells, 
I infected WT (clone2), ΔC (clone1) or M6 (clone1) β-catenin rescued ES cells with the 
TOPFLASH lentiviral reporter. Upon stimulation with CHIR99021, a Gsk3 inhibitor (Bain et 
al., 2007; Murray et al., 2004), TOPFLASH reporter activity was increased in the β-catfl/fl 
control cells and WT β-catenin rescued ES cells, but not detectable in β-cat∆/∆ ES-cells or ΔC β-
catenin rescued ES cells (Fig. 14D). However, consistent with previous observations slight 
transcriptional activity was observed in the M6 β-catenin rescued ES cells (Sustmann et al., 
2008).  
Notably, TOPFLASH reporter activity correlated with β-catenin protein levels in the β-catfl/fl 
and WT β-catenin rescued ES cell lines. Transcriptional activity in WT rescued β-catenin cells 
(WT resc 2 in Fig. 14A), in which β-catenin levels were approx. 3 times lower than in WT (fl/fl 
in Fig. 14A), was only at 30% of the control β-catfl/fl cells. My data show that all the products of 
all three re-expressed β-catenin transgenes localize to the cell membrane and I could clearly 
establish that the ΔC β-catenin variant cannot participate in TCF-mediated signaling.  
1.3. Analysis of self-renewal using β-catenin-deficient ES cells 
1.3.1. Self-renewal is not affected in the absence of β-catenin  
As described earlier, β-catfl/fl ES cells can contribute to chimaeras and the germline. This 
knowledge allowed me to study self-renewal and pluripotency potentials of β-catfl/fl and their 
derivative β-cat∆/∆ ES cells. Therefore, I analyzed transcriptional levels and protein expression 
of a number of stem cell markers in β-catfl/fl and β-cat∆/∆ ES cell lines.  Both ES cell lines are 
positive for alkaline phosphatase (AP) at early and late passages (Fig. 15A and data not shown). 
No differences in transcriptional expression levels were found for the stem cell specific 
transcription factors Oct-3/4, Nanog, Rex-1/Zfp42 and Sox2 using real-time PCR (Fig. 15B). 
Protein levels of Nanog and Oct-3/4 analyzed by western blot analysis were similar between β-
catfl/fl and β-cat∆/∆ ES cells (data not shown). FACS analysis showed no difference in the 
expression levels of SSEA-1, an antigen expressed specifically in undifferentiated ES cells (Fig. 
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15C). Immunofluorescent analysis of Nanog and Oct3/4 revealed normal localization in the 
nucleus (Fig. 15D and data not shown). Furthermore, phospho-Stat3 levels upon LIF 
stimulation were also not altered (Fig. 15E). These results suggest that there is no defect in self-
renewal potentials of β-cat∆/∆ ES cells. 
 
 
 
 
Figure 15 - Self-renewal markers in β-catfl/fl and β-cat∆/∆ ES cells are not affected 
(A) Colony morphology and AP expression at passage 13. (B) Quantitative RT-PCR analysis of transcription 
factors involved in self-renewal showed no change. mRNA levels of these genes were normalized to HPRT mRNA 
levels. (C) β-cat∆/∆ ES cells stained with anti-SSEA1 antibodies were analyzed by FACS sorting. As a control (left 
FACS blot) cells were only stained with the Alexa488-coupled secondary antibodies. (D) IF staining of Nanog 
showed localization in the nucleus. Nuclei were counterstained with DAPI (blue). (E) Western blot showing 
normal kinetics of STAT3 phosphorylation (anti-p-STAT3 (705Tyr)) upon treatment with 1000U/ml LIF and the 
corresponding total STAT3 levels.    
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1.3.2. Requirement of β-catenin for self-renewal maintenance 
Activation of the canonical Wnt/β-catenin pathway via Wnt3a CM or the GSK3 inhibitor BIO 
can maintain mouse and human ES identity (Sato et al., 2004). However, none of these factors 
is absolutely specific for the Wnt/β-catenin pathway (Bain et al., 2003; Ogawa et al., 2006). 
Thus, I addressed the question whether the effects mediated by BIO, rWnt3a, Wnt3a CM or 
CHIR treatment on self-renewal maintenance of murine ES cells require β-catenin activity 
using our β-catenin-deficient ES cells. For the self-renewal assay, ES cells were plated at low 
density (20000cells/well) and cultured for 5 days in the presence or absence of LIF and stained 
for AP. In contrast to 5 day cultures on gelatin in the presence of LIF, withdrawal of LIF 
resulted in differentiation of β-catfl/fl and β-cat∆/∆ ES cells (Fig. 16A). Replacement of LIF with 
200 ng/ml rWnt3a maintained self-renewal in control β-catfl/fl, but not in β-cat∆/∆ ES-cells (Fig. 
16A). Similar results were obtained with 3µM CHIR (Fig. 17, upper panel). In contrast, self-
renewal was maintained in β-catfl/fl, but also in β-cat∆/∆ ES cells upon treatment with either 
Wnt3a CM (50%) or 2.5 µM BIO (Fig. 16A). This suggests that Wnt3a CM contains additional 
components that can activate other self-renewal pathways thereby substituting for the loss of β-
catenin and that BIO is probably a less specific inhibitor than CHIR. In addition, I determined 
the expression levels of the self-renewal marker nanog by real-time PCR 24 hours after 
changing the culture conditions. As expected nanog expression levels were reduced upon LIF 
withdrawal in β-catfl/fl control and β-cat∆/∆ ES cells (Fig. 16B).  Interestingly, nanog expression 
was maintained in β-cat∆/∆ ES cells treated with Wnt3a CM or BIO at levels similar to LIF 
treated ES cells, however, no up-regulation of nanog expression as seen in stimulated β-
catfl/fl control ES cells was observed (Fig. 16B).  This suggests that β-catenin activity is 
required for nanog transcriptional activation induced by Wnt3a CM or BIO, in agreement with 
previous reports that nanog is regulated by canonical Wnt signaling (Takao et al., 2007). 
However, after 5 days of treatment with rWnt3a Nanog protein levels were maintained in 
control ES cells, but not in β-catenin-deficient ES cells (Fig. 16C), suggesting that rWnt3a acts 
directly through β-catenin to support self-renewal of mouse ES cells.  
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Figure 16 - Self-renewal potentials of β-catfl/fl and β-catΔ/Δ ES cells upon activation of Wnt signaling  
(A) Morphology of β-catfl/fl and β-cat∆/∆ AP-stained colonies. ES cells were plated at low density in FCS-
containing medium supplemented with LIF or without LIF, rWnt3a, Wnt3a CM or BIO for 5 days.  (B) Real-time 
PCR analysis of nanog expression in β-catfl/fl and β-cat∆/∆ ES cells after 24 hours with LIF or without LIF and in 
the presence of Wnt3a CM or BIO. Error bars = SEM. (C) Western blot analysis of Nanog protein levels in β-
catfl/fl and β-cat∆/∆ ES cells 5 days after treatment with rWnt3a. Tubulin levels are used as a loading control.  
  
 
I also tested, whether the β-cat∆/∆ ES cells would be more sensitive to reductions of LIF 
concentration by performing LIF titration experiments, but found no differences in the behavior 
between control and β-cat∆/∆ ES cells (data not shown).  This argues against a previously 
proposed model whereby LIF and Wnt signaling cooperatively maintain self-renewal (Ogawa et 
al., 2006). 
Next I performed a similar self-renewal assay using the WT, ΔC and M6 β-catenin-rescued ES 
cells with the GSK3 inhibitor CHIR treatment. Upon LIF withdrawal all 5 ES cell lines were 
differentiated within 5 days (2nd column in Fig. 17). As expected, most of the WT β-catenin-
rescued ES cell colonies were AP-positive after 5 days in culture in the presence of rWnt3a or 
CHIR (Fig. 17 and data not shown). 
C
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Figure 17 - Self-renewal potentials of pCAGGS rescued β-catΔ/Δ ES cells upon CHIR treatment  
AP-stained colonies of β-catfl/fl, β-cat∆/∆, pCAGGS-WT, ΔC and M6 ES cells. ES cells were plated at low density 
in FCS-containing medium supplemented with LIF (1st column), without LIF (2nd column) or with 3µM CHIR (3rd 
column) in the absence of LIF for 5 days. Percentages of undifferentiated (red), half-differentiated (pink) and 
differentiated (white) colonies were calculated (right panel) for each of the wells. Total number of colonies in each 
well was set as 100%.  
 
Not unexpectedly, M6 β-catenin-rescued ES cell behaved similarly (Fig. 17) as they still have 
some residual Wnt signaling activity according to the TOPFLASH assay (Fig. 14D). However, 
to our surprise ΔC β-catenin-rescued ES cells also maintained self-renewal under these 
conditions (Fig. 17). This was quite unexpected since ΔC β-catenin had shown no TCF-
mediated transcriptional activity (Fig. 14D). One possible explanation would be that upon 
stimulation of Wnt signaling ΔC β-catenin might be able to interact with other transcriptional 
co-factors maintaining self-renewal. This possibility will have to be investigated in the future.  
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1.3.3. Wnt/β-catenin target genes in mouse ES cells  
My results showed that rWnt3a is able to support self-renewal of mouse ES cells in the 
presence of serum, but without LIF, to some extent. Therefore, I decided to investigate, which 
genes are regulated by canonical Wnt signaling in ES cells. In order to do so I performed cDNA 
microarray analysis comparing the transcriptomes of β-catfl/fl and β-cat∆/∆ ES cells either 
untreated (PBS) or treated with rWnt3a at the 24 hour time point. RNA from each sample was 
isolated and hybridized to in-house cDNA microarrays. The experiment was performed in 
triplicates using two independent β-catfl/fl and β-cat∆/∆ ES cell clones each. Results from 
independent clones were combined in one table and statistic analysis was performed (by Harald 
Scheuch). By comparing β-catfl/fl versus β-cat∆/∆ ES cells both treated with rWnt3a, a list of the 
300 top up-regulated genes was compiled, which is shown in the Supplementary table 1. 
Significantly up-regulated genes were filtered using the following thresholds: logarithmic fold 
change = >0,7, adjusted p-value (adjPvalue) = <0,03. Interestingly, only 5 genes out of 21785 
analyzed on the chip were significantly differentially expressed in β-cat∆/∆ versus β-catfl/fl 
untreated ES cells: l7Rn6, H19, Rhox5 (up-regulated) and Trpv6, Daam1 (down-regulated). 
This suggests that ablation of β-catenin in undifferentiated ES cells does not influence global 
gene expression. 
In contrast, 2503 genes were up-regulated in β-catfl/fl ES cells treated with rWnt3a and 2310 
down-regulated in comparison to β-cat∆/∆ ES cells. The up-regulated genes included established 
Wnt signaling target genes such as c-Myc (He et al., 1998), Axin2 (Jho et al., 2002; Lustig et al., 
2002; Yan et al., 2001) and Nanog. With the exception of Axin2 and Nanog, interesting hits 
would still need to be confirmed by real-time PCR. 
1.4. Cell-cell adhesion and self-renewal  
1.4.1. Cell-cell adhesion defect in β-catenin-deficient ES cells 
As mentioned earlier, in cultures of β-cat∆/∆ ES-cells an increased number of single cells could 
be observed (Fig. 10C). This suggested that there might be a slight cell-cell adhesion defect.  To 
further address this I looked at cell-cell adhesion at the ultrastructural level by transmission 
electron microscopy (TEM). This revealed that the areas with close attachment between 
neighboring cells were severely reduced in β-cat∆/∆ ES cell colonies, leaving big holes between 
plasma membranes of two neighboring cells (compare Fig. 18A and B).  
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Figure 18 - Cell-cell adhesion defect in β-catenin-deficient ES cells 
TEM pictures of ultra-thin sections from β-catfl/fl and β-cat∆/∆ ES cells. (A) β-catfl/fl ES cell colony consisting of six 
cells tightly connected via adherens junctions. (B) β-cat∆/∆ ES cell colony consisting of seven cells loosely 
connected. Images on the right show a higher magnification of plasma membranes (black arrows) of two 
neighboring ES cells.  
Thus, on the ultrastructural level cell-cell adhesion is clearly affected, in contrast to the overall 
appearance of β-cat∆/∆ ES cell colonies. 
However, some cell junctions are still present in β-cat∆/∆ ES cells. This raises the question how 
this partial cell-cell adhesion is achieved in the absence of β-catenin. As mentioned earlier, 
plakoglobin levels were upregulated in β-cat∆/∆ ES cells (Fig. 12 C, D). Like β-catenin, 
plakoglobin can link E-cadherin to actin filament cytoskeletons through α-catenin in adherens 
junctions (Zhurinsky et al., 2000b). Thus, plakoglobin is the likely candidate to substitute in 
part for the cell-cell adhesion function of β-catenin in ES cells. To analyze this further, 
immunoprecipitation (IP) using anti-E-cadherin antibodies was performed to assess complex 
formation of E-cadherin, plakoglobin, β-catenin and α-catenin (Fig. 19A). In β-catfl/fl control 
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cells, β-catenin, α-catenin and plakoglobin co-precipitated with E-cadherin. In contrast, the 
amount of plakoglobin associated with E-cadherin was significantly increased in β-cat∆/∆ ES 
cells, while to our surprise the amount of α-catenin bound to E-cadherin decreased. These data 
support the notion that plakoglobin substitutes for the loss of β-catenin in adherens junctions.  
 
 
 
Figure 19 - Plakoglobin substitutes for β-catenin in adherens junctions 
(A) IP analysis of adherens junction complex in β-catfl/fl and β-cat∆/∆ ES cells. Cytosolic fractions from β-catfl/fl and 
β-cat∆/∆ ES cells were affinity precipitated with anti-E-cadherin antibody and analyzed by SDS-PAGE and Western 
blotting with anti- E-cadherin, α-catenin, β-catenin and plakoglobin antibodies. (B) Western blotting analysis of β-
catenin, myc-tag and plakoglobin in β-catfl/fl, β-cat∆/∆, WT rescued, ΔC rescued and M6 rescued ES cells. Two 
independent clones of each rescued ES cell line were analyzed.   
To verify that the observed changes in plakoglobin levels in β-cat∆/∆ ES cells were due to an 
increase of membrane bound plakoglobin levels and dependent on the absence of β-catenin, I 
examined plakoglobin protein levels in WT, ΔC and M6 β-catenin-rescued ES cells. 
Reintroduction of WT, ΔC or M6 β-catenin variants into β-cat∆/∆ ES cells resulted in a 
reduction of plakoglobin levels in all rescued cell lines (Fig. 19B).  
In summary, these experiments show that cell-cell adhesion is affected in ES cells lacking β-
catenin, however, cells are still connected with each other via adherens junctions, which contain 
plakoglobin instead of β-catenin. 
1.4.2. Loss of adhesion in β-catenin/ plakoglobin-deficient ES cells 
What types of cell junctions are present in ES cells? Unfortunately, very little literature exists 
concerning this question. Based on the observations that β-catenin, plakoglobin and E-cadherin 
are expressed in cell membranes of ES cells, I can hypothesize that adherens junctions are 
present in ES cells (Fig. 12A, B, C). Desmosome-like structures were characterized in ES cells 
by IF and immunoelectron microscopy (Eshkind et al., 2002). However, these structures are not 
typical desmosomes, because they lack desmoplakin, a component of desmosomal plaque. At 
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the ultrastructural level I was able to identify a few electron dense structures at cell membranes, 
similar to what has been described as desmosomes (black arrow heads in Fig. 20). These 
observations would suggest that ES cells have at least two types of cell-cell junctions: adherens 
junctions and desmosomes.  
Interestingly, unlike β-catenin, plakoglobin plays a role in adherens junctions as well as in 
desmosomes. In the desmosomal structure, plakoglobin links desmosomal cadherins 
desmocollin and desmoglein to the intermediate filament cytoskeletons (Franke et al., 1987). 
However, in mutants lacking plakoglobin, desmosomal localization of β-catenin has been 
reported (Bierkamp et al., 1999). Thus, I would hypothesize that plakoglobin is present in both 
adherens junctions and desmosomes in β-cat∆/∆ ES cells. If adherens junctions and desmosomes 
are the only structures mediating cell-cell adhesion in ES cells, ablation of plakoglobin in β-
cat∆/∆ ES cells should result in a complete loss of cell-cell adhesion.  
 
 
Figure 20 - Cell junctions in undifferentiated WT ES cells 
TEM was performed on ultrathin section of WT ES cells. Desmosome-like structures are indicated with black 
arrow heads. Nuc, nucleus; rer, rough endoplasmatic reticulum; L, lysosome. Scale bar = 100nm. 
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In order to test this, I performed knock-down experiment using siRNA against plakoglobin in 
β-catfl/fl, β-cat∆/∆, as well as in WT and ΔC β-catenin rescued ES cells. Knock-down of 
plakoglobin was confirmed by Western blot analysis (Fig. 21A) and IF staining (Fig. 22). 
Already after 48 hours about 80% of the β-cat∆/∆ ES cell colonies transfected with plakoglobin 
siRNA displayed a different morphology (Fig. 21B) in comparison to control siRNA treated β-
cat∆/∆ or β-catfl/fl ES cells. Instead of the typical dome-shaped compact colonies of ES cells, 
cells were spindle-shaped and flattened. The percentage of affected colonies correlates with the 
siRNA-transfection efficiency (data not shown). In contrast, in plakoglobin siRNA treated β-
catfl/fl ES cells only 5-10% of the colonies had a different appearance (Fig. 21B). Similarly, 
knock-down of plakoglobin in WT and ΔC β-catenin rescued ES cells did not affect cell 
morphology, resembling the control situation (Fig. 13B). 
 
      
Figure 21 – Knock-down of plakoglobin in β-catΔ/Δ ES cells results in loss of cell-cell adhesion 
(A) Western blot analysis of E-cadherin and plakoglobin in β-cat∆/∆ and control β-catfl/fl ES cells untransfected or 
transfected with control siRNA or siRNA against plakoglobin. Cells were collected for analysis after 48 hours 
post-transfection. (B) Phase contrast live images of β-catfl/fl, β-cat∆/∆, WT and ΔC rescued ES cells 48 hours after 
transfection with control or plakoglobin siRNA. Scale bar for all images = 50µm 
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E-cadherin has been shown to play an important role during mouse early development, since E-
cadherin-/- embryos fail to develop beyond the blastocyst stage (Larue et al, 1994). In addition, 
loss of E-cadherin has been described as a defining event in epithelial-mesenchymal transition 
(EMT), which is required for epiblast cell movements during primitive streak formation in early 
mouse development (Zohn et al., 2006). Notably, E-cadherin protein levels were reduced in 
plakoglobin siRNA treated β-cat∆/∆ ES cells compared to the treated control cells (Fig. 21A). By 
immunofluorescent staining I observed that in plakoglobin siRNA treated β-cat∆/∆ ES cells, E-
cadherin was not located at the cell membrane (data not shown). Thus, this suggests that loss of 
E-cadherin upon knock-down of plakoglobin in β-catenin-deficient ES cells causes an EMT-
like transformation of these cells, which would correspond to my observation that these cells 
were also motile.   
In addition, I analyzed the localization of another cell-cell adhesion molecule, PECAM-1 (also 
known as CD31), which has been shown to be expressed in ES cells (Li et al., 2005). PECAM-
1 can also form a complex with plakoglobin and localizes it to the cell-cell junctions as shown 
by overexpression experiments in SW480 cells (Ilan et al., 2000). Interestingly, PECAM-1 was 
absent from the cell membranes in plakoglobin siRNA treated β-cat∆/∆ ES cells (Fig. 22). 
However, knock-down of plakoglobin in WT and ΔC β-catenin rescued ES cells did not affect 
PECAM-1 localization (Fig. 23). These data suggests that β-catenin and plakoglobin are 
required for PECAM-1 expression and localization to the cell membrane. 
Taken together, I was able to show that knock-down of plakoglobin in β-cat∆/∆ ES cells results 
in the complete loss of cell-cell adhesion, that can be rescued by introducing WT as well as the 
signaling-defective ΔC form of β-catenin. Moreover, loss of both plakoglobin and β-catenin in 
ES cells interferes with proper expression and localization of cell-cell adhesion molecules. 
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Figure 22 – Knock-down of plakoglobin results in loss of Pecam-1  
(A) (Top panel) Phase contrast live images of control β-catfl/fl and β-cat∆/∆ ES cells 48 hours after transfection with 
control or plakoglobin siRNA. Scale bar = 50µm. (Lower panels) IF images of β-catfl/fl and β-cat∆/∆ ES cells 48 
hours after transfection with control or plakoglobin siRNA. PFA-fixed colonies were co-stained with anti-
plakoglobin (red) and anti-Pecam-1 (greed) antibodies. Nuclei were counterstained with DAPI (blue). Scale bar = 
50µm. 
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Figure 23 – Knock-down of plakoglobin does not affect Pecam-1 in rescued ES cells 
(Top panel) Phase contrast live images of WT and ΔC rescued ES cells 48 hours after transfection with control or 
plakoglobin siRNA. Scale bar = 50µm. (Lower panels) IF images of WT and ΔC rescued ES cells 48 hours after 
transfection with control or plakoglobin siRNA. PFA-fixed colonies were co-stained with anti-plakoglobin (red) 
and anti-PECAM-1 (green) antibodies. Nuclei were counterstained with DAPI (blue). Scale bar = 50µm. 
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1.4.3. Self-renewal is affected in adhesion-defective ES cells  
Self-renewal of murine ES cells involves binding of LIF to the cell surface receptor complex 
LIFR beta/gp130 and activation of STAT3 (Robson et al., 2001). ES cell specific isoforms of 
PECAM-1 have been implicated in activation of STAT3 and as such may play a role in LIF-
mediated maintenance of undifferentiated ES cells (Ilan et al., 2001). Therefore, changes in the 
expression of PECAM-1 in ES cells may lead to defects in ES cell maintenance (Li et al., 
2005).  
Since plakoglobin siRNA-treated β-cat∆/∆ ES cell colonies resembled differentiated ES cells 
and showed down-regulation of the cell-adhesion molecules, E-cadherin and PECAM-1, I 
asked next whether down-regulation of plakoglobin in β-cat∆/∆ ES cells affects self-renewal 
marker expression. Real-time PCR analysis revealed a decrease in nanog mRNA levels in β-
cat∆/∆ ES cells 48 hours after transfection with plakoglobin siRNA in comparison to cells 
transfected with control siRNA (Fig. 24A). This result was confirmed by double-fluorescent 
staining for Nanog and plakoglobin (Fig. 24B). Cells that were negative for plakoglobin 
expressed only low levels of Nanog in the nucleus. In contrast, knock-down of plakoglobin in 
WT and ΔC β-catenin rescued ES cells did not affect Nanog expression (Fig. 25). However, I 
did not see significant changes of protein levels of Nanog and Oct3/4 by Western blot analysis 
48 hours after transfection (data not shown). It has to be mentioned, that between 48 and 72 
hours ES cell-like colonies started to reappear in β-cat∆/∆ ES cells transfected with plakoglobin 
siRNA and no significant knock-down of plakoglobin protein levels could be detected at these 
time points by western blot analysis (data not shown). This observation can be explained in two 
ways: 1) siRNA was transfected transiently, therefore it was not working longer than 72 hours; 
2) only 80% of the cells were transfected, therefore transfected ES cells were eventually 
overgrown by non-transfected ones. To avoid these complications I decided to generate β-cat∆/∆ 
ES cell lines that stably expressed plakoglobin shRNA. Unfortunately, all attempts to establish 
stable lines upon infection with lentiviral plakoglobin shRNA (from Dharmacon) were not 
successful. All generated stable lines expressed plakoglobin at endogenous level. My 
speculation is that downregulation of plakoglobin results in low clonogenicity of β-cat∆/∆ ES 
cells due to loss of cell-cell adhesion. Therefore, I switched to a doxycyclin-inducible RNAi 
system (see Materials & Methods). For this I generated β-cat∆/∆ ES cell lines that constitutively 
expressed the tetracycline reverse transcriptional activator (rtTA) under the control of the 
Rosa26 promoter. 
Natalia Lyashenko Results 
[80] 
 
           
 
 
Figure 24 – Knock-down of plakoglobin results in loss of nanog expression 
(A) Real-time PCR analysis of nanog expression in β-catfl/fl and β-cat∆/∆ ES cells 48 hours after transfection with 
control or plakoglobin siRNA. Error bars = SEM. (B) (Top panel) Phase contrast live images of β-catfl/fl and β-
cat∆/∆ ES cells 48 hours after transfection with control or plakoglobin siRNA. Scale bar = 50µm. (Lower panels) IF 
images of β-catfl/fl and β-cat∆/∆ ES cells 48 hours after transfection with control or plakoglobin siRNA. PFA-fixed 
colonies were co-stained with anti-plakoglobin (red) and anti-nanog (green) antibodies. Nuclei were counterstained 
with DAPI (blue). Scale bar = 50µm.  
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Figure 25 - Knock-down of plakoglobin does not affect Nanog in rescued ES cells  
(Top panel) Phase contrast live images of WT and ΔC rescued ES cells 48 hours after transfection with control or 
plakoglobin siRNA. Scale bar = 50µm. (Lower panels) IF images of WT and ΔC rescued ES cells 48 hours after 
transfection with control or plakoglobin siRNA. PFA-fixed colonies were co-stained with anti-plakoglobin (red) 
and anti-nanog (green) antibodies. Nuclei were counterstained with DAPI (Blue). Scale bar = 50µm. 
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In order to do so, I used a construct kindly provided by Martin Leeb (from Anton Wutz lab), 
which contained the 5’ and 3’ homology arms of the genomic Rosa26 locus, the rtTA 
transgene, a neomycin resistance cassette and as a negative selection cassette the diphtheria 
toxin gene (DTA). This construct was electroporated into β-cat∆/∆ ES cells and neomycin-
resistant ES cell clones were analyzed for correct integration by Southern blot. This yielded in 
the identification of two positive β-cat∆/∆-R26rtTA ES cells clones out of 192.  
Next, four shRNAs directed against mouse plakoglobin RNA were designed and cloned into 
pSiren plasmid, containing tetracycline operator elements (TetO) under the control of the U6 
promoter (Clontech). Plasmids containing corresponding shRNA were transfected separately 
into β-catΔ/Δ rtTA ES cells, selected with puromycin and several ES cell clones for each shRNA 
were established and named inducible plakoglobin RNAi β-catΔ/Δ ES cells. Upon doxycyclin 
treatment, rtTA should bind to the TetO element in pSiren and shRNA should be expressed. 
Unfortunately, I was not able to get efficient knock-down with any of four plakoglobin shRNA. 
Still my data from the transient knock-down experiments suggest that self-renewal is 
compromised in ES cells that lack both β-catenin and plakoglobin. 
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2. β-catenin and pluripotency of mouse ES cells  
2.1. Cell-cell adhesion defects during in vitro differentiation 
Ablation of β-catenin in the mouse embryo results in defects in primitive streak formation and 
failure to develop and properly position mesoderm and embryonic ectoderm (Haegel et al., 
1995; Huelsken et al., 2000). It has also been observed that β-catenin-deficient embryos have 
increased rate of apoptosis (Haegel et al., 1995). However, the molecular mechanism explaining 
why β-catenin-deficient mice fail to develop beyond the gastrulation stage is still unknown. Our 
β-cat∆/∆ ES cells opened the possibility to study in details the role of Wnt signaling in early 
mouse development using as an in vitro approach embryoid body (EB) formation assay. 
Thus, using the suspension culture differentiation method, I generated EBs from β-cat∆/∆ and β-
catfl/fl ES cells. During a differentiation time course from day 0 to day 7, β-catfl/fl ES cells 
formed cyst-like round-shaped EBs, while β-cat∆/∆ ES cells failed to form this kind of cyst-like 
structures and, moreover, from around day 5 of differentiation onwards defects in cell-cell 
adhesion were observed (Fig. 26A). 
As mentioned earlier, β-catenin-deficient embryos have increased rate of apoptosis (Haegel et 
al., 1995). Therefore, I measured the apoptosis in EBs at day 5 of differentiation by FACS 
sorting (Fig. 26B). Cells were co-stained with anti-annexinV (AnV) antibodies, detecting 
apoptotic cells (AnV+ PI-) and propidium iodide (PI), detecting post-apoptotic dead cells (AnV- 
PI+), whereas the necrotic cell population co-stains with both (AnV+ PI+). In control β-catfl/fl 
EBs at day 5 of differentiation 6,79% of apoptotic cells and 4,37% necrotic cells were sorted in 
comparison to 2,53% and 2,36% respectively in undifferentiated ES cells. This was expected, 
because apoptosis is a natural biological process occurring in early development during 
cavitation process (Choi et al., 2005; Coucouvanis and Martin, 1995), thus formation of cyst-
like EBs. In contrast, 11,38% of apoptotic and 6,96% necrotic cells were detected in β-cat∆/∆ 5 
day old EBs (Fig. 26B), showing an increase in cell death in comparison to the control EBs. 
This result is consistent with observations from β-catenin-deficient embryos. 
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Figure 26 – Cell-cell adhesion defect during EB differentiation of β-cat∆/∆ ES cells 
(A) Morphology of EBs formed from β-catfl/fl and β-cat∆/∆ ES cells during differentiation time-course. Scale bar = 
200 µm. (B) FACS sorting analysis of β-catfl/fl and β-cat∆/∆ ES cells and EBs at day 5 of differentiation stained for 
annexinV (X axis) and propidium iodide (Y axis). Numbers indicate the percent cells in a specific gated cell 
population (C) Western blotting of β-catfl/fl and β-cat∆/∆ EBs during time course of differentiation from day 1 to 7. 
Total proteins were separated by SDS-PAGE and membranes stained for β-catenin, Nanog, plakoglobin and 
tubulin (loading control). ESC=embryonic stem cells.  
 
I then asked whether plakoglobin protein levels were altered during EB differentiation, which 
could explain the adhesion defect observed in β-cat∆/∆ EBs. Interestingly, throughout the time 
course of differentiation I noticed in β-catfl/fl EBs that β-catenin protein levels gradually 
increased, while plakoglobin levels were constant until day 5 and then gradually decreased in 
the control cells (Fig. 26C). A similar downregulation of plakoglobin from day 5 of 
differentiation onwards was seen in β-cat∆/∆ EBs (Fig. 26C). 
These data suggest that plakoglobin cannot support cell-cell adhesion in the absence of β-
catenin longer than until day 5 of differentiation and as a consequence cells start to dissociate 
and die. 
2.2. Pluripotency of β-catenin-deficient ES cells is impaired 
As mentioned earlier, β-catfl/fl EBs developed normally into cyst-like structures, while β-cat∆/∆ 
EBs never formed these transparent cysts under identical conditions. When β-catfl/fl EBs were 
A B 
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plated at day 7 of differentiation onto gelatin-coated dishes, more than 70% of the EBs 
contained regions of spontaneously contracting cardiomyocytes by day 9 (data not shown). In 
contrast, β-cat∆/∆ EBs only formed loose clumps of cells without any characteristic morphology, 
with the exception of the formation of an epithelial-like cell monolayer, which surrounded the 
cell clump (data not shown). Therefore, next I asked the question whether the ability to 
differentiate into three germ layers was impaired in ES cells lacking β-catenin.  
In order to find out to which germ layers β-cat∆/∆ EBs can differentiate I performed semi-
quantitative RT-PCR analysis of β-catfl/fl and β-cat∆/∆ EBs at different time points during 
differentiation (Fig. 27). Prior to the onset of differentiation, β-catfl/fl and β-cat∆/∆ ES cells 
expressed nanog and oct3/4, markers of undifferentiated ES cells. Throughout the time-course 
in both cell lines nanog and oct3/4 were gradually down-regulated indicating ES cell 
differentiation. In the absence of β-catenin ectoderm specific genes fgf5 and nestin became up-
regulated at day 2 of differentiation and their expression persisted up to day 8 of EB 
differentiation, very similar to control β-catfl/fl EBs. In contrast, the mesendoderm-specific gene 
mixl1 was not expressed in the β-cat∆/∆ EBs in comparison to control EBs, where it peaked on 
day 4 of differentiation. Expression of T (Brachyury) was initiated in both β-catfl/fl and β-cat∆/∆ 
EBs, but it did not peak at day 2 of differentiation in the absence of β-catenin. The endoderm 
(cer1 and foxa2) and mesoderm (hand1 and eomes) specific markers, also did not peak between 
day 2 and 4 of β-cat∆/∆ EBs differentiation, when their expression normally peaked in control 
EBs.  
This result suggests that mesoderm and endoderm formation in ES cells lacking β-catenin is 
impaired; however, ectoderm formation is probably not affected. This conclusion is also 
supported by earlier observation that attached β-cat∆/∆ EBs form epithelial-like cell layer 
around. These results are consistent with observations from β-catenin mutant mice (Haegel et 
al., 1995; Huelsken et al., 2000), which possess severe defects in anterior-posterior axis 
formation and stop to develop at the egg cylinder stage. Subsequently, mesoderm does not 
develop, visceral endoderm is displaced, but extraembryonic ectoderm and embryonic ectoderm 
are formed correctly. 
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Figure 27 – Mesoderm end endoderm formation is affected during differentiation of β-cat∆/∆ ES cells 
β-catfl/fl and β-cat∆/∆ ES cells were subjected to EB differentiation time course from day 0 (ESC) to day 8. 
Mesoderm (hand1 and eomes), endoderm (cer1 and foxa2), mesendoderm (mixl1 and T) and ectoderm (fgf5 and 
nestin) lineage specific markers and self-renewal (nanog and oct3/4) markers were analyzed by semi-quantitative 
RT-PCR. Samples were normalized to HPRT expression. 
 
When injected into immunodeficient mice, ES cells can form tumors, so-called teratomas 
(Wobus et al., 1984). When these tumors develop from pluripotent ES cells they are show 
terminally differentiated tissues structures of ecto-, meso-, and endodermal origin.  
Thus in order to assess the in vivo potential of my ES cells, suspensions of two independent 
clones of β-cat∆/∆ and two clones of β-catfl/fl ES cells each were mixed with Matrigel (as a 
supportive matrix) and injected subcutaneously into the abdominal flank of MF1 nude mice. 
Interestingly, three weeks after injection only small tumors with a volume of about 0,5-1,0 cm3 
were formed from β-cat∆/∆ ES cells, while very big tumors with a volume of about 2,0-3,0 cm3 
developed from β-catfl/fl ES cells (Fig. 28A). The teratoma growth curve and the overall 
appearance of the tumors can be seen in Fig. 28 (B, C). Staining with hematoxylin and eosin 
revealed several distinct histological features in β-catfl/fl teratomas, including glandular 
epithelial structures indicative of endoderm (Fig. 29A), large regions of neuronal tissues 
indicative of ectoderm (Fig. 29B), cartilaginous elements and muscles indicatives of mesoderm 
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(Fig. 29C). In contrast, teratomas derived from β-cat∆/∆ ES cells were much smaller in size and 
appeared histologically primarily homogeneous with cells embedded in Matrigel (Fig. 29D). 
The only differentiated structures, which were occasionally observed, were epithelial-like 
rosettes (Fig 29E). The other interesting feature of β-cat∆/∆ teratomas was that they were 
hypervascularized with large areas filled with blood (Figs. 29F).  
 
 
Figure 28 – Tumor growth from ES cells is impaired in the absence of β-catenin 
(A) Overall appearance of teratomas in MF1 nude mice three weeks after subcutaneous injection with β-catfl/fl ES 
cells (black arrow) and β-cat∆/∆ ES cells (blue arrow). (B) Growth curve of teratomas from day 10 to 14 post-
injection of two independent clones of β-catfl/fl and β-catΔ/Δ ES cells. Teratomas were measured in three dimensions 
(length, width and height) and total volume (cm3) was calculated. Error bars = SEM. (C) Morphology of teratomas 
from three independent injections. Note that the β-cat∆/∆ teratomas are highly vascularized (dark red areas). 
Whether these hypervascularization originated from the injected ES cells or the host mouse 
tissues is currently unclear. Immunostaining for β-catenin showed the expected localization in 
β-catfl/fl teratomas, predominantly in epithelial structures (Fig. 29G). As expected, no β-catenin 
staining was observed in β-cat∆/∆ teratomas (Fig. 29H).       
To study the tumors in more detail, I performed a marker analysis for the different germ layers. 
Paraffin sections of teratomas derived from β-catfl/fl and β-cat∆/∆ ES cells were stained with 
antibodies specific for the endodermal marker – alpha-fetoprotein (AFP) (Fig. 29J, N), the 
ectodermal marker – glial fibrillary acidic protein (GFAP) (Fig. 29H, L) and the mesodermal 
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marker – smooth muscle actin (SMA) (Fig. 29 M). As anticipated given my EB differentiation 
results, SMA-positive cells (Fig. 29M) were absent in β-cat∆/∆ teratomas, while GFAP-positive 
astrocytes were detected in β-cat∆/∆ teratomas. However, in much lower numbers in comparison 
to the WT teratoma (Fig. 29L). In contrast, to what we expected based on the analysis of early 
endodermal markers, such as Foxa2, Cer1 (Fig. 27), Gata4 and Gata6 (data not shown), which 
suggest that endoderm formation is not initiated in the absence of β-catenin, we found AFP-
positive structures (Fig. 29N), suggesting that visceral endoderm formation can occur even in 
the absence of β-catenin. An alternative explanation might be that the AFP antibody used in the 
teratoma analysis is not absolutely specific.  
Taken together, these data indicates that β-cat∆/∆ ES cells can efficiently recapitulate the 
developmental defects observed in β-catenin-deficient embryos and can be used to study the 
role of β-catenin in early mouse development. Thus, I have shown that β-cat∆/∆ ES cells fail to 
differentiate into endoderm (according to the EB results) and mesoderm, but not into ectoderm. 
Moreover, β-cat∆/∆ ES cells fail to form teratomas in vivo. 
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Figure 29 – Analysis of teratomas generated from β-catfl/fl and β-cat∆/∆ ES cells 
Teratomas generated from β-catfl/fl ES cells are heterogeneous (A-C). Histological sections of teratomas stained 
with hematoxylin and eosin possess many regions of glandular epithelium (A), neuronal tissue (B), muscle and 
bone (C). Teratomas, generated from β-cat∆/∆ ES cells are homogeneous (D), with supportive Matrigel still present 
between cells (arrow). However, some epithelial-like structures can be recognized (E) and large regions filled with 
blood (F). Immunohistochemical staining of paraffin sections from β-catfl/fl (G-J) and β-cat∆/∆ (K-N) ES cells with 
β-catenin (G, K), GFAP (H, L), SMA (I, M) and AFP (J, N). Scale bar = 100µm.         
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2.3. CAG β-catenin transgenes rescue cell-cell adhesion, but not 
pluripotency  
In order to see whether the cell-adhesion defects observed in differentiating β-cat∆/∆ ES cells 
can be rescued by either the WT, signaling-defective ΔC or M6 β-catenin transgenes I analyzed 
the corresponding stable pCAGGS ES cells clones (shown in Fig. 14). As demonstrated earlier 
these β-catenin variants localize to the cell membrane, indicating they might be able to restore 
cell-cell adhesion in β-cat∆/∆ ES cells (Fig. 14B). In addition, I had shown earlier that Wnt 
signaling is not restored by the ΔC form, while it is restored by the WT and to certain extend 
also by the M6 form of β-catenin (Fig. 16D). These tools enabled me to address a very 
important question in developmental biology that has not yet been tackled: how to distinguish 
between cell-cell adhesion and signaling function of β-catenin in early mouse development? 
In order to address this question I employed initially the in vitro differentiation assay of EB 
suspension culture. As was described before β-cat∆/∆ ES cells fail to form cyst-like EBs and 
cell-cell adhesion defect becomes obvious after day 5 of differentiation, probably due to the 
observed down-regulation of plakoglobin. First I analyzed, if the pCAGGS rescued lines 
maintained cell-cell adhesion. For this EB differentiation was performed using standard 
conditions in the presence of G418 to maintain selection pressure for the pCAGGS expression 
vector. My initial morphological analysis revealed that at day 5 EBs from WT, ΔC or M6 β-
catenin rescued ES cell lines had a round, smooth shape and were indistinguishable from β-
catfl/fl EBs (Fig. 30A). However, after approximately day 7 of differentiation the EBs from all 
three different rescued ES cell lines started to disaggregate and many floating cells were 
observed in the medium (Fig. 30A, day8).  
This observation suggested that the CAG promoter might not be able to sustain expression of 
WT, ΔC and M6 β-catenin variants during EB differentiation. This suspicion was confirmed 
when I stained EBs for β-catenin at day 8 of differentiation (Fig. 30A, last column). β-catenin 
was hardly detected in the WT, ΔC and M6 β-catenin rescued EBs. Moreover, when I analyzed 
β-catenin protein levels by western blot, in contrast to control β-catfl/fl EBs where β-catenin 
levels increased gradually during differentiation, in the three different rescued lines β-catenin 
levels gradually decreased (Fig. 30B).  
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Figure 30 – EB differentiation of β-cat∆/∆ ES cells rescued with CAG-driven WT, ΔC and M6 β-catenin 
variants 
 
(A) Morphology of EBs formed from control and WT, ΔC and M6 β-catenin rescued ES cells during time course 
of EB differentiation (from day 5 to day 8). Pictures were taken using phase contrast filter with 5x magnification 
objective. IF staining of EBs at day 8 for β-catenin is shown in the last column. Scale bar = 20µm (B) Western blot 
analysis of total proteins extracted from control β-catfl/fl ES cells as well as WT, ΔC and M6 β-catenin rescued ES 
cells subjected to EB differentiation (from day 2 to day 8). Membranes were stained with antibodies recognizing 
N-terminus of β-catenin. Tubulin is a loading control (Note that tubulin bands in the WT rescued blot expanded 
due to transfer problem).    
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So contrary to other published data indicating that CAG promoter is able to maintain long-term 
expression of transgenes during ES cells differentiation (Alexopoulou et al., 2008), I found that 
it was not the case with β-catenin.  
EBs derived from pluripotent ES cells display clear signs characteristic for self-organization: 
they are able to establish a anterior-posterior polarity, develop a primitive streak-like domain 
and undergo EMT followed by mesendoderm formation (ten Berge et al., 2008). Therefore, 
EBs can recapitulate aspects of normal embryonic development to some extent. Despite the fact 
that it was not possible to rescue the cell-cell adhesion beyond day 7 of EB differentiation using 
the WT, ΔC or M6 β-catenin pCAGGS constructs, I analyzed the material to see whether 
differentiation into mesoderm and endoderm had occurred by performing semi-quantitative RT-
PCR for early differentiation markers. Unfortunately, expression of endodermal and 
mesodermal lineage markers was not rescued during EB differentiation of WT, ΔC or M6 β-
catenin ES cells (data not shown). The expression pattern of the analyzed genes was similar to 
that of β-cat∆/∆ EBs. Failure to rescue the pluripotency was probably due to the inability of CAG 
promoter to maintain β-catenin transgene expression at high levels during differentiation. 
2.4. Generation and analysis of R26 WT, ΔC and M6 ES cells 
To overcome the problem of unstable transgene expression I cloned WT as well as myc-tagged 
ΔC or M6 β-catenin variants into Rosa26 targeting constructs (Fig. 31A). The Rosa26 locus has 
previously been successfully used to drive stable expression of transgenes in ES cells as well as 
in all tissues of the developing and adult organism (Hohenstein et al., 2008; Nyabi et al., 2009). 
Targeting constructs were electroporated in β-cat∆/∆ ES cells. Homologous recombination was 
screened by mini-Southern blot and two independent clones from each targeting vector (WT, 
ΔC or M6 β-catenin) were verified (Fig. 31B) by Southern blot and further referred to as 
R26WT, R26ΔC and R26M6 ES cells. Homologously recombined ES cell clones expressed β-
catenin at the cell membrane, similar to the control β-catfl/fl ES cells (Fig. 31C). In later 
experiments I used only R26 WT and R26 ΔC, but not R26M6 ES cells, because their 
establishment was postponed due to the fact that the M6 β-catenin variant had shown a minimal 
response in the TOPFLASH reporter assay, thus being not completely signaling-defective (Fig. 
14D).  
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Figure 31 - Generation of R26 WT, ΔC and M6 ES cells 
(A) The WT, DC or M6 variants of β-catenin were inserted by blunt-end cloning into the XbaI site of the targeting 
vector. The targeting constructs were inserted into Rosa26 locus by homologous recombination after 
electroporation of linearized vectors into β-catΔ/Δ ES cells. B - BamHI, X - XbaI, DTA - diphtheria toxin A, SA – 
splice acceptor, pA – polyadenylation site, red bar indicates 5’ external probe for Southern blot detection of correct 
recombination event and red triangles indicate LoxP sites. (B) Correctly targeted ES cell clones (D1WT, D12WT, 
H8ΔC, H9ΔC, F10M6 and F11M6) were verified by Southern blot. Genomic DNA was digested with BamHI, 
yielding a 6kb WT band and a 3kb targeted band. (C) IF images of β-catfl/fl and β-cat∆/∆ ES cells as well as Rosa26 
WT, ΔC or M6 ES cell clones stained with anti-β-catenin antibodies (green), an anti-C-terminal β-catenin antibody 
was used with the exception of ΔC rescued cells, which were stained with an anti-myc antibody, DAPI nuclear 
staining is blue. Scale bar = 50µm. 
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2.4.1. Rescue of cell-cell adhesion and apoptosis  
Next I examined the differentiation potentials of R26 WT and R26ΔC ES cells. As 
demonstrated earlier β-cat∆/∆ ES cells fail to form cyst-like EBs and cell-cell adhesion defect 
becomes obvious after day 5 of differentiation, probably due to the down-regulation of 
plakoglobin. First I analyzed, if the expression of transgenes was maintained in R26WT and 
R26ΔC ES cell lines during differentiation. EB formation in suspension culture upon 
withdrawal of LIF was performed as described earlier. In contrast to pCAGGS rescued β-cat∆/∆ 
ES cells, R26WT and R26ΔC ES cells formed smooth round-shaped EBs throughout the whole 
differentiation time-course (Fig. 32A). Moreover, β-catenin was expressed at significant level 
even at day 16 of EB differentiation in contrast to pCAGGS rescued EBs (Compare Fig. 30A to 
Fig. 32A). This result suggests that cell-cell adhesion defects observed in differentiated β-cat∆/∆ 
ES cells can be rescued by expression of WT as well as signaling-defective ΔC β-catenin 
transgenes from the Rosa 26 locus. 
As shown earlier apoptosis and subsequent death of cells was increased in 5 day old EBs 
lacking β-catenin. Reintroduction of WT as well as signaling-defective ΔC form of β-catenin 
was able to rescue the increased rate of apoptosis at day 5 as shown by FACS sorting analysis 
(Fig. 32B). In contrast to β-cat∆/∆ EBs which had 12,14% AnV+ PI- apoptotic and 6,78% AnV+ 
PI+ dead cells, R26WT EBs had only 7,09% AnV+ PI- and 4,29% AnV+ PI+ cells and R26ΔC 
EBs 7,77% AnV+ PI- and 4,17% AnV+ PI+ cells, which were comparable to control β-catfl/fl  EBs 
(6,79% AnV+ PI- and 4,37% AnV+ PI+) (Fig. 32B). 
These findings suggested that the rate of apoptosis and subsequent death of cells was rescued in 
the β-cat∆/∆ EBs by expressing WT and signaling-defective ΔC β-catenin transgenes. 
Furthermore, my result indicates that the developmental arrest of β-catenin-/- embryos at the 
gastrulation stage could partially be due to the loss of adhesion function of β-catenin.  
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Figure 32 – Rescue of cell-cell adhesion and apoptosis by expression of WT and ΔC β-catenin transgenes 
from the Rosa26 locus 
 
(A) Morphology of EBs formed from β-catfl/fl, β-catΔ/Δ, R26WT and R26ΔC β-catenin rescued ES cells during time 
course of EB differentiation. Pictures were taken at day 6 and day 9 using phase contrast filter. Scale bar=200µm 
Immunofluorescent (IF) staining of EBs at day 16 for β-catenin is shown in the last column. DAPI nuclear staining 
is blue Scale bar=50µm (B) FACS sorting analysis of β-catfl/fl, β-catΔ/Δ, R26WT and R26ΔC β-catΔ/Δ EBs at day 5 
of differentiation stained for annexinV (X axis) and propidium iodide (Y axis). 
A 
B 
Natalia Lyashenko Results 
[96] 
 
2.4.2. Rescue of endoderm formation during in vitro differentiation 
Next I asked the question whether β-cat∆/∆ ES cells expressing WT or signaling-defective ΔC 
forms of β-catenin were able to differentiate into endoderm and mesoderm lineages.  
Therefore I performed semi-quantitative RT-PCR analysis using material from β-catfl/fl, β-
cat∆/∆, R26WT and R26ΔC EBs during differentiation time course (Fig. 33 A). As described 
earlier in the absence of β-catenin ectodermal markers are expressed, however endodermal and 
mesodermal markers fail to be expressed during EB differentiation (Fig. 27). Remarkably, not 
only rescued R26WT, but also R26ΔC ES cells regained the ability to differentiate towards 
endoderm and probably mesoderm as judged by the appearance of specific markers for those 
lineages. However, additional markers would have to be used to verify the results for the 
mesoderm lineage. Thus, in contrast to β-cat∆/∆ EBs, endoderm-specific markers Gata6, Cer1 
and Foxa2 are expressed in R26ΔC EBs as well as in R26WT EBs (with the exception of Cer1) 
during differentiation.  
 
 
 
 
 
 
Figure 33 - Endoderm formation is rescued with a WT and ΔC β-catenin transgenes expressed from the 
Rosa26 locus  
 
(Α) β-catfl/fl, β-cat∆/∆, R26WT, R26ΔC ES cells were subjected to EB differentiation time course from day 0 (ESC) 
to day 8. Mesendoderm (mixl1) and endoderm (gata6, foxa2 and cer1) lineage specific markers were analyzed by 
semi-quantitative RT-PCR. HPRT expression is a loading control. (B) IF staining of β-catfl/fl, β-cat∆/∆, Rosa26 WT 
and ΔC EBs at day 16 with anti-Foxa2 antibodies (green), DAPI nuclear staining is blue. Scale bar=50µm. 
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Similarly, expression of the mesendoderm specific gene Mixl1 was also rescued. It has to be 
noted that the intensity of bands was lower and that the onset of expression was premature in 
comparison to those of β-catfl/fl EBs. These differences might be due to the constant exogenous 
expression of the β-catenin transgenes from the Rosa26 locus, which is not absolutely equal to 
the endogenous levels. 
Nevertheless, expression of endoderm-specific genes can be rescued by re-expression of WT as 
well as signaling-defective ΔC form of β-catenin. In order to confirm that endoderm 
development can be rescued at late differentiation stages I checked the expression of endoderm-
specific transcription factor Foxa2 at day 16 of EB differentiation by IF (Fig. 33B). In control 
β-catfl/fl EBs Foxa2 was expressed in the nucleus and co-localized with DAPI staining, while no 
Foxa2-positive cells were observed in β-cat∆/∆ EBs. Confirming my RT-PCR results Foxa2-
positive cells could be detected in R26WT and R26ΔC rescued EBs suggesting that endoderm 
formation was indeed restored.    
2.4.3. Rescue of ectoderm formation during in vitro differentiation 
As described earlier, ectodermal markers were expressed normally at the early stages of β-cat∆/∆ 
EB differentiation (Fig. 27). However, I was not able to detect at day 16 any ectoderm-derived 
β3-tubulin or GFAP-positive cells, which are markers of neuronal and astrocyte cells 
respectively (Fig. 26 and data not shown). This result is consistent with observations from β-
catenin mutant mice, which possess normal initiation of ectodermal germ layer, but fail to 
develop beyond egg cylinder stage due to increased apoptosis in the ectoderm (Haegel et al., 
1995; Huelsken et al., 2000). As I was able to show that apoptosis was indeed rescued in R26 
WT and R26ΔC EBs (Fig. 32B), I can speculate that development of ectoderm lineage to 
terminally-differentiated cells might also be rescued.  
In order to test this, I checked the expression of ectoderm-specific marker β3-tubulin at day 16 
of EB differentiation by IF (Fig. 34). No β3-tubulin-positive neurons were found in β-cat∆/∆ ES 
cell derived EBs in comparison to control β-catfl/fl EBs, which contained multiple regions with 
β3-tubulin-positive cells. As suspected, neuronal differentiation occured in R26WT and R26ΔC 
rescued EBs suggesting that ectoderm (at least neuroectoderm) formation was restored even in 
the absence of Wnt signaling. 
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Figure 34 - Ectoderm formation is rescued with a WT and ΔC β-catenin transgenes expressed from the 
Rosa26 locus  
 
IF staining of β-catfl/fl, β-cat∆/∆, R26 WT and ΔC EBs at day 16 with anti-β3-tubulin antibodies (green), DAPI 
nuclear staining is blue. Scale bar=50µm. 
 
2.4.4. In vivo differentiation potentials of R26WT and R26ΔC ES cells 
Next I asked the question whether the tumor growth can be rescued in β-cat∆/∆ ES cells by 
expression of WT and signaling-defective ΔC β-catenin transgenes from the Rosa26 locus.  
Suspensions of two independent clones of R26WT and two clones of R26ΔC ES cells each 
were mixed with Matrigel and injected subcutaneously into the abdominal flank of MF1 nude 
mice. Tumors were dissected after three weeks (Fig. 35A). As in the experiment performed 
earlier β-cat∆/∆ ES cells failed to form tumors, while β-catfl/fl ES cell clones formed large tumors 
(Fig. 28C and Fig. 35A). Interestingly, growth of tumor, originating from R26WT and R26ΔC 
ES cells, was restored (Fig. 35A). On the growth curve it is clear to see that, while the control 
tumors were growing exponentially, β-cat∆/∆ tumors failed to increase in size, but that defect 
could be rescued by expressing WT and ΔC β-catenin transgenes in β-cat∆/∆ ES cells (Fig. 35B). 
Depending on the clones used, the tumor volumes could reach even the volumes of the control 
β-catfl/fl ES cell clone (Fig. 35A, B). 
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Figure 35 – Tumor growth is restored with WT and ΔC β-catenin transgenes expressed from the Rosa26 
locus 
(A) Overall appearance of teratomas developed in MF1 nude mice three weeks after subcutaneous injection of β-
catfl/fl, β-cat∆/∆, R26 WT (clones D1 and D12) and ΔC (clones H8 and H9) ES cells. (B) Growth curve of teratomas 
from day 8 to 14 post-injection of β-catfl/fl, β-cat∆/∆, R26 WT (clones D1 and D12) and ΔC (Clones H8 and H9) ES 
cells. Teratomas were measured in three dimensions (length, width and height) and total volume (cm3) was 
calculated. Error bars = SEM. n=3. 
As already described previously (Fig. 29), staining with hematoxylin and eosin revealed 
heterogeneous features in β-catfl/fl teratomas (Fig. 36A, B) and a more homogeneous 
appearance in β-cat∆/∆ tumors (Fig. 36D, E). However, R26WT and R26ΔC tumors had a 
different appearance with primarily loose connective-like tissue (Fig. 36G, J) and some 
epithelial-like structures (Fig. 36H, K). Hypervascularization observed previously in β-cat∆/∆ 
tumors was still present in the ‘rescued’ tumors (Fig. 36D, G). Immunostaining for β-catenin 
showed the expected localization in β-catfl/fl teratomas (Fig. 36C), no β-catenin staining above 
background was observed in β-cat∆/∆ teratomas (Fig. 36F), while R26WT and R26ΔC tumors 
stained homogeneously for β-catenin (Fig. 36I and L) as expected. 
As described earlier, GFAP-positive cells, which are of ectodermal origin were detected in β-
cat∆/∆ tumors, however in a much lower numbers in comparison to WT teratomas, while 
mesoderm derived SMA-positive cells were never observed in β-cat∆/∆ tumors. Thus next I 
asked the question whether the re-expression of WT and ΔC β-catenin transgenes in β-cat∆/∆ ES 
cells rescues the expression of these markers comparable to WT. Although, tumor growth was 
rescued, the R26WT and R26ΔC tumors were not as heterogeneous as WT teratomas. Instead 
these tumors were consisting of neural-like tissue with few neuronal rosettes as verified by β3-
tubulin and GFAP staining (Fig. 37A, B, D, E). This result indeed confirms the in vitro 
observations that expression of WT and ΔC β-catenin transgenes in β-cat∆/∆ ES cells restored 
their potentials to differentiate towards ectodermal lineage. 
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No mesoderm-derived SMA positive cells could be found in tumors derived from R26WT and 
R26ΔC ES cells, with the exception of SMA positive blood vessels that could potentially be of 
host origin (Fig. 37I, L).     
All together, my results from the in vivo differentiation assay suggest that (neuro-) ectoderm 
growth can be rescued in β-cat∆/∆ teratomas upon re-expression of WT and most importantly 
upon re-expression of the signaling-defective ΔC form of β-catenin. 
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Figure 36 – Morpholgy of teratomas generated from R26WT and R26ΔC ES cells 
(A, B) Histological analysis of sections of teratomas generated from β-catfl/fl ES cells stained with hematoxylin and 
eosin. (D, E) Teratomas generated from β-cat∆/∆ ES cells are homogeneous with supportive Matrigel (pink) still 
present between cells. Hematoxylin and eosin staining of teratomas generated from R26WT (G, E) and R26ΔC (J, 
K) ES cells Immunohistochemical staining of paraffin sections of teratomas generated from β-catfl/fl (C), β-cat∆/∆ 
(F), R26WT (I) and R26ΔC (L) ES cells with anti-N-terminus of β-catenin antibody.      
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Figure 37 - Analysis of differentiation markers in teratomas generated from R26WT and R26ΔC ES cells 
IHC on paraffin sections of teratomas from β-catfl/fl (A, B, C), β-cat∆/∆ (D, E, F), R26WT rescued (G, H, I) and 
R26ΔC rescued ES cells. Sections were stained with β3-tubulin (A, D, G, J), GFAP (B, E, H, K) and SMA (C, F, I, 
L) specific antibodies. Nuclei counterstained with hematoxylin.  
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3. Generation of tamoxifen-inducible β-cateninex3fl/ex3fl ES cell lines   
In order to examine the role of active canonical Wnt signaling in ES cell self-renewal and 
during differentiation I decided to generate tamoxifen-inducible β-catenin gain-of-function ES 
cells. For this I used a mouse line homozygous for the β-cateninex3fl allele (Harada et al., 1999) 
and the inducible Cre recombinase (Cre-ERT2) allele, targeted to the ubiquitously expressed 
ROSA26 locus (R26CreERT2; (Seibler et al., 2003)). The estrogen receptor T2 (ERT2) moiety 
fused to Cre retains the recombinase in the cytosol, until tamoxifen administration releases this 
inhibition. Thus, addition of tamoxifen allows to induce Cre recombination between the LoxP 
sites, that surround exon 3 of β-catenin. This results in the generation of a smaller constitutively 
“active” form of β-catenin, since it cannot be phosphorylated by Gsk3 and targeted for 
proteasome-mediated degradation.    
Initially, I tried to isolate tamoxifen-inducible β-cateninx3fl/ex3fl ES cells from 3.5 dpc old 
blastocysts, using standard conditions in the presence of serum, LIF and a feeder layer, which I 
had successfully used for the generation of β-catfl/fl ES cells. However, all attempts to do so 
failed due to unknown reason. Therefore, I switched to the recently described MEF-independent 
serum-free ES culture system, called 2i (Ying et al., 2008). As described earlier, this system is 
based on N2B27 serum-free medium, supplemented with 1µM MEK inhibitor PD03, 3µM 
Gsk3 inhibitor CHIR and 1000U/ml LIF. Using this culture conditions I was able to establish 7 
independent ES cell lines out of 5 blastocysts (several ES cell lines can normally be established 
from one blastocyst after its initial dissociation), referred to as E3BR followed by the number of 
the line. Morphologically all the established lines resembled normal ES cells, forming dome-
shaped compact colonies (Fig. 38A). However, they grow slower than ES cells under serum-
containing conditions (data not shown). In order to test their pluripotency potentials, E3BR3-2 
and E3BR5 expanded ES cell lines were injected into blastocysts. From the two lines only 
E3BR3-2 gave chimaeras and transmitted through the germline (Fig. 38B). This experiment 
indicated that only E3BR3-2 ES cell line was fully pluripotent. One possible explanation for the 
poor performance of the E3BR5 ES cells might be that they were not fully pluripotent, given 
that they exhibited lower levels of Nanog (Fig. 38D).  
Next I tested whether I could induce recombination in the established ES cell lines using 
tamoxifen. 24 hours after treatment of E3BR3-2 and E3BR5 ES cells with tamoxifen a shorter 
β-catenin protein could be detected by western blot analysis (Fig. 38D), suggesting efficient 
excision of exon3 of β-catenin. 
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Considering that initial 2i culture system contained Gsk3 inhibitor CHIR and that this results in 
stabilization of β-catenin as discussed in the introduction, part 1.3, the E3BR ES cells would not 
be useful for analysis of canonical Wnt signaling effects under self-renewal conditions. 
Therefore, I tried to switch from culturing them in 2i to normal LIF-dependent serum-
containing conditions. This was successful, as judged by the morphology (Fig. 38C). Treatment 
of E3BR3-2 ES cells with tamoxifen under normal culture conditions resulted in β-catenin 
localization in cytoplasm and nucleus, as a consequence of β-catenin activation.in comparison 
to untreated control cells (Fig. 38C).  
 
 
 
 
 
Figure 38 – Characterization of serum-free tamoxifen-inducible β-catex3fl/ex3fl ES cells 
(A) Morphological appearance of E3BR3-2 ES cells line at passage 8. Image was taken using 10x magnification. 
(B) E3BR3-2 and E3BR5 ES cells were injected into C57BL/6 blastocyst. Statistics of injection results are shown 
in the table. (C) IF images of E3BR3-2 ES cells untreated (-TAM) or treated with tamoxifen (+TAM) for 24 hours 
cultured under normal conditions. β-catenin is stained in green, DAPI nuclear staining is blue. Note the intense 
green β-catenin staining in the cytoplasm and the nucleus in “+TAM” compared to the primarily membranous 
green staining in “-TAM”.  (D) Western blot analysis of β-catenin and Nanog in E3BR3-2 and E3BR5 ES cells 
untreated (-TAM) or treated with tamoxifen (+TAM) for 24 hours cultured in 2i medium. Tubulin levels serve as a 
loading control.      
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Discussion 
Development of multicellular organism is orchestrated by the cross-talk between evolutionary 
conserved signaling pathways that direct cell-type specific differentiation programs. One of 
such pathways is the Wnt/β-catenin signaling pathway. Together with transcriptional regulation 
of differentiation cell-adhesion plays an important role in regulating cell movements and 
communication between cells during development. Various studies suggested, that β-catenin, a 
transcriptional mediator of the canonical Wnt pathway, can also participate in adherens 
junctions and as such plays a dual role in transcription and cell adhesion. However, little is 
known how the balance between transcriptional and adhesion functions of β-catenin is 
achieved. Moreover, knockout studies do not allow to distinguish between the requirement of 
these two functions during development.  
In my efforts to discriminate between the adhesive and transcriptional functions of β-catenin 
during development, I generated β-catenin-deficient murine ES cell lines (β-catΔ/Δ) and re-
expressed the full-length (WT) and a signaling-defective C-terminal deleted (ΔC) β-catenin 
transgene in one of these lines. Using these important tools I was able to show that endogenous 
β-catenin is dispensable for ES cell self-renewal, but important for differentiation into 
mesoderm and endoderm lineages. Moreover, during in vitro differentiation of β-catΔ/Δ ES cells 
in EBs cell-cell adhesion defects and apoptosis become apparent, which are probably due to 
alterations in plakoglobin protein levels, a molecule highly related to β-catenin. By siRNA-
mediated silencing of plakoglobin in β-catΔ/Δ ES cells I could show that cell-cell adhesion is 
most likely essential for proper maintenance of ES cell pluripotency. Utilizing the β-catΔ/Δ ES 
cell lines expressing full-length or signaling-defective ΔC β-catenin transgenes I was able to 
rescue the cell-cell adhesion phenotype and apoptosis during differentiation. Furthermore, my 
results from in vivo and in vitro differentiation studies of the rescued ES cell lines suggest that 
adhesion function of β-catenin is important for endoderm induction and proper ectoderm 
differentiation.   
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1. β-catenin in mouse ES cell self-renewal 
1.1. Role of Wnt signaling in mouse ES cell maintenance 
ES cells, derived from the inner cell mass (ICM) of the blastocyst, are able to maintain their 
properties in culture for undefined time. Since the first isolation of mouse ES cells, researchers 
are focusing on deciphering the mechanisms that control ES cell self-renewal. In addition to 
already established signaling pathways, like LIF/Stat3, which is sufficient to maintain self-
renewal, the canonical Wnt signaling pathway had recently been implicated as well (Dreesen 
and Brivanlou, 2007; Sato et al., 2004). 
1.1.1. Endogenous levels of active β-catenin 
When I started this project, one of the open questions in ES cell field was whether the Wnt/β-
catenin pathway is endogenously active in ES cells, cultured under normal LIF-dependent 
culture conditions.   
Active canonical Wnt signaling is normally characterized by a free cytoplasmic pool of β-
catenin that can enter the nucleus and act as a co-activator in the transcription of downstream 
targets. Several experimental tools are usually used to define the active state of β-catenin in cell 
culture. Among them are the broadly used TOPFLASH reporter constructs, containing varying 
numbers of multimerized TCF binding sites, inserted upstream of the either the firefly 
luciferase gene, GFP or LacZ in other cases (Korinek et al., 1997). Active nuclear β-catenin 
binds to TCF or LEF transcription factors, that occupy corresponding binding sites within the 
reporter construct resulting in reporter gene expression, such as luciferase. The latter approach 
allows one to measure levels of β-catenin signaling activity in cells, transfected with a 
TOPFLASH construct using a conventional luminometer. Sato and colleagues had previously 
used a yellow fluorescent protein (YFP)-based TOPFLASH reporter line to examine the 
endogenous transcriptional activity of Wnt/β-catenin signaling in mouse ES cells. They showed 
that ES cells expressed YFP under normal LIF-dependent culture conditions, but upon 
withdrawal of LIF followed by differentiation the cells rapidly lost YFP-TOPFLASH 
expression (Sato et al., 2004). Consistently, other groups have shown that β-catenin was 
localized throughout the cytoplasm and in the nucleus of ES cells, and that nuclear β-catenin 
levels decreased upon LIF withdrawal and furthermore that ES cells express several canonical 
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Wnt ligands (Anton et al., 2007; Takao et al., 2007). These results indicated that canonical Wnt 
signaling might be endogenously active in ES cells at low levels.   
However, these approaches to measure endogenous levels of the canonical Wnt signaling have 
some limitations. Concerning TOPFLASH reporter, a possibility of TCF/LEF-independent 
activation of target genes by β-catenin makes its usage limited (Filali et al., 2002). As shown in 
the recent study by Takao and colleagues by over-expression of a stabilized form of β-catenin, 
β-catenin cooperates with Oct-3/4 to activate the Nanog promoter (Takao et al., 2007). Based 
on this data, it was proposed that β-catenin is involved in ES cell self-renewal in a TCF/LEF-
independent fashion. Generation of β-catenin fl/fl (β-catfl/fl) and its derivative β-catenin-
deficient (β-catΔ/Δ) ES cells, described in my thesis, gave me the possibility to reliably examine 
endogenous β-catenin activity. Importantly, as shown by blastocyst injection and germline 
transmission, the newly established β-catfl/fl ES cell line was fully pluripotent. Comparing the 
TOPFLASH reporter activity, using the highly sensitive BAR-lentiviral system in β-catfl/fl and 
β-catΔ/Δ ES cell lines, I observed in both cases only basal levels of the reporter. 
Additionally, a functionality of nuclear β-catenin to activate specific target genes has to be 
proven. Although activation of many Wnt targets is cell type-specific, so far only Axin2 has 
been established as a unique target gene in almost all system (Jho et al., 2002). Axin2 was 
expressed at the same level in β-catfl/fl and β-catΔ/Δ ES cell lines. These results are in contrary to 
published data, discussed above, suggesting a possible endogenous transcriptional activity of 
Wnt/β-catenin signaling, that, in concert with LIF-dependent stimulation, maintains ES cell 
pluripotency (Anton et al., 2007; Sato et al., 2004; Takao et al., 2007).  
Other studies showed, that expression of Stat3 (Hao et al., 2006) and c-Myc (Cartwright et al., 
2005; Hao et al., 2006; He et al., 1998) was activated by β-catenin. Again my data based on the 
analysis of self-renewal markers, cDNA expression profiling and LIF-induced STAT3-
activation experiments with β-catΔ/Δ ES cells revealed no differences between the ES cells 
lacking β-catenin and the parental β-catfl/fl ES cell lines. Thus, my results are contradictory to 
the proposed role of active endogenous β-catenin in the maintenance of LIF-dependent self-
renewal. However, they further support the notion that Wnt/β-catenin signaling is not detectable 
in the pre-implantation embryo, as demonstrated by monitoring the expression of the TCF/Lef-
LacZ transgene and non-phosphorylated β-catenin localization (Mohamed et al., 2004).     
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1.1.2. Exogenous activation of Wnt signaling 
Activation of Wnt signaling pathway has been demonstrated by different approaches to 
maintain mouse and human ES cell in the pluripotent state. 
Addition of Wnt3a CM in the absence of LIF was shown to be sufficient to maintain ES cell 
self-renewal and as confirmed by generation of germline-competent chimaeric mice also 
pluripotency, (Ogawa et al., 2006; Singla et al., 2006). However, this effect is partially due to 
the presence of LIF, in an amount similar to 10 Units of recombinant LIF, in Wnt3a CM 
favoring a potential synergistic effect of Wnt and LIF signaling on self-renewal. Though, these 
data do not rule out that the Wnt3a CM can contain some additional factors supporting self-
renewal. These experiments might in part explain my observation, that Wnt3a CM supports the 
formation of AP-positive undifferentiated colonies, even in the absence of β-catenin. Given that 
we have seen in the embryo that canonical Wnt-signaling can regulate the levels of BMPs 
together with the fact that BMPs can support ES cell self-renewal I had also checked whether 
the Wnt3a CM contains any BMP4 activity using the C2C12BRA and HepG2BRA reporter 
cells (Zilberberg et al., 2007); gift from Daniel Rifkin). However, these experiments did not 
show any increase in BMP4 activity in the CM (data not shown). In contrast, to Wnt3a CM 
rWnt3a was very specific, as β-catΔ/Δ ES cells underwent rapid differentiation in the absence of 
LIF, while WT ES cells could be maintained undifferentiated at least for 5 days under the same 
conditions. The reports in the literature on the competence of rWnt3a in supporting self-renewal 
are mixed. Two studies reported that rWnt3a is not sufficient to keep ES cells in an 
undifferentiated state (Dravid et al., 2005; Ogawa et al., 2006), while our observations goes 
along with the finding of another study showing that rWnt3a can maintain compact ES cell 
colonies up to 3 days (Singla et al., 2006). These discrepancies might be based on genetic 
variations due to the usage of different ES cell lines and/or serum or might simply be explained 
by differences in rWnt3a concentrations used (200ng/ml in my experiments and 100ng/ml in 
other studies). Furthermore, it has to be noted here that I did not test the effects of rWnt3a 
beyond the 5 day time point.  
One of the first studies implicating Wnt/β-catenin signaling in ES self-renewal was the study by 
Sato and colleagues, which reported that the Gsk3-specific inhibitor BIO is sufficient to 
maintain self-renewal of mouse as well as human ES cells through activation of β-catenin (Sato 
et al., 2004). However, more recent studies, including my own observations, partially disproved 
this conclusion. As such BIO is only able to support human ES cell propagation short-term and 
facilitate differentiation long-term (Dravid et al., 2005). Additionally, BIO reduces viability and 
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proliferation of mouse ES cells (my observations and (Ying et al., 2008). Moreover, using β-
catΔ/Δ ES cells I demonstrated that treatment with BIO results in AP-positive colonies formation 
and decreased proliferation of ES cells lacking β-catenin. This result can be explained by 
additional effects of BIO, which might inhibit also other protein kinases besides Gsk3, thereby 
eliciting β-catenin independent effects (Bain et al., 2003). This idea is supported by the study of 
Gsk3α/β double-knockout ES cells, which possess enhanced retention of ES cell markers under 
differentiation conditions, but still differentiate eventually (Doble et al., 2007).    
Recently the effect of a more specific Gsk3 inhibitor CHIR99021 (CHIR) on ES cell 
maintenance was demonstrated. Here, addition of CHIR in the absence of LIF could maintain 
ES cell survival at low density and partially maintain undifferentiated colonies at high density 
(Ying et al., 2008). Moreover, Ying and colleagues showed that CHIR in combination with 
MEK inhibitor allows long-term propagation of ES cells in undifferentiated state even in the 
absence of serum. My data support the notion that CHIR is more specific than BIO in the self-
renewal assay, as β-catΔ/Δ ES cells rapidly differentiated upon CHIR treatment in the absence of 
LIF, phenotypically resembling rWnt3a treatment. Intriguingly, when I performed the same 
experiment using ∆C rescued β-catΔ/Δ ES cells, which are defective in TCF/LEF mediated 
signaling, the ES cells maintained their self-renewal state for 5 days upon CHIR treatment. One 
possible explanation could be that ΔC β-catenin might still be able to interact with 
transcriptional co-factors other than TCF/LEF family members in order to maintain ES cell 
self-renewal. In the literature it has been reported that β-catenin can interact with the specific 
homeodomain factor, Prop1 (Olson et al., 2006) or Oct3/4 (Takao et al., 2007). This will have 
to be examined in the future. 
Taken together, my data, along with other published studies, suggest that Wnt/β-catenin 
signaling supports self-renewal of mouse ES cells, depending on the stimuli used: rWnt3a and 
CHIR showed clear β-catenin dependency, while BIO and Wnt3a CM medium can mediate 
self-renewal in part in a β-catenin-independent manner.   
1.2. Cell-cell adhesion and the maintenance of ES cell self-renewal 
One of the characteristics of undifferentiated ES cells, that distinguishes them phenotypically 
from differentiated cells, is their ability to grow in compact multilayered colonies, consisting of 
round cells with low cytoplasm to nucleus ratio (Evans and Kaufman, 1981). Once forced to 
differentiate, ES cells colonies lose their compact morphology and flatten in the cell culture 
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dish. This process is normally accompanied by the loss of transcriptional regulators of self-
renewal as well as ES cell-specific adhesion-related molecules. 
As demonstrated in my thesis ES cells have at least two types of cell junctions: adherens 
junctions and desmosomes. Components of adherens junction, β-catenin and E-cadherin, are 
broadly expressed in ES cells as well as plakoglobin, which participates in adherens junctions 
and desmosomes (Franke et al., 1987). Interestingly, β-catΔ/Δ ES cells had elevated levels of 
plakoglobin in their cell membranes. Moreover, the amount of plakoglobin associated with E-
cadherin was increased. This result is consistent with published data about β-catenin mutant 
mice and F9 cells lacking β-catenin, where plakoglobin has been shown to substitute for β-
catenin in adherens junctions (Fukunaga et al., 2005; Huelsken et al., 2000). However, my 
ultrastructural analysis revealed that cell membranes were more loosely connected in the 
absence of β-catenin. This result together with the observation of increased amounts of single 
cells in β-catΔ/Δ ES cell culture suggests, that plakoglobin might not be sufficient to substitute 
entirely for the loss of β-catenin in ES cells. Nevertheless, β-catΔ/Δ ES cells appeared to have all 
self-renewal characteristics that were discussed in chapter 1.1.1. Interestingly, knock-down of 
plakoglobin in β-catΔ/Δ ES cells resulted in a complete loss of cell-cell adhesion. This 
phenotype did not occur, when pCAGGS WT, M6 or ΔC β-catΔ/Δ ES cells were transfected with 
plakoglobin siRNA. Plakoglobin siRNA-treated β-catΔ/Δ ES cells had flattened spindle-shaped 
morphology and self-renewal markers were affected. Consequently, AP expression was 
reduced, nanog mRNA and protein levels were significantly down-regulated and PECAM-1 
expression was lost. Unfortunately, I was not able to generate the inducible plakoglobin shRNA 
β-catΔ/Δ ES cells to study the effects of β-catenin and plakoglobin loss on self-renewal in long-
term experiments. Perhaps, a cleaner and more reliable system to study this would be to 
establish ES cells form β-cateninfl/fl; plakoglobin-/- blastocysts. It should be possible to generate 
β-catfl/fl; plako-/- blastocyst, because plakoglobin-/- mice die only between days 12-16 of 
embryogenesis due to defects in heart function (Ruiz et al., 1996). Thus, upon Cre 
recombination double-knockout ES cells, lacking both β-catenin and plakoglobin, could be 
established.  
Despite the fact that more markers should be analyzed, my data suggest that β-catΔ/Δ ES cells, 
transfected with plakoglobin siRNA, have probably lost their self-renewal potentials.  
The characterization of E-cadherin-null ES cells has also been reported (Larue et al., 1994). It 
was shown that loss of E-cadherin in ES cells does not change expression of oct-3/4 and nanog, 
however the expression of brachyury, a mesoderm-specific marker, was elevated in these cells. 
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Blastocyst injection experiments showed that E-cadherin-null ES cells did not contribute to 
chimaeras, thus are not pluripotent (Larue et al., 1994). I received the E-cadherin-null cells 
from Prof. Rolf Kemler (MPI, Freiburg) and compared their appearance in culture to β-catΔ/Δ 
plakoglobin siRNA treated ES cells (Fig. 39). Although E-cadherin-/- ES cells expressed nanog 
as described, morphologically cell-cell contacts were still present between some cells, 
occasionally forming compact ES cell colonies. Moreover, very recent study demonstrated that 
the same E-cadherin-/- ES cell line has an ability to form embryoid bodies (EBs) (Moore et al., 
2009). According to the previously mentioned statement that ES cells have adherens junctions 
and desmosomes, I would hypothesize that E-cadherin-/- ES cells are not absolutely cell-
adhesion defective, as E-cadherin present only in adherens junctions and deletion of E-cadherin 
does not affect desmosomes. This could explain why ES cells lacking E-cadherin express self-
renewal markers and are able to form EBs upon LIF withdrawal.       
 
Figure 39 – Comparison of E-cadherin-/- and plakoglobin siRNA-transfected β-catΔ/Δ ES cells 
Arrows indicate compact colonies of E-cadherin-/- ES cells. Pictures were taken with 10x magnification. 
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2. β-catenin in early mouse development 
2.1. β-catenin-deficient ES cells as a model for developmental 
studies 
The formation of the primary body axis during early embryogenesis is controlled in many 
organisms by canonical Wnt signaling pathway (Sokol, 1999). In particular, knockouts of 
different components of this pathway contributed to our understanding of the mechanisms 
controlling early developmental events. β-catenin mutant mice were independently generated 
by two groups (Haegel et al., 1995; Huelsken et al., 2000). In both cases ablation of β-catenin 
resulted in a failure to position distal visceral endoderm at the anterior side of the embryo at 
E6,0 and a lack of primitive streak and mesoderm formation at E6,5. Additional studies, 
employing the generation of chimeric embryos from mutant and WT cells, suggest, that β-
catenin acts in the epiblast, where it regulates the expression of other secreted molecules that 
direct positioning of visceral endoderm at this developmental stage (Huelsken et al., 2000; 
Lickert et al., 2002). Notably, the ectodermal cell layer was properly formed in β-catenin 
mutant embryo, however after E7,0 apoptosis became apparent and the embryos failed to 
develop beyond that developmental stage. 
My in vitro and in vivo differentiation experiments, using β-catΔ/Δ ES cells, showed, that the 
differentiation defects, observed in β-catenin mutant mice, could in principle be recapitulated. I 
was able to show that β-catΔ/Δ ES cells failed to differentiate into mesoderm and endoderm, 
while differentiation into ectodermal layer was initiated. Moreover, β-catΔ/Δ ES cells failed to 
form cyst-like EBs, displayed cell-cell adhesion defects and showed increased apoptosis, 
starting at day 5 of EB differentiation, correlating with onset of the endogenous down-
regulation of plakoglobin. These defects correlate nicely with the onset of Wnt/β-catenin 
signaling activity in the mouse embryo, arguing about the significance of Wnt/β-catenin 
signaling in the primitive streak, but not in the ectoderm. It was demonstrated by monitoring the 
expression of the TCF/Lef-LacZ transgene (Maretto et al., 2003; Mohamed et al., 2004) or by 
non-phosphorylated β-catenin localization(Mohamed et al., 2004). The onset of transgene and 
non-phosphorylated β-catenin expression was first detected in the extraembryonic visceral 
endoderm of the early egg cylinder stage embryo (E5,5). Later it is restricted first to the 
posterior epiblast (E6,0) and then to the primitive streak (E6,25-7,0) and the node (E7,0-) 
(Mohamed et al., 2004). However, using different transgenic TCF/LEF reporter line it was 
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demonstrated that activity of the reporter can be detected not only in the primitive streak, but 
also found in the proximal epiblast region at E6,5 (Maretto et al., 2003).  
2.2. Role of the β-catenin C-terminus in Wnt signaling 
One of the important problems in developmental biology that has not yet been tackled is to 
distinguish between cell-cell adhesion and signaling function of β-catenin during early mouse 
development. In order to address this problem I generated β-catΔ/Δ ES cells, expressing murine 
full-length (WT; amino acids 1-781) and human ΔC (Δ amino acids 696-781) β-catenin 
transgenes, integrated into Rosa26 locus. There is evidence suggesting that the C-terminus of β-
catenin has important functions. It was proposed that different confirmations of β-catenin exist 
in the cell participating either in cell adhesion or transcription (Gottardi and Gumbiner, 2004). 
Here the C-terminus of β-catenin plays an important role it can fold back onto the armadillo 
repeat region thereby competing with β-catenin binding to the cytoplasmic domain of E-
cadherin and favoring interaction with TCF/LEF transcription factors (Castano et al., 2002; Cox 
et al., 1999; Piedra et al., 2001). Moreover, the C-terminus of β-catenin contains the 
transactivation domain, which has been reported to interact with multiple transcriptional co-
activators including CBP/p300 and TRRAP/GCN5. Deletion of the β-catenin C-terminus results 
in reduced binding efficiency to TCF/LEF transcription factors, but does not interfere with 
binding to E-cadherin (Sustmann et al., 2008). A very recent study proposed a model, where the 
C-terminal region of β-catenin promotes β-catenin stability by restricting its association with 
Axin, a key scaffold component of β-catenin destruction complex (Mo et al., 2009). All 
together, the published data based mostly on biochemical analysis suggests that the C-terminus 
of β-catenin plays an important role in regulation of β-catenin participation in Wnt signaling. 
However, its biological role is still not well characterized. 
In order to address the activity of the ΔC β-catenin variant in Wnt signaling, I had generated 
different stable lines, which expressed either the WT, as a control, or the ΔC form of β-catenin 
either under the control of the CAG promoter or from the Rosa26 locus. Both isoforms 
localized to the membrane and moreover this led to a reduction in total plakoglobin levels, 
arguing that they could participate in adherens junctions. Upon stimulation with a Gsk3 
inhibitor CHIR, TOPFLASH reporter activity was increased in the WT rescued β-catΔ/Δ ES 
cells, but no activity above the baseline was detectable in ΔC rescued β-catΔ/Δ ES cells. Thus, I 
was able to show that in β-catenin-deficient background the C-terminal truncated form of β-
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catenin is indeed defective in canonical Wnt signaling mediated by TCF/LEF. However, we 
cannot rule out that the C-terminal truncated form of β-catenin might still possess the ability to 
activate target genes in a TCF/LEF-independent fashion, through interaction with other 
transcription factors. This possibility will have to be examined in the future, using, for example, 
reporters for alternative target genes.  
2.3.  Differentiation potentials of adhesion-rescued R26ΔC ES cells 
Knowing that the ΔC variant of β-catenin was signaling defective, but could participate in cell 
adhesion, enabled me to address its biological function during early development, performing 
EB differentiation assays with the R26WT and R26ΔC ES cells. This revealed that, in 
particular, the ΔC variant of β-catenin was able to fully rescue the adhesion defect and 
apoptosis, which I had observed in the absence of β-catenin. Moreover, my analysis revealed 
that, by rescuing adhesion and apoptosis, the expression of endoderm lineage markers and 
ectoderm differentiation was restored as well. 
With regard to the endoderm lineage, expression of foxa2 and mixl1 was initiated in the control 
R26WT, but most importantly also in the R26ΔC EBs. The conserved forkhead transcription 
factor Foxa2 has been shown to be expressed in visceral endoderm, during gastrulation in the 
node, and later in the notochord and midline neural plate giving rise to all axial tissues of the 
embryo (Ruiz i Altaba et al., 1993). The homeobox transcription factor Mixl1 is required for 
mesendoderm specification and definitive endoderm formation (Hart et al., 2002). Besides 
Foxa2 and Mixl1, the expression of other visceral endoderm markers, such as the transcription 
factor Gata6 (Morrisey et al., 1998) and the Cerberus 1 homologue (Cer1) (Yamamoto et al., 
2004), was also restored. These results suggest that the cell-cell adhesion function of β-catenin 
is important for endoderm layer formation during early mouse development.  
Knowledge from developmental studies points to the importance of β-catenin in the 
neurogenesis. β-catenin mutant mice can initiate formation of the ectodermal layer, but it fails 
to develop further to neuroectoderm due to massive apoptosis (Haegel et al., 1995; Huelsken et 
al., 2000). Conditional ablation of β-catenin using Wnt1-Cre line results in severe 
malformations in brain development and increased apoptosis in brain structures (Brault et al., 
2001). I could observe similar effects in EB differentiation of β-catΔ/Δ ES cells. Thus, 
ectodermal-specific markers were induced, but EBs lacking β-catenin did not develop beyond 
day 5, probably due to increased apoptosis. However, neurons and also astrocytes could 
occasionally be observed in teratoma formation assay, arguing that β-catenin is not necessary 
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for neuroectoderm formation, but for cellular survival. The role of Wnt/β-catenin signaling in 
neuroectoderm formation and the formation of neurons is controversial in the literature, based 
on the in vitro experiments, employing mainly ES cell differentiation. Thus, enhancement of 
Wnt/β-catenin signaling promotes neuronal differentiation of ES cells (Otero et al., 2004; 
Papadimou et al., 2009). On the other hand, using PC-12 cell model of neuronal differentiation, 
TCF/β-catenin mediated transcription was proposed to limit neuronal differentiation (Teo et al., 
2005). In addition, data from developmental studies in mouse and frog clearly show that Wnt/β-
catenin signaling has to be suppressed in order to allow the formation of the anterior neural 
ectoderm (Marikawa, 2006). Using R26 ΔC ES cells I wanted to decipher the cell-adhesion 
function of β-catenin during neurogenesis. The identification of neurons positive for β3-tubulin 
in R26WT and R26ΔC 16 days old EBs, which were not present in the β-catΔ/Δ EBs suggests, 
that the ectodermal layer could propagate further, contributing to the formation of neurons upon 
rescue of the cell-adhesion defects and apoptosis. This notion is further supported by my 
findings from the teratoma formation assay. These results are also consistent with recently 
published studies, indicating the importance of cell-cell interactions for neuroectodermal 
specifications and lineage commitment (Parekkadan et al., 2008; Sun et al., 2008).  
All together, my data show that there is an important role for the cell-cell adhesion function of 
β-catenin for the development of certain germ layers and that the defects observed in β-catenin 
mutant embryos are probably not exclusively due to the signaling function of β-catenin. The 
working model, presented in the Fig. 40, demonstrates that, using correlation of EB 
differentiation to the early embryonic development. However, it is still not clear whether 
R26ΔC ES cells can contribute to the primitive streak and mesoderm. Future experiments, using 
injection of these cells into a host blastocyst should clarify that point.  
Still one of the unresolved issues, that might put some of my results into question, is based on 
the observation, that the teratomas, formed from R26WT ES cells, did not develop the full 
complement of differentiated structures, as seen in teratomas, derived from β-catfl/fl ES cells. 
This might be explained in several ways: firstly the WT β-catenin transgene was expressed at 
lower than endogenous levels from the Rosa26 locus; Secondly, the endogenous β-catenin 
expression might be regulated by transcription factors, binding to tissue-specific enhancers, and 
this regulatory network would, of course, be not maintained, when the transgene was expressed 
from the Rosa 26 locus. 
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Figure 40 – Working model 
The model shows the pre-implantation (A, B) and post-implantation mouse development (C, D, E, F). Wnt/β-
catenin signaling is not active during preimplantation development (A, B); however β-catenin is expressed in all 
developing tissues before and after implantation. The differences become apparent from the egg cylinder stage (C) 
onwards. In WT embryo (D) epiblast (blue) undergoes asymmetric rearragments culminating with the primitive 
streak formation (orange) on the posterior side of the epiblast that gives rise to the mesoderm and definitive 
endoderm. Ectoderm forms at its anterior side and DVE migrates to the anterior side forming AVE. The β-catenin-/- 
embryo (E) stops to develop at the egg cylinder stage, DVE does not migrate to the anterior side and apoptosis 
becomes apparent in the ectoderm. R26ΔC embryo (F) should form definitive endoderm and ectoderm might 
develop further. However, it is not clear whether the primitive streak and mesoderm develop, and DVE migrates in 
the rescued embryo. DVE, definitive visceral endoderm; AVE, anterior visceral endoderm; ExE, extraembryonic 
ectoderm; PrE, primitive endoderm 
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3. Future directions 
My analysis under self-renewal conditions points at a potential role for β-catenin and 
plakoglobin mediated cell-cell adhesion for proper maintenance of mouse ES cell pluripotency. 
However, additional studies are needed to confirm this observation. In particular, the generation 
of β-cateninfl/fl; plakoglobin-/- ES cells would be a helpful tool for further investigations, as 
transient knock-down of plakoglobin by siRNA does not allow to study long-term defects. 
Moreover, in order to rule out the existence of other types of cell junctions in mouse ES cells 
and to prove that, indeed, adherens junctions and desmosomes are the only cell junctions 
present, further characterization at the ultrastructural level, using antibody labeling specific for 
different adhesion-related molecules, would be necessary. 
With regard to my findings, concerning the rescue of germ layers upon rescuing presumably 
exclusively the cell adhesion function of β-catenin, it would be necessary to perform in vivo 
blastocyst injection experiments with these lines to confirm the in vitro findings. This could be 
done by either labeling the respective ES cell lines with, for example, GFP or LacZ or by 
injecting the ES-cell lines into host blastocyst, that express a marker ubiquitously, thus allowing 
to discriminate between injected and host cells in their contribution to developing embryonic 
structures. Ultimately, it would be necessary to generate conditional ΔC β-catenin mice in order 
to study the cell-cell adhesion function of β-catenin in different tissues during embryonic or 
adult mouse development.  
Last, but not least, it would be necessary to examine the expression of endogenous targets of 
Wnt/β-catenin signaling in R26∆C rescued ES cells to confirm our findings, using the artificial 
TOPFLASH reporter. Furthermore, TCF/LEF independent β-catenin regulated targets should 
be analyzed to rule out that ∆C β-catenin has still some TCF/LEF independent signaling 
function. 
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Supplementary information 
Supplementary Table 4 - Top 300 Wnt3a activated genes identified by cDNA microarray analysis 
Unigene_ID Symbol Log fold change Fold change adjPvalue 
Mm.9086 Slc16a1 2.90 7.48 0.00464293 
Mm.33764 Ivns1abp 2.64 6.24 0.00246058 
Mm.31911 Ercc6l 2.43 5.40 0.00305295 
Mm.4105 Lmnb1 2.43 5.40 0.00601027 
Mm.245119 Lancl3 2.40 5.29 0.00293802 
Mm.277024 Copb1 2.40 5.26 0.00101472 
Mm.61526 Hmgcs1 2.36 5.14 0.00382273 
Mm.274086 Kif18a 2.35 5.09 0.00076503 
Mm.291029 Skiv2l2 2.33 5.05 0.00085122 
Mm.133560 Ddx10 2.32 4.98 0.00244651 
 Ccdc139 2.27 4.81 0.00081044 
Mm.248779 Pop1 2.24 4.72 0.00239357 
Mm.274086 Kif18a 2.23 4.68 0.00060955 
 Gclc 2.21 4.63 0.00059003 
Mm.239865 Hspa4 2.21 4.62 0.00557398 
Mm.132208 Ipo11 2.20 4.59 0.00267387 
 Opa1 2.18 4.53 0.00216536 
Mm.4606 Bcat1 2.17 4.51 0.00147099 
Mm.54126 Pnpla8 2.15 4.44 0.00227039 
Mm.416918 4930413M19Rik 2.14 4.42 0.00300272 
Mm.278471 Mphosph1 2.13 4.39 1.8661E-06 
Mm.292001 Prpf6 2.13 4.38 0.00318447 
Mm.291233  2.12 4.35 0.00263802 
 Mthfd1 2.11 4.33 0.00390583 
Mm.261453 Ect2 2.10 4.27 0.00638884 
 Phip 2.08 4.22 0.00532291 
 Opa1 2.07 4.20 0.00289975 
Mm.278471 Mphosph1 2.07 4.19 4.7766E-07 
Mm.289441 Cldn1 2.04 4.11 0.00260808 
Mm.46397 Vps53 2.03 4.10 0.00287193 
 Socs6 2.03 4.09 0.02083752 
Mm.311585 Polh 2.03 4.07 0.00010807 
Mm.4649 Cenpc1 2.02 4.05 0.00082971 
 Opa1 2.01 4.02 0.00148957 
Mm.38813 9030612M13Rik 2.00 4.00 0.00093302 
 Otud4 1.99 3.97 0.00268413 
Mm.36785 Aggf1 1.98 3.94 0.00226005 
Mm.38816 Wdr36 1.97 3.92 0.00263092 
 Dclre1c 1.97 3.91 4.7041E-05 
Mm.200497 Hadha 1.96 3.88 0.00418915 
 Rrn3 1.94 3.85 0.0035357 
 Ccdc139 1.94 3.84 0.00118793 
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 Ccdc139 1.94 3.84 0.00092048 
 Eml4 1.94 3.83 0.0009345 
Mm.176695 Trim59 1.93 3.82 0.00461971 
Mm.331007 Ndufc1 1.93 3.81 0.00229888 
 Tmem181 1.93 3.81 2.2992E-06 
Mm.2185 Bub1 1.93 3.81 0.00235023 
 Papd1 1.92 3.80 0.00424986 
Mm.36785 Aggf1 1.92 3.79 0.00235023 
Mm.389595 Vmn2r-ps14 1.92 3.79 0.00458214 
Mm.251548 Topors 1.92 3.79 0.00152598 
 Nedd4 1.92 3.79 0.00046247 
Mm.196638 Cdc23 1.91 3.76 0.0062297 
 Zfp60 1.91 3.75 0.00050074 
 Ipo7 1.90 3.74 0.00279563 
 Wdr48 1.90 3.73 0.00152058 
 Cpsf2 1.90 3.73 0.00239294 
 Matr3 1.90 3.72 0.00244601 
Mm.176695 Trim59 1.90 3.72 0.00552203 
Mm.22339 Vwf 1.90 3.72 0.0015547 
Mm.30660 Prpf4 1.89 3.72 0.00055843 
Mm.36291 Heatr3 1.89 3.71 0.00377752 
Mm.243849 Sycp1 1.89 3.69 1.0215E-05 
Mm.299955 Lypla1 1.87 3.65 0.00488397 
Mm.149071 Mre11a 1.85 3.62 0.00347772 
Mm.426052 Afg3l2 1.85 3.60 0.00839698 
Mm.28221 Utp15 1.84 3.59 0.00348573 
 Gtpbp4 1.84 3.59 0.00728206 
 Zmym1 1.84 3.58 0.00389193 
Mm.40802 Rbm28 1.84 3.58 0.00068735 
Mm.40292 Nol14 1.84 3.58 0.00234327 
Mm.21629 Abcf2 1.84 3.57 0.01603707 
Mm.3110 Ktn1 1.84 3.57 0.00070214 
 Gtdc1 1.84 3.57 0.00360946 
Mm.25298 Elp2 1.84 3.57 0.00968757 
Mm.378921 Gja1 1.83 3.56 0.00021564 
 Ppp1cb 1.83 3.56 0.0024201 
Mm.132208 Ipo11 1.83 3.55 0.00110182 
Mm.304899 Gstcd 1.82 3.54 0.00124369 
 Arhgap12 1.82 3.54 0.00900016 
Mm.315909 Hnrph2 1.82 3.54 0.00088799 
Mm.21299 AW549877 1.82 3.53 0.00042774 
 C920006C10Rik 1.82 3.52 0.00102409 
Mm.265615 Wdhd1 1.81 3.51 0.00612643 
Mm.28366 Ide 1.81 3.51 0.0008018 
 Eif3c 1.81 3.50 0.00068573 
 Yes1 1.81 3.50 0.00385311 
 Atad1 1.81 3.50 0.00191982 
 Zmym1 1.81 3.50 0.00017711 
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Mm.30088 Clpx 1.80 3.48 0.00514916 
Mm.102903  1.80 3.48 0.00854619 
 2610018G03Rik 1.80 3.47 0.00472144 
 Mapre1 1.79 3.46 0.00278793 
 Zcchc7 1.79 3.45 0.00157996 
Mm.32009 5830406J20Rik 1.79 3.45 0.0031452 
Mm.338175 Ints7 1.78 3.44 0.00071855 
Mm.102970 Sbf2 1.78 3.44 0.00255353 
Mm.227274 Prc1 1.78 3.44 0.00934741 
Mm.293811 Rb1cc1 1.78 3.43 0.00012165 
Mm.303534 Dr1 1.77 3.42 0.00134408 
 Strbp 1.77 3.41 0.01122501 
Mm.34606 Krr1 1.77 3.40 0.00264817 
 Ifi203 1.77 3.40 0.01336614 
Mm.282700 Hars2 1.76 3.39 0.00264703 
Mm.291928 Ctnnb1 1.76 3.39 0.00041324 
 Phtf2 1.76 3.38 0.00928041 
Mm.286061 Tars 1.76 3.38 0.0011551 
Mm.40292 Nol14 1.75 3.37 0.00128992 
Mm.380307 Nfasc 1.75 3.37 0.00147134 
 Atrx 1.75 3.37 7.5969E-05 
Mm.10027 Prpf4b 1.75 3.36 0.00015469 
Mm.371585 Suclg2 1.75 3.35 0.00433728 
Mm.40292 Nol14 1.74 3.35 0.00049629 
 Opa1 1.74 3.35 0.00194607 
Mm.30264 Chfr 1.74 3.34 0.00152598 
Mm.2238 Eif3a 1.74 3.34 0.00046217 
 Vcp 1.74 3.34 0.00236143 
Mm.292109 Casc4 1.74 3.34 0.00286549 
Mm.209419 Hspa9 1.74 3.34 0.00717005 
Mm.200497 Hadha 1.74 3.33 0.00454667 
 A430062P19Rik 1.74 3.33 0.00297018 
 Plaa 1.74 3.33 0.00252746 
 Mdm4 1.73 3.32 0.01637867 
 D230025D16Rik 1.73 3.32 0.00344089 
 Kit 1.73 3.31 0.00883776 
Mm.142872 Hnrpk 1.72 3.30 0.00143581 
 Dsp 1.72 3.30 0.00110186 
Mm.36785 Aggf1 1.72 3.29 0.00279563 
Mm.259638 4933421E11Rik 1.72 3.29 0.00127523 
Mm.22480 Dmtf1 1.72 3.29 0.00811389 
Mm.219675 Gfm2 1.71 3.28 0.00047379 
Mm.251255 Ddx1 1.71 3.27 0.00282537 
Mm.389595 Vmn2r-ps14 1.71 3.27 0.00244419 
Mm.267061 Ddx6 1.71 3.26 1.5379E-05 
Mm.291029 Skiv2l2 1.70 3.25 0.0005998 
Mm.71710 Axin2 1.70 3.25 0.00068437 
Mm.34606 Krr1 1.70 3.25 0.00081411 
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 Dtl 1.70 3.24 0.0014403 
 Fasn 1.69 3.23 0.00019324 
Mm.1904 Ttk 1.69 3.23 0.00053807 
 2810405J04Rik 1.69 3.23 0.00442262 
Mm.439768 Fgf14 1.69 3.23 0.00209416 
Mm.219684 Usp53 1.69 3.22 0.00025697 
 Rngtt 1.69 3.22 0.0011089 
 Hnrnpr 1.69 3.22 0.00239357 
 Dock2 1.69 3.22 0.00214788 
 Atad1 1.68 3.21 0.00124369 
 E2f2 1.68 3.21 0.00124369 
 Arl15 1.68 3.20 0.00287338 
Mm.66853 Iws1 1.67 3.19 0.00173972 
Mm.25794 Fbxl5 1.67 3.19 0.00251847 
Mm.247566 Meis2 1.67 3.19 0.00077775 
 Rnd3 1.67 3.19 0.00139284 
Mm.284654 Wdr37 1.67 3.18 0.00068735 
Mm.271986 Pcmtd2 1.67 3.18 0.00166474 
 Tmem181 1.67 3.18 0.00013704 
Mm.463007 2900073C17Rik 1.67 3.18 0.02297919 
Mm.87389 Wdr35 1.67 3.17 0.00422119 
Mm.390978 A930001N09Rik 1.67 3.17 0.00657119 
 Pfkp 1.66 3.17 0.01098636 
Mm.276279 Zfp667 1.66 3.17 0.00022379 
 Atrx 1.66 3.17 9.4745E-05 
 Bclaf1 1.65 3.15 0.01108978 
 Hmgcr 1.65 3.15 0.0009897 
Mm.188979 9530056K15Rik 1.65 3.14 0.01679349 
Mm.25527 Hbs1l 1.65 3.14 0.00144553 
Mm.356580 Aftph 1.65 3.13 0.00021535 
 Wdr3 1.64 3.13 0.00142507 
  1.64 3.13 0.010608 
Mm.24593 4833439L19Rik 1.64 3.12 0.01396053 
 Pi4k2b 1.64 3.11 0.00341587 
 Nfib 1.64 3.11 0.01047721 
Mm.38927 Ppil4 1.64 3.11 0.00138532 
 Exod1 1.64 3.11 0.00174312 
Mm.133560 Ddx10 1.63 3.10 0.00118549 
Mm.21848 Bzw1 1.63 3.09 0.00017464 
 Ap1g1 1.63 3.09 0.00507989 
 Terf2 1.62 3.08 0.01930874 
 Dars 1.62 3.08 0.00075126 
 Ccdc88a 1.62 3.08 0.00032835 
Mm.67366 Zfp75 1.62 3.08 0.00222876 
Mm.294503 Trmt11 1.62 3.07 0.0025469 
Mm.271178 Arl8b 1.62 3.07 0.00197415 
 Rnf6 1.62 3.07 0.00103874 
Mm.3131 Dld 1.62 3.07 0.00042822 
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Mm.61526 Hmgcs1 1.62 3.07 0.00054299 
Mm.689 Acvr1 1.62 3.07 0.0018538 
Mm.12568 Nup107 1.61 3.05 0.00381945 
 Ccne2 1.61 3.05 0.00024525 
 Cep57 1.61 3.05 0.0020724 
 Trim23 1.61 3.05 0.00301432 
Mm.28152 BC055324 1.61 3.05 0.00284053 
Mm.4375 Fto 1.61 3.04 0.00268413 
 1700047O18Rik 1.61 3.04 0.00508761 
 Ktelc1 1.60 3.04 0.00251168 
 Sfrs1 1.60 3.03 0.00544874 
Mm.290704 C330007P06Rik 1.60 3.03 0.00251168 
Mm.403916  1.60 3.03 0.00275377 
Mm.30088 Clpx 1.60 3.03 0.00195461 
Mm.390681 P2ry5 1.59 3.02 0.00060955 
 Ccne2 1.59 3.02 0.0002024 
Mm.282743 Ikbkap 1.59 3.01 0.00161842 
 Hnrpf 1.59 3.01 0.01037536 
 Atp2c1 1.59 3.01 0.00104151 
 Zcchc7 1.59 3.00 0.01236954 
Mm.31911 Ercc6l 1.59 3.00 0.00059118 
Mm.183042 Impa1 1.58 3.00 0.00017711 
Mm.207345 Zfp449 1.58 3.00 0.0025469 
Mm.301585 Tbc1d24 1.58 3.00 0.00091959 
Mm.221499 Disp2 1.58 3.00 0.01227483 
Mm.290791 Ndufs1 1.58 2.99 0.00216009 
Mm.16753 Chek1 1.58 2.99 0.0002024 
Mm.22448 Ckap2 1.58 2.99 0.00217175 
 C230085J04Rik 1.58 2.99 0.00115651 
Mm.183102 Actr3 1.58 2.99 0.00163235 
 Srd5a1 1.58 2.99 0.00138738 
Mm.29515 Pxk 1.58 2.98 0.00274117 
Mm.255858 Ctr9 1.57 2.97 0.00236041 
Mm.383091 Kif4 1.57 2.97 0.00417878 
Mm.87773 Hsp90b1 1.57 2.97 0.00507989 
Mm.38927 Ppil4 1.57 2.97 0.00046247 
 Smek2 1.57 2.96 0.00012777 
Mm.276109 Cwf19l1 1.57 2.96 0.00481453 
Mm.143719 Dll4 1.57 2.96 0.00108036 
 Piga 1.57 2.96 5.6447E-05 
 C430003P19Rik 1.56 2.96 0.00051901 
Mm.7709 Scnn1b 1.56 2.96 0.00191013 
Mm.274086 Kif18a 1.56 2.95 0.00188096 
 Hook3 1.56 2.95 0.00894639 
Mm.326089 Top3b 1.56 2.95 0.02021386 
 Fem1c 1.56 2.95 0.00109614 
Mm.41447 Chd1l 1.56 2.94 0.00868475 
 Suz12 1.56 2.94 0.00298939 
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 D030022P06Rik 1.56 2.94 0.02645496 
Mm.443996 9030612E09Rik 1.55 2.94 0.0026614 
Mm.4606 Bcat1 1.55 2.94 0.00101289 
Mm.335237 Zwilch 1.55 2.93 0.01089622 
Mm.303534 Dr1 1.55 2.93 0.00121184 
 Atrx 1.55 2.93 7.4313E-05 
 Slc25a13 1.55 2.93 0.00299202 
 Tpx2 1.55 2.92 0.0029598 
Mm.255044 Pank3 1.55 2.92 0.02325396 
Mm.25794 Fbxl5 1.54 2.92 0.00251764 
 Ptcd3 1.54 2.91 0.00810648 
 Eif3c 1.54 2.91 0.00827024 
Mm.28524 D6Wsu116e 1.54 2.90 0.000248 
Mm.329194 Lycat 1.54 2.90 0.00463499 
Mm.25548 Kpna3 1.54 2.90 0.00087915 
Mm.275354 Qtrtd1 1.53 2.90 0.00163612 
 Pbx1 1.53 2.90 0.00281179 
Mm.154078 Gm1964 1.53 2.89 3.9787E-05 
 Wdr3 1.53 2.89 0.00207322 
Mm.100450 Sptlc3 1.53 2.89 0.0036876 
 Trpc1 1.53 2.88 0.01554793 
 Mtm1 1.53 2.88 0.00581665 
 Serinc3 1.53 2.88 0.00569264 
 C430048L16Rik 1.53 2.88 0.00081501 
 2900084C01Rik 1.53 2.88 0.01198282 
 Stam 1.53 2.88 0.00085522 
Mm.196638 Cdc23 1.53 2.88 0.0019755 
 Alkbh8 1.53 2.88 0.00097473 
Mm.271986 Pcmtd2 1.52 2.88 0.00287338 
 B230312C02Rik 1.52 2.87 0.00838793 
Mm.9086 Slc16a1 1.52 2.87 0.00463022 
Mm.20522 Lancl1 1.52 2.87 0.00050227 
Mm.186329 Trpa1 1.52 2.87 0.00056293 
Mm.390681 P2ry5 1.52 2.87 0.00032815 
Mm.10100 Trpc4 1.52 2.86 3.1976E-05 
Mm.443222 Pot1a 1.52 2.86 0.00058993 
Mm.20294 Sephs2 1.52 2.86 0.00880138 
Mm.290341 Tmem50b 1.51 2.86 0.00611202 
Mm.21649 Nkrf 1.51 2.85 0.00288582 
Mm.290602 4930453O09Rik 1.51 2.85 0.00059118 
 Nek2 1.51 2.85 0.00157499 
Mm.378921 Gja1 1.51 2.85 0.00042244 
 EG622129 1.51 2.85 0.0022908 
Mm.271178 Arl8b 1.51 2.85 0.00360498 
Mm.284944 Hsd17b13 1.51 2.85 0.0039017 
Mm.137021 Tcfap2b 1.51 2.84 0.00060595 
 Cul5 1.51 2.84 4.9877E-05 
 Lrrc40 1.51 2.84 0.00667631 
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Mm.100125 Sh3bgrl2 1.51 2.84 0.00011725 
 AI314180 1.50 2.84 0.00469518 
 Pscdbp 1.50 2.84 0.00117969 
 Fyttd1 1.50 2.83 0.00138372 
Mm.65316 Nos1ap 1.50 2.83 0.00585472 
Mm.41715 Gpbp1l1 1.50 2.83 0.00284791 
Mm.273769 D030074E01Rik 1.50 2.83 0.00332841 
Mm.390681 P2ry5 1.50 2.83 0.00104881 
Mm.1904 Ttk 1.50 2.83 0.0005968 
 Dars 1.50 2.83 0.00046247 
 AF529169 1.50 2.83 0.00053611 
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Abstract 
Ror1 is a member of the Ror-family receptor tyrosine kinases.  Ror1 is broadly expressed in 
various tissues and organs during mouse embryonic development, however, so far little is 
known about its function.  The closely related family member Ror2 was shown to play a crucial 
role in skeletogenesis and has been shown to act as a co-receptor for Wnt5a mediating non-
canonical Wnt-signaling.  Previously it has been shown that during embryonic development 
Ror1 acts in part redundant with Ror2 in the skeletal and cardiovascular systems.  In this study 
we report that loss of the orphan receptor Ror1 results in a variety of phenotypic defects within 
the skeletal and urogenital systems and that Ror1 mutant mice display a postnatal growth 
retardation phenotype.   
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Introduction 
Ror1 is one of the two vertebrate Ror-family members of orphan receptor-tyrosine kinases 
(Green et al., 2008; Minami et al., 2009; Yoda et al., 2003).  Like its closely related family 
member Ror2, Ror1 contains extracellular a cysteine rich domain (CRD) similar to the CRD 
domain of the Wnt-receptor frizzled (Saldanha et al., 1998).  For Ror2 binding to Wnt-ligands 
as well as to the BMP/TGFβ-family member, Gdf5, has been demonstrated (Liu et al., 2008; 
Oishi et al., 2003; Sammar et al., 2004).  Ror2 activity can mediate non-canonical Wnt-
signaling through interaction with Wnt5a, and modulates the canonical Wnt-signaling pathway 
through differential interaction with the Frizzled receptor (He et al., 2008; Hikasa et al., 2002; 
Li et al., 2008; Mikels and Nusse, 2006).  Ror1 has been recently demonstrated to be capable of 
binding the Wnt5a ligand as well, however, if this binding results in functional activity is 
currently not known (Fukuda et al., 2008).  Both Ror genes are widely expressed during 
embryonic development, in limbs, teeth, heart, lung, liver, gut, and hippocampal neurons (Al-
Shawi et al., 2001; Matsuda et al., 2001; Oishi et al., 1999; Paganoni and Ferreira, 2003; 
Rodriguez-Niedenfuhr et al., 2004; Schwabe et al., 2004).  Mutations in ROR2 in humans cause 
autosomal dominant brachydactyly type B (BDB) and are associated with autosomal recessive 
form of Robinow syndrome (RS) (Afzal et al., 2000; Hamamy et al., 2006; Oldridge et al., 
2000; Schwabe et al., 2000; van Bokhoven et al., 2000).  Loss of Ror2 in mice results in 
phenotypic changes resembling RS (DeChiara et al., 2000; Schwabe et al., 2004; Takeuchi et 
al., 2000).  The point mutation Ror2-W749X, linked to human BDB, behaves as a recessive 
mutation in the mouse causing brachydactyly and models recessive RS (Raz et al., 2008).  In 
addition, ROR family member have been implicated in tumor formation in humans.  ROR1 has 
been found to be overexpressed in patients with acute and chronic lymphoblastic leukemia 
(Daneshmanesh et al., 2008; Shabani et al., 2007; Shabani et al., 2008) and was found to act as 
a survival kinase in HeLa cervical carcinoma cells (MacKeigan et al., 2005).  ROR2 has been 
found to be overexpressed in squamous cell carcinoma and to regulate osteosarcoma cell 
invasiveness (Enomoto et al., 2009; Kobayashi et al., 2009).  Previously it was reported that 
loss of Ror1 in mice results in perinatal lethality due to respiratory defects, but that these mice 
lack any abnormalities in skeletogenesis (Nomi et al., 2001).  Here, we have re-examined the 
Ror1-ablated mutants and found that the mice have subtle skeletal defects at birth; they showed 
fusions of the sternebrae, a cleft in the basisphenoid bone, and abnormal development of the 
cervical vertebral element C2.  Homozygous mice survived in our facility and displayed 
abnormal synchondrosis in the cranial base, postnatal growth retardation and age-related 
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skeletal changes.  Furthermore, we observed additional phenotypic defects in Ror1-/- mutants, 
such as female infertility probably due to an imperforated hymen, kidney defects and 
occasionally enlarged seminal vesicles in Ror1-/- males.  
 
Material and Methods 
Mouse husbandry 
The generation of the Ror1 mutant allele has been previously described (Nomi et al., 2001).  
The Ror1 strain was maintained in a C57Bl/6 background.  Mutants were generated by 
intercrosses of heterozygous mice, or through breeding of homozygous males with 
heterozygous females to increase the number of mutant offspring.  Genotyping of mice was 
performed by PCR using the following primer pairs: for detection of the 1.1kb wild-type allele 
theWT_for-primer 5’GGCAACAAATGGCAAGAAAGTGGTGTC and WT_rev-primer 5’ 
GAAATGGAATCCTTAGACTCCGTTATC were used.  For detection of the 1.1kb mutant 
allele, the WT_for-primer was used in combination with the neo-primer 5’ 
ATCGCCTTCTATCGCCTTCTTGACGAG. 
 
Skeletal preparations, microCT and bone densitometry 
For the alcian blue /alizarin red staining of newborns, postnatal and adult mouse skeletons the 
mice were sacrificed, skinned, eviscerated, fixed in 95% ethanol and stained according to 
(McLeod, 1980).  Harvested organs were visually inspected for abnormalities.  Three 
dimensional medium-resolution images were obtained from the skulls, spine, ribs and digits of 
Ror1-/- and control mice (Ror1+/-; Ror1+/+) using microcomputed tomography (eXplore locus 
SP, GE Healthcare, London, Ontario, Canada).  Scans were taken at 28 µm isotropic resolution 
and 720 projections were acquired over an angular range of 360°.  Images were reconstructed 
and thresholded to distinguish bone voxels with MicroView software version 5.2.2 (GE 
Healthcare).  One threshold was chosen for all specimens (or as previously described Amarilio 
et al., 2008).  Volumetric bone mineral density (BMD) of the femurs was measured by 
peripheral quantitative computed tomography (pQCT) using a XCT Research M+ pQCT 
machine (Stratec Medizintechnik, Pforzheim, Germany) as described (Schneider et al., J Bone 
Miner Res 24:455-67, 2009). One slice (0.2 mm thick) in the mid-diaphysis of the femur, and 3 slices 
in the distal femoral metaphysis located 1.5, 2, and 2.5 mm proximal to the articular surface of the knee 
joint were measured. BMD values of the distal femoral metaphysis were calculated as the mean over 3 
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slices. A voxel size of 0.070 mm and a threshold of 600 mg/cm³ were used for calculation of 
BMD. . 
 
Histology and section in situ hybridizations 
For histology and section in situ hybridizations material from embryos and pups was dissected, 
washed in PBS and fixed overnight in 4% PFA/PBS, dehydrated to 70% ethanol, and processed 
using a standard program of the Tissue-Tek VIP5 Vacuum Infiltration Processor (Sakura).  
Processed tissue was embedded in paraffin and sectioned at 5µm.  Hematoxylin/eosin stainings 
were performed using standard protocols.  Alcian blue / van Kossa staining on sections were 
performed as following: tissue was rehydrated, washed twice in deionized water, exposed for 
60 minutes in 2% silver-nitrate solution to a 60 watt lamp, washed three times in deionized 
water, incubated for 2 minutes in 1% acetic acid, stained with alcian blue solution (pH 2.2) for 
15 minutes, washed in 1% acetic acid, dehydrated into 75% ethanol, counterstained for 30 
seconds with eosin, destained with 100% ethanol and xylene and mounted using DPX (Fluka).  
Section in situ hybridizations were done as previously described (Murtaugh et al., 1999).    
 
Immunohistochemistry, Western blot and Elisa for IGF1serum levels 
Immunohistochemistry for the following hormone precursors, GH (1:10000), TSHβ (1:2000), 
LHα (1:2000), LHβ (1:2000), ACTH (1:3000), was performed on paraffin sections of the 
pituitaries from E17 embryos and P2 mice.  Antibodies were obtained from the National 
Hormone and Pituitary Program and immunohistochemistry was performed using the Ventana.  
Briefly sections were dewaxed and rehydrated, antigen-retrieval was done using citrate buffer 
pH6.0.  Western blots to determine GH protein levels were performed on 50 µg protein extracts 
from dissected pituitaries from P17 & P19 mice (α-GH at a dilution of 1:2000).  IGFI serum 
levels were determined in the plasma of Ror1-/- and control mice at 3 months of age using an 
IGF-I Elisa assay following the manufacture instructions (Quantikine Kit, R&D systems).   
 
Results 
 
Skeletal defects in Ror1-/- embryos 
Ror1 mutant embryos displayed very distinct skeletal defects, which were apparent prior to 
birth.  The sternum of Ror1-/- embryos was shortened and showed fusion of caudal sternebrae 
(S) involving to a variable degree S1-S4 (Fig. 1A and Table 1).  In addition the xyphoid process 
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was abnormally bifurcated and had two ossification centers (Fig. 1A).  Defects in sternal 
development were already detectable at E15.5 where the two sternal bands were still separated 
from each other in the caudal region of Ror1-/- embryos, while they were already almost 
completely fused along the entire length in the wild-type littermate controls (Fig. 1B).  The 
sternal-costal junctions, demarcations between the end of the ribs and the sternal tissue, can be 
distinguished by their reduced reactivity with the proteoglycan staining reagent alcian blue and 
low levels of Collagen 2α1 (Col2α1) transcript, appeared right at the sternal bands in the wild-
type (see arrowheads in Fig. 1Ba, b), while they were located more laterally in the Ror1 
mutants (Fig. 1Ba’, b’).  In situ hybridizations for the prehypertrophic marker, Ihh, revealed 
that the onset of chondrocyte differentiation occurs normal in the Ror1 mutant sterni (Fig. 1Bc, 
c’).  However, in the caudal part the Ihh expression domains were not absolutely restricted to 
the intercostal segments (arrowheads in Fig. 1Bc’).  At E17.5 the abnormal shape of the shape 
and location of the sternal-costal junctions was still present in the mutant sterni.  The sternal 
bands had either begun to fuse abnormally, visible by the presence of alcian blue positive and 
Col2α1 (not shown) expressing cells in the midline, or were still separated by a small band of 
none-chondrogenic cells (data not shown).  However like in the wild-type, chondrocytes within 
the sternal bands had maturated into hypertrophic chondrocytes, which expressed Collagen 
10α1 (Col10α1) and Osteopontin (Opn) and produced mineralized matrix in all mutants 
examined (Fig. 1Ca-c’).  In contrast to the controls where this process was restricted to the 
intercostals regions, hypertropic cells differentiated also at the ends of ribs in the mutants 
leading to the formation of continuous hypertrophic domains in the region of sternebrae 3-4 
(Fig. 1Cb’, c’).  Concomitantly, Ihh expression was altered and expressed all around the 
hypertrophic regions (Fig. 1Cd, d’).  The abnormal expression of maturation markers, such as 
Ihh and Col10α1 suggests that the absence of functional Ror1 affects the normal organization 
into a growth plate-like structure in the intercostals region, instead growth plate-like structures 
are now located at the end of the ribs.  This defect was even more apparent at P0 where 
Col10α1 and Ihh were expressed almost all around the fused sternebrae elements, including the 
regions at the ends of the ribs (data not shown).  
 In addition to the defects in the sternum we detected skeletal abnormalities in the 
cervical vertebral element C2 and the base of the skull in newborns (P0).  The cervical element 
C2 appeared in most mutants wider and was split in some mutants (Fig. 2A).  In the skulls of 
mutant newborns clefts were present in the posterior region of the basisphenoid bone and in the 
anterior borders of the exoccipitale bones in 100% of the mutants analyzed (n=9; Fig. 2B).  At 
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P5 the clefts had developed into holes, which were still visible at later stages and in adults (Fig. 
2C, D, and data not shown).  Furthermore, we noticed in the cranium of P5 and P19 heads a 
bony bridge within the spheno-occipitale synchondrosis connecting the basioccipitale with the 
basisphenoid bone (arrows in Fig. 2C, D).  This resulted in premature synostosis of the spheno-
occipitale synchondrosis in the cranial base and an overall shortening of the skull with a more 
dome-shaped appearance in X-rays at the adult stage (Fig. 2E).  At P5 it was also apparent, that 
the vomeral bones were hypoplastic (Fig. 2C).  In the P17 and P19 mutant heads we noticed a 
hole in the exoccipitale bones, which probably was the result of the cleft that we had noticed in 
the newborn skulls (n= 5; Fig. 2D).  The fusion of the basisphenoid and basioccipitale bone was 
also clearly visible on microCTs of aged mutant specimens (Fig. 2F).  
 Growth retardation of the Ror1 mutant pups became apparent at P2 (see Fig. 4), 
associated with morphological and molecular changes in the growth plates of long bones (Fig. 
3B), while there were no changes detectable at E17.5 or in newborns (Fig. 3A and data not 
shown).  At P2 the prehypertrophic, Ihh expressing and the hypertrophic, Col10a1 expressing 
zones of the mutant growth plates were shorter compared to wild-type or heterozygous 
littermate controls (Fig. 3B).  In the wild-type growth plates at P2 only the last 3-4 rows of 
hypertrophic chondrocytes had mineralized matrix, while the hypertrophic chondrocytes 
towards the articular region were slightly smaller and had a non-mineralized matrix (Fig. 3B).  
Similarly, osteopontin was expressed in the last 3-4 rows of hypertrophic chondrocytes in the 
wild-type growth plate (Fig. 3B).  In contrast, in the Ror1 mutant growth plate only 3-4 rows of 
hypertrophic cells were present, which all expressed osteopontin and had a slightly hyper-
mineralized matrix (Fig. 3B).  Thus, loss of Ror1 seems to affect the differentiation of a distinct 
subpopulation of hypertrophic cells and prehypertrophic chondrocytes.  Examination of P5 
specimens revealed a similar phenotype in the growth plate, with a hyper-mineralized matrix 
and reduced zones of Ihh and ColX expressing chondrocytes in the mutant (Fig. 3C).  In 
addition, we noticed in the skeletal preparations as well as in the sections that the formation of 
the secondary ossification center was delayed in Ror1 mutants (Fig. 3C and data not shown).    
 
Ror1 mutants show postnatal growth retardation and have a reduced life expectancy 
At postnatal day 2 Ror1 mutant pups could easily be identified by their reduction in size and 
weight (Fig. 4A, B).  Statistically significant reduction in the weight was apparent already at 
P1, however, the size reduction was less apparent at that age (Fig. 4A and data not shown).  
Within the first 6 postnatal days mutant pups reached only approximately 50% of the weight of 
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their heterozygous and wild-type littermates (Fig. 4A).  The life expectancy of the mutants was 
reduced, only 60% of the mutants (32/53) survived until weaning (Fig. 4C).  The reduced life 
expectancy might in part be due to the occasional kidney defects (see below) or physical 
weakness of the runted pups compared to their littermates.  Ror1-/- pups, which survived until 
after weaning stayed smaller and reached only 60-75% of the weight of their littermates (Fig. 
4D, F).  X-rays of 3 months old female mice suggested a decrease in bone density and in 
cortical thickness (Fig. 4D, see also inset).  This finding prompted us to examine volumetric 
bone mineral density (BMD) and bone geometry by peripheral quantitative computed 
tomography.  Femurs from Ror1-ablated male and female mice were characterized by reduced 
cross-sectional area, total BMD, and cortical thickness in the shaft and the metaphyseal region 
(Table 2).  Cortical bone osteopenia at the femoral shaft was more pronounced in females than 
in males (Table 2) (waer mir da aber nicht so sicher, denn bei n = 2 kann man eigentlcih wenig 
sagen, varianz in der male-Gruppe ist hoch).  Likewise, the reduction in weight and size was 
more prominent in females than in males at the age of 3 months (Fig. 4F and data not shown).  
Together, this suggests a possible involvement of sex hormones in the expressivity of the 
mutant phenotype.  Mutant males aged for 13-18 months still showed severe weight reduction 
(32-60%), however, the difference in size was relatively small (5-10%) compared to their 
littermate controls (Table 3).   
 
Abnormal ossifications develop in the spine of aged Ror1 mutants 
In alizarin red / alcian blue stained skeletal preparations of aged mutant mice (15-18 months) 
we observed abnormal mineralizations in the intervertebral discs of the lower thoracic region 
(n=2/2; T10-T13; arrow heads in Fig. 5A) and occasionally within un-fused sternal 
synchondroses (data not shown).  Abnormal ossifications within the axial skeleton could also be 
observed in microCTs of the lower thoracic spine of 15-18 months old male mice (n=2/3; 
arrows in Fig. 5B).  In addition, we noticed that there were abnormal ossifications between the 
spine and the proximal ends of the ribs (white arrowheads in Fig. 5C).  The reduction in cortical 
bone thickness was also visible in the microCTs of the ribs and vertebral bodies (Fig. 5C and 
data not shown).   
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IGFI serum levels are reduced in Ror1 mutants 
Given that the hole in the basisphenoid bone of Ror1-/- embryos was located directly below the 
pituitary gland (see Fig. 6A), we suspected that the postnatal growth retardation might be due to 
altered hormone production by the pituitary gland.  Thus, we examined the specification of 
different hormone producing cells using immunohisto-chemical stainings for growth hormone 
(GH), thyroid-stimulating hormone beta (TSHβ), luteinizing hormone alpha and beta (LHα, β) 
and adrenocorticotropin (ACTH) on E17.5 and P2 sagittal sections.  However, no obvious 
differences in hormone staining were detected between wild-type and Ror1 mutant pituitaries at 
both stages of development (Fig. 6A and data not shown).  Older pituitary glands of Ror1 
deficient animals were slightly hypoplastic and had a different shape compared to wild-type and 
heterozygous littermate controls (Fig. 6B and data not shown).  Western blots on pituitary gland 
extracts of P17 and P19 old littermates revealed, however, no difference in GH levels (Fig. 6C).  
Although GH production seemed not to be affected, its possible that the levels of secreted GH 
might be altered in Ror1-/- animals.  Since GH synthesis and release from pituitary 
somatotrophs is pulsatile, the serum GH levels fluctuate accordingly.  Thus, instead of 
measuring the serum GH levels we measured the serum levels of IGF-I, since they directly 
depend on GH levels.  The IGF-I levels were indeed reduced in 3 months old male and female 
Ror1 mutant animals (Fig. 6D).    
 
Urogenital defects in Ror1 mutant animals 
Approximately 90% of the Ror1 mutant females had an abnormal vagina with an imperforated 
hymen and could therefore not reproduce (Fig. 7A).  With age these Ror1-/- females 
accumulated liquid and cellular material in their uteri resulting in a swelling of the uteri and 
abdomen (Fig. 7B, C).  Almost all Ror1 mutant males tested could reproduce normal, but 3/7 
dissected Ror1-/- males showed abnormal seminal vesicles that were either cystic or solid and 
unilateral enlarged (Fig. 7D, D’).  Approximately 30% (5/17) of the Ror1-/- mice had abnormal 
kidneys, where double kidneys and double ureters were present unilateral (Fig. 7E).  All of the 
mutants with kidney defects had been found dead within the first week, with the exception of 
one male that was sacrificed at the age of 13 months that had a cystic right kidney (see Table 1).  
In addition to the urogenital defects, we noticed that the mutant animals had almost no 
subcutaneous fat and that the visceral fat pads associated with the urogenital system were also 
reduced in size (Fig. 7D, F).  
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Discussion 
In contrast to Ror2, loss-of Ror1 activity resulted only in minor skeletal defects, affecting 
primarily the sternum, the basisphenoid bone and the axial element C2 during embryonic 
development.  Ror1 and Ror2 have been implicated as co-receptors in Wnt-signaling and for 
Ror2 it was shown that it can modulate Gdf5/BMP receptor signaling (Green et al., 2008; 
Sammar et al., 2004).  As such it is interesting to note that a similar phenotype in the 
basisphenoid bone has been observed in embryos double mutant for Tcf4/Lef1 during 
development at E15.5 and in mutants for Bmp7 or conditional mutants of the Tgf-beta receptor 
2, Tgfbr2∆Col2, (Baffi et al., 2004; Brugmann et al., 2007; Jena et al., 1997).  Furthermore, it is 
interesting to note that double mutants for the heparan sulfate 6-O-endosulfatase genes Sulf1 
and Sulf2, which alter sulfate modification of heparan molecules in the extracellular matrix, 
showed a similar phenotype in the basisphenoid bone (Holst et al., 2007; Ratzka et al., 2008).  
In these mutants signaling of several growth factors (including Wnts, hedgehogs and fibroblast 
growth factors) is probably affected.  Mutants for Gli3∆699/∆699, which encodes only a N-
terminal truncated version of Gli3 solely acting as a repressor, also have a hole in the 
basisphenoid bone (Bose et al., 2002).  Fusions of sternebrae or ectopic mineralization within 
the fibrocartilage separating the sternebrae have been reported also in Sulf1/2 double mutants 
and in mutants for the TGFβ/BMP family members, Bmp5 and Gdf5 (Holst et al., 2007; Ratzka 
et al., 2008; Storm and Kingsley, 1996).  Thus given the phenotypic similarities it might be 
possible that in analogy to Ror2, Ror1 might not only interact with Wnt-ligands altering Wnt-
signaling, but might also modulate TGFβ/BMP signaling.  
Besides the patterning defects in certain skeletal elements, we noticed postnatal alterations in 
the growth plates of the long bones of Ror1 mutants.  Here the zones of prehypertrophic and 
hyperthrophic chondrocytes were reduced from postnatal day 2 onwards.  Based on our 
analyses, it seemed that primarily the zone of immature hypertrophic chondrocytes, in which 
the cells do not have a mineralized matrix nor do they express osteopontin, is severely reduced 
or maybe even lost.  This specific defect in chondrocyte maturation might contribute to the fact 
that the appearance of the secondary ossification centers was delayed as well.  Currently, we 
have no explanation for the molecular nature of the specific defect.  The previous study by 
Nomi and colleagues suggests that Ror1 has redundant functions with Ror2 during embryonic 
skeletal development (Nomi et al., 2001).  However, the study gave no insights into the 
underlying mechanism explaining the further shortening of the skeletal elements particularly in 
the stylopode region.  Ror2 seems to be regulating chondrocyte maturation primarily at the 
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level of prehypertrophic chondrocytes (Schwabe et al., 2004).  Our analysis suggests that in 
contrast to Ror2, Ror1 might be required at a slightly different step of chondrocyte maturation 
acting primarily in immature hypertrophic chondrocytes.  This could explain the additional 
decrease in overall length and of the mineralized zone of the stylopode elements, humerus and 
femur, upon loss of Ror1 in a Ror2 mutant background.  This would also explain why there was 
no significant effect on zeugopode elements such as ulna and radius upon additional removal of 
Ror1 (Nomi et al., 2001).  Here the differentiation of prehypertrophic and hypertrophic 
chondrocytes is already severely delayed in Ror2 single mutants, while it still occurs in the 
stylopode at E15.5 (Schwabe et al., 2004).  
In addition to the specific reduction in immature hypertrophic chondrocytes, the postnatal 
growth deficiency might in part be influenced by the reduction in IGF-I serum levels but is 
probably also influenced by sex hormones given that the differences in size are much more 
pronounced in females than in males.  Whether the reduced IGF-I serum levels are related to 
altered growth hormone production due to the morphological alteration in the basisphenoid 
bone and the associated pituitary gland deformation or if they might be due to local Ror1 
activity in IGF-I producing organs is currently unclear.  While Ror1 is expressed fairly broadly 
in the organism it is not expressed in the liver, which is the major site of IGF-I production (Al-
Shawi et al., 2001; Baskar et al., 2008).  Concomitantly, liver-specific deletion of Igf-1 does not 
affect growth of the appendicular skeleton (Sjogren et al., 2002; Yakar et al., 1999).  Local 
IGF-I production in the growth plate of the long bones is probably affected in Ror1 mutants, 
given the reduction in the hypertrophic zone that is the predominant region in which Igf-1 is 
transcribed postnatally (Reinecke et al., 2000; Smink et al., 2002).  IGF-I has been shown to 
stimulate hypertrophic chondrocyte differentiation (Mushtaq et al., 2004), thus a reduction in 
IGF-I producing hypertrophic chondrocytes might exaggerate the phenotype.  Our phenotypic 
analysis suggests that Ror1 activity is required for postnatal growth and hypertrophic 
chondrocyte differentiation and that the phenotype is possibly mediated in part via the GH/IGF-
I system.  Since Ror1 is fairly broadly expressed it is currently unclear to what extent the 
growth plate phenotype is due to a requirement of Ror1 activity particular in chondrocytes.  In 
addition, it is well known that cortical bone mass and size is severely reduced in IGF-I-ablated 
mice (Moerth et al. Endocrinology 2007).  Therefore, it remains to be determined whether the 
cortical bone osteopenia observed in Ror1 mutants is caused by lack of Ror1 and concomitantly 
reduced Wnt signaling in periosteal osteoblasts, or by an indirect effect through the GH/IGF-1 
axis. 
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Furthermore, our phenotypic analysis revealed a requirement for Ror1 in the urogenital system.  
The relatively low penetrance of the kidney defects makes it difficult to study the underlying 
mechanisms.  Interestingly, we noticed in Ror2 mutants a very similar kidney phenotype with 
double ureters, unilateral or bilateral double kidneys, cystic kidneys or even sporadically 
agenesis of one kidney in 30-40% of Ror2 mutants (C. Hartmann, unpublished observation).  
Thus, it is possible that Ror1 and Ror2 act redundantly in kidney development, although no 
defect in kidney development was reported in the double mutant analysis (Nomi et al., 2001).  It 
is possible that Ror1 and Ror2 modulate Wnt or TGF-β/BMP-signaling during kidney 
development as Wnt-signaling as well as TGF-β/BMP-signaling has been implicated at 
different aspects of kidney development (Martinez and Bertram, 2003; Pulkkinen et al., 2008).      
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Figure Legends 
 
Figure 1: Sternum defects in Ror1 mutant mice.  A) Schematic representation of the 
ossification centers in the sternum (colored in red), from rostral to caudal: manubrium, 
sternebrae (s) 1- 4, xyphoid process.  Alcian blue / alicarin red stained sterni with ribs of 
postnatal day 5 (P5) old wild-type (WT) and two Ror1 mutant animals.  B) Sections from E15.5 
old wild-type (Oliveira et al.) and mutant (a’-c’) embryos, stained with alcian blue and eosin (a, 
a’), hybridized with probes for Col2a1 (b, b’) and Ihh (c, c’).  Arrowheads in a-b’ indicate the 
normal (a, b) and abnormal shape and location of the sternal-costal junctions.  Arrowheads in c’ 
indicate the fused expression domain across two intercostals segments.  C) Sections from E17.5 
old wild-type (a-d) and mutant (a’-d’) embryos, stained with von Kossa / alcian blue (vK/AB), 
or hybridizied with probes for Col10a1 (b, b’), Osteopontin (Osp) (c, c’) and Ihh (d, d’).  
 
Figure 2:  Skull and vertebral defects in Ror1 mutant mice.  A) Cervical region of the axial 
skeleton of wild-type and Ror1-/- newborns, showing a widening of the C2 element or a split C2 
element with a dorsal floating piece (arrowheads).  B) Schematic view of the basal cranial 
bones (bo, basioccipitale, bs, basisphenoid, ps, presphenoid, eo exoccipitale) and ventral view 
on alcian blue / alizarin red stained skulls of wild-type and Ror1-/- newborns (PO), showing the 
cleft in the basisphenoid bone (arrow).  The magnified regions on the right show the 
exooccipitale bone of wild-type (WT) and Ror1-/- (M), with the arrowhead pointing at the cleft 
in the mutant.  C) Dorsal view on the alcian blue / alizarin red stained base of a wild-type and 
mutant P5 old skull, after removal of the ventral flat bones.  The arrow indicates the bony 
bridge between the basioccipitale and basisphenoid bone, the arrowhead points at the hole in 
the basisphenoid bone and the asterisks mark the vomeral bones.  D) Ventral view on alcian 
blue / alizarin red stained skulls of wild-type and Ror1-/- P19 old mice, with the arrow pointing 
at the bony bridge between the basioccipitale and basisphenoid bone. The magnified regions on 
the right show the exooccipitale bone of wild-type (WT) and Ror1-/- (M), with the arrowhead 
pointing at the hole in the mutant.  E) X-ray of 3 months old mice showing the round, dome-
like shape of the mutant skull in comparison to the wild-type.  F) MicroCT image of the cranial 
base of wild-type and mutant 18 months old animals, with the white arrowhead pointing at the 
synostosis of the basioccipitale and basisphenoid bones in the mutant. 
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Figure 3:  Postnatal growth plate phenotypes of Ror1 mutants showing the proximal end of the 
humerus of wild type and Ror1-/- at P0, P2 and P5.  A) P0 growth plate stained with von Kossa / 
alcian blue (AB) and hybridized with probes for Ihh, Col10a1 and osteopontin (Osp).  Note 
there is no difference between wild type and mutant at this stage.  Black bars indicate the zone 
of hypertrophic chondrocytes in the von Kossa / alcian blue staining and the Col10a1 positive 
zone.  B) P2 growth plate stained with von Kossa / alcian blue (AB) and hybridized with probes 
for Ihh, Col10a1 and osteopontin (Osp).  Note the reduced size of the Ihh and Col10a1 positive 
zones in the mutant compared to the wild type.  White bars indicate the zone of Col10a1 
positive hypertrophic chondrocytes.  C) P5 growth plate stained with von Kossa / alcian blue 
(AB) and hybridized with probes for Ihh, Col10a1 and osteopontin (Osp), showing reduced 
zones of Ihh and Col10a1 positive cells in the mutant.  Alizarin red (AR) / alcian blue (AB) 
stained wild-type (left) and mutant (right) humeri at P5, showing reduced or absent secondary 
ossification centers in the mutant (arrowheads). 
 
Figure 4:  Postnatal growth retardation and reduced survival of Ror1 mutant mice.  A) Bar 
graph showing weight reduction of the Ror1 mutants (n= 6-9) at postnatal days P1-P6 compared 
to their heterozygous (n= 8) and wild type (n= 8) littermates.  B) Pictures of P2 old pups 
showing size reduction of mutants compared to heterozygous littermate.  C) Kaplan Meier 
survival blot of Ror1 mutants (red line) compared to heterozygous and wild type littermates 
(green line) until weaning in percent survival.  D) X-ray picture of 3 months old Ror1-/- (left) 
and Ror1+/+ (right) female littermates showing size reduction (white arrows point at the tip of 
the tail) and reduced bone density and cortical thickness of the mutant femur (M) compared to 
the control (WT) in the inset.  E) Bar graphs showing weight reduction of mutant females and 
males at 3, 6, 8 and 14 weeks of age, compared to littermate controls.  
 
Figure 5:  Alterations in the aged skeleton.  A) Spines of 18 months old Ror1+/- and Ror1-/- 
males stained with alizarin red / alcian blue, showing abnormal mineralizations in the 
intervetebral discs (white arrowheads) between thoracic segments T10-T13 of the mutant.  B) 
MicroCTs of 18 months old Ror1+/+ and Ror1-/- males showing abnormal mineralizations in the 
intervetebral discs (black arrows) of the mutant spine.  C) MicroCTs of the same specimens 
showing abnormal mineralization in the costovertebral joint of the mutant (white arrowhead). 
Figure 6:  Analysis of the pituitary gland.  A) Sagittal sections through the skull and the 
pituitary gland of wild-type and Ror1-/- littermates at P0 stained with von Kossa / alcian blue 
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(AB) and at P2 stained with antibodies to hormones produced by specific subpopulations of the 
anterior lobe: growth hormone (GH), thyroid-stimulating hormone β subunit (TSHβ), 
luteinizing hormone α (LHα) and β (LHβ) subunits, and adrenocorticotropic hormone (ACTH).  
B) Morphological appearance of pituitary gland at P17.  C) Western blot for growth hormone 
(GH) and tubulin (tub) from P17 old males and females showing no significant differences in 
pituitary GH levels between mutants and littermate controls.  D) Blot of IGF serum levels from 
2-3 month old males and females, showing reduced IGF serum levels in Ror1-/- males and 
females (red bars) compared to littermate controls.  
 
Figure 7:  Non-skeletal defects in Ror1 mutant adult animals.  A) Abnormal vagina in the Ror1 
mutant female (on the right).  B) Swelling of the uteri in a Ror1 mutant female (on the right).  
C) Dissected uteri of wild-type and Ror1 mutant females.  D) Abnormal seminal vesicles (sv) in 
Ror1 mutant male (right side) and reduced urogenital fat pads (fp) attached to the testis (t).  D’) 
Fixed genital tract of a Ror1 mutant male, showing enlargement of one of the seminal vesicles.  
E)  Kidneys of wild-type (left) and Ror1 mutant (right) newborn animals, showing unilateral 
double kidney in the Ror1 mutant.  F) P18 old skinned wild-type (top) and Ror1 mutant 
(bottom) specimens, showing absence of subcutane white adipose tissue (arrows) in the mutant.   
 
Table 1:  Summery of the observed sternebrae fusion defects in mutant and control (Wt/Het) 
animals. 
 
Table 2:  Bone densitometry data of femurs of 3-4 months old mice. 
 
Table 3:  Comparison of weight and size in 13-18 months (M) old Ror1 mutants and 
littermates.  
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Tables: 
 
 
Table 1: Phenotypic variability of sternebrae fusions 
Genotype s4+s3 s4-s2 s4-s1 s4-manubrium 
Wt/Het (n=108)*  0  0 0  0 
Mut (n=35) 12 14 8 1 
 
* Occasionally a slight misalignment of sternum halves was observed (n=3; e.g. WT in Fig. 1C) 
 
Table 2: Bone densitometry data 
Genotype sex  age Cross-sect.  Total BMD  Trab. BMD  Cort. thick-  
  (wk) area (mm)  (mg/cm³) (mg/cm³) ness (mm) 
Femoral shaft 
Wt/Het (n=5)  F 15  1.78±0.09 713±37        - 0.230±0.009 
Mut (n=2)  F 15  1.44±0.11 628±4         - 0.188±0.002 
 
Het (n=2)  M 14  2.54±0.03 660±7         - 0.247±0.005 
Mut (n=2)  M 14  1.94±0.08 645±84        - 0.219±0.014 
 
Femoral metaphysis 
Wt/Het (n=5)  F 15  3.35±0.30 509±29 172±14 0.211±0.013 
Mut (n=2)  F 15  2.75±0.51 420±6  153±12 0.149±0.014 
 
Het (n=2)  M 14  4.20±0.02 510±47 228±25 0.226±0.032 
Mut (n=2)  M 14  3.24±0.40 427±70 172±17 0.155±0.028 
 
BMD = bone mineral density, Cort. = cortical, wk = weeks, F = female, M = male 
 
Table 3: Weight and size of aged male animals 
Genotype age (M) weight (g) size (cm) 
Het 18 46 18.2 
Mut 18 29 17.5 
Wt 16  52 18.7 
Het 16  51 19 
Mut 16 35 18 
Wt 15  41 18.5 
Het 15 42 18.5 
Mut 15 23 16.5 
Het 13 45 17.7 
Mut* 13 18 16 
 
*Cystic right kidney, left seminal vesicle enlarged 
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